Browse Trials
Find Breast Cancer Clinical Trials That Are Right For You
The clinical trials listed below are open in the U.S. for people with DCIS (stage 0), stage 1, stage 2, stage 3, or stage 4 (metastatic)
breast cancer. Clinical trials are available for people who are newly diagnosed with breast cancer, currently in treatment, experiencing
breast cancer recurrence, living with metastatic disease, as well as breast cancer survivors who have completed treatment.
Use the search box and filters to find a trial that’s right for you.
Currently viewing trials
(Last updated: March 10, 2026)
Close
Treatment
Brain Mets
BRCA1/2 (inherited)
Chemotherapy
Hormone Therapy
Leptomeningeal Disease
Radiation Oncology
Surgery
Surgery: Reconstruction
Targeted Therapy: All
Targeted Therapy: ADC
Targeted Therapy: Anti-HER2 Therapy
Targeted Therapy: CDK Inhibitors
Targeted Therapy: PARP Inhibitors
Targeted Therapy: Tumor Mutations
Targeted Therapy: Other Targeted Therapy
Vaccines and Immunotherapy
Other Treatment
Non-Treatment
Activities
Complementary and Integrative Medicine
Decision Support
Diagnosing Breast Cancer
Genetics/Family History
Having Children
Healthy/High Risk
Imaging
Lymphedema
Managing Side Effects
No Travel Required
Predicting Response to Treatment
Preventing Breast Cancer
Preventing Recurrence
Support/Education
Surveys/Interviews/Registries
Close
AKT
ALK
AR
BARD1
BRCA1/2 (tumor)
BRIP1
CD205
CD70
CHEK2 or CHEK1
dMMR/MSI-H
ESR1
FGFR
HER2/ERBB2
HLA
MET or C-Met
NTRK
PALB2
PIK3CA or PI3K
PTEN
RAD51
RAF (including BRAF)
RAS (KRAS or NRAS)
RB
ROS1
TP53
Click here to view online studies and trials that do not require site visits
1
NEAREST SITE: 2 miles
Zuckerberg San Francisco General
San Francisco,CA
VISITS: Up to 2 to 4 times per month for 1 year
PHASE: NA
NCT ID: NCT05297734
Supportive Cancer Care Delivered Virtually or by a Health Worker for Stage 0-IV Breast Cancer
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer Scientific Title
Purpose
To compare a technology-based supportive cancer care approach with a team-based supportive cancer care approach.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV breast cancer that is newly diagnosed or whose cancer has come back.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational materials, virtual, weekly for 4 months, then every 2 weeks for 8 months</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational materials, in person or by phone, weekly for 4 months, then every 2 weeks for 8 months</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The educational materials are designed to assist with advance care planning and symptom management. Topics include surrogate decision-makers, advance directives, and physician orders for life-sustaining treatment. The education is delivered to the participant by an electronic health record message or email, or by a lay health worker. </li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05297734' target='_blank'>ClinicalTrials.gov</a> </li></ul>
2
NEAREST SITE: 2 miles
Zuckerberg San Francisco General Hospital
San Francisco,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06648278
Virtual Support and Navigation for People with Stage I-IV Breast Cancer
The Patient Care Outreach, Navigation, Technology and Support 2.0 Study (COUNTS2) Scientific Title
Purpose
To study a virtual patient navigation program to support people with breast cancer.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have not yet started treatment or are currently receiving treatment. You must speak English, Mandarin/Cantonese/Chinese, or Spanish.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will complete the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Participate in patient navigation program, online or in-person</li> <li class="seamTextUnorderedListItem">Participate in focus groups</li> <li class="seamTextUnorderedListItem">Complete questionnaires, 2 times in 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The focus groups will be used to develop parts of the program specific to culture and language.</li> <li class="seamTextUnorderedListItem">While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.</li> <li class="seamTextUnorderedListItem">Your family member may also be asked to participate in this study.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06648278' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://patientcounts.ucsf.edu/s/About?language=en_CA' target='_blank'>University of California San Francisco: Patient COUNTS</a> </li></ul>
3
NEAREST SITE: 3 miles
University of California, San Francisco
San Francisco,CA
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT06215469
Portable Scalp Cooling System to Reduce Hair Loss During Chemotherapy for Stage I-III Breast Cancer
Amma™ Portable Scalp Cooling System (PSCS) Study: A Post-market Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Early-stage Breast Cancer (Cooler Heads) Scientific Title
Purpose
To study the ability of the AMMA Portable Scalp Cooling System to reduce hair loss in people receiving chemotherapy.
Who is this for?
People with stage I, stage II, or stage III breast cancer who are planning to receive paclitaxel (Taxol®) or docetaxel (Taxotere®) chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Photographs of your hair</li> <li class="seamTextUnorderedListItem">Wear the AMMA Portable Scalp Cooling System 30 minutes before, during, and 2.5 hours after every chemotherapy visit</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">Photographs of your hair</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many chemotherapy medications cause hair loss.</li> <li class="seamTextUnorderedListItem">The AMMA Portable Scalp Cooling System is a small refrigeration device that is designed to reduce hair loss. It circulates liquid coolant at low pressure through a cooling cap on your head.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06215469' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://coolerheads.com/#how-amma-works' target='_blank'>Amma Portable Scalp Cooling System</a> </li></ul>
4
NEAREST SITE: 3 miles
Zuckerberg San Francisco General
San Francisco,CA
VISITS: Up to 2 visits every month for 6 months
PHASE: NA
NCT ID: NCT06633926
Nutrition, Yoga, and Healing Touch Program to Improve Quality of Life for Stage I-III Breast Cancer
Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study (Aim 2) (IACS3) Scientific Title
Purpose
To study if the Ayurveda nutrition, yoga, and healing touch program improves quality of life and cancer-associated symptoms.
Who is this for?
People with stage I, stage II, or stage III breast cancer who completed treatment less than 3 years ago. You must have received chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Ayurveda (nutrition, yoga, healing touch) program, in person, 2 times every month for 6 months</li> <li class="seamTextUnorderedListItem">Virtual meeting, monthly for 6 months (optional)</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Health education program, virtual, 2 times every month for 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Ayurveda program includes nutrition education, lifestyle practices, yoga, and therapeutic touch to help the body and mind feel balanced.</li> <li class="seamTextUnorderedListItem">The health education program includes interactive videos based on the latest science in cancer survivorship.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06633926' target='_blank'>ClinicalTrials.gov</a> </li></ul>
5
NEAREST SITE: 3 miles
Kaiser Permanente-San Francisco
San Francisco,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05896189
Computer Games to Improve Thinking for People with Stage I-III Breast Cancer
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors: A Multi-Center Randomized Double-Blinded Controlled Trial Scientific Title
Purpose
To study how well computer games improve thinking problems.
Who is this for?
People with stage I, stage II, or stage III breast cancer who have completed treatment 6 months to 5 years ago. You must be experiencing problems thinking.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Computer games designed to improve thinking skills</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 9 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General computer games</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 9 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognition is your ability to think.</li> <li class="seamTextUnorderedListItem">Problems with thinking, called cognitive impairment, can happen during and after breast cancer treatment.</li> <li class="seamTextUnorderedListItem">These problems can last for years and can affect a person's ability to work or participate in social activities.</li> <li class="seamTextUnorderedListItem">The computer games may help re-organize the connections of nerve cells in the brain to improve thinking ability.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05896189' target='_blank'>ClinicalTrials.gov</a> </li></ul>
6
NEAREST SITE: 22 miles
Contra Costa Regional Medical Center
Martinez,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06112613
Mobile Health Tools to Help Take Medication as Prescribed for People with Metastatic Breast Cancer
Improving Medication Adherence in Metastatic Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP) Scientific Title
Purpose
To study if WiseBag and CONCURxP mobile health tools will improve the ability of people to take their medication as prescribed compared to WiseBag alone.
Who is this for?
People with metastatic (stage IV) hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who are planning to receive a CDK4/6 inhibitor or started receiving a CDK4/6 inhibitor within the past month.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Enhanced Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">WiseBag, 1 year</li> <li class="seamTextUnorderedListItem">Educational materials, monthly for 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">WiseBag, 1 year</li> <li class="seamTextUnorderedListItem">CONCURxP, 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li> <li class="seamTextUnorderedListItem">Interviews, 6 months after completing study</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">CDK4/6 inhibitors need to be taken as prescribed to receive the best benefit.</li> <li class="seamTextUnorderedListItem">Using WiseBag and CONCURxP may reduce forgetfulness for taking medications.</li> <li class="seamTextUnorderedListItem">WiseBag is a lunch box sized medication monitoring device that holds and monitors medications.</li> <li class="seamTextUnorderedListItem">The CONnected CUstomized Treatment Platform (CONCURxP) includes personalized text message reminders for missed medications, monitoring of the medications you take, and notifications to doctors about missed doses.</li> <li class="seamTextUnorderedListItem">CONCURxP sends a text message when a medication is not taken when it should be.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06112613' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/staying-on-track-with-treatment' target='_blank'>Breastcancer.org: Following Your Treatment Plan</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/targeted-therapy/what-are-cdk46-inhibitors' target='_blank'>Breastcancer.org: CDK4/6 Inhibitors</a> </li></ul>
7
NEAREST SITE: 336 miles
University of California at Los Angeles
Los Angeles,CA
VISITS: 1 visit
PHASE: NA
NCT ID: NCT04297020
Studying the Effects of Anti-Estrogen Therapy on the Brain of Women with Stage I-III Breast Cancer
Brain Health in Breast Cancer Survivors: Interaction of Menopause and Endocrine Therapy Scientific Title
Purpose
To see if anti-estrogen therapy affects brain health.
Who is this for?
Women between the ages of 35 and 65 with stage I, stage II, or stage III breast cancer who are taking hormone therapy after surgery. This trial is also enrolling women who have never been diagnosed with breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">1 Brain fMRI (functional MRI)</li> <li class="seamTextUnorderedListItem">Cognitive testing</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial will use an advanced brain MRI technique called functional MRI (fMRI).</li> <li class="seamTextUnorderedListItem">fMRI measures changes in blood flow that happen during mental activity. </li> <li class="seamTextUnorderedListItem">Research suggests that the cognitive issues experienced by some women who receive treatment for breast cancer--also called <q>chemo brain</q>--may actually be caused by anti-estrogen therapy and not chemotherapy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04297020' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.medscape.com/viewarticle/932091' target='_blank'>MedScape: In Breast Cancer, Is Chemobrain Really Endocrine Brain?</a> </li><li class='seamTextUnorderedListItem'><a href='https://en.wikipedia.org/wiki/Functional_magnetic_resonance_imaging' target='_blank'>Wikipedia: Functional MRI</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.radiologyinfo.org/en/info.cfm?pg=fmribrain' target='_blank'>RadiologyInfo.org: fMRI</a> </li></ul>
8
NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT05595499
Fisetin to Improve Physical Function in Older Women After Chemotherapy
A Phase II Randomized Double-Blind Placebo-Controlled Study of Fisetin to Improve Physical Function in Frail Older Breast Cancer Survivors Scientific Title
Purpose
To study whether fisetin improves physical function in older women after treatment with chemotherapy.
Who is this for?
Women who were at least 65 years old and postmenopausal when diagnosed with stage I, stage II, or stage III breast cancer. You must have completed chemotherapy within the last year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Additional Procedures</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Grip strength test</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin is a naturally occurring substance that is found in strawberries and other foods.</li> <li class="seamTextUnorderedListItem">Fisetin eliminates cells that have stopped dividing but have not died.</li> <li class="seamTextUnorderedListItem">Chemotherapy causes a build-up of these cells which may cause inflammation. damage nearby healthy cells, and cause reduced physical function.</li> <li class="seamTextUnorderedListItem">Improving physical function is also called improving frailty.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05595499' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://restorativemedicine.org/digest/fisetin-powerful-polyphenol-supports-healthy-aging/' target='_blank'>Association for the Advancement of Restorative Medicine: Fisetin</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.urmc.rochester.edu/news/story/frailty-in-cancer-patients-young-and-old-is-linked-to-inflammation' target='_blank'>University of Rochester: Frailty and Breast Cancer</a> </li></ul>
9
NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05978128
Increasing Breast Cancer Screening Using Advocates and Supporters
Utilizing Spheres of Influence to Increase Cancer Screening: Empowering Community Health Advocates Scientific Title
Purpose
To investigate why some people may receive breast cancer screening but not lung cancer screening and to determine if advocates and supporters can increase screening.
Who is this for?
People at least 40 years old who do not currently have cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Access to online educational materials, 3 times within 2 years</li> <li class="seamTextUnorderedListItem">Meet with a patient navigator</li> <li class="seamTextUnorderedListItem">Education materials to share with friends/family on benefits of breast cancer screening</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Breast cancer screening with mammography is widely accepted and commonly used.</li> <li class="seamTextUnorderedListItem">Advocates and supporters of lung cancer screening may increase the willingness to receive this screening.</li> <li class="seamTextUnorderedListItem">This trial also includes lung cancer screening.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05978128' target='_blank'>ClinicalTrials.gov</a> </li></ul>
10
NEAREST SITE: 336 miles
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT06113016
Fisetin Supplement and Exercise to Improve Health After Treatment for Postmenopausal Women with Stage I-III Breast Cancer
A Phase II Randomized Placebo-Controlled Study of Fisetin and Exercise to Prevent Frailty in Breast Cancer Survivors (PROFFi) Scientific Title
Purpose
To study how well fisetin, a nutritional supplement, and exercise prevent frailty (weakness).
Who is this for?
Postmenopausal women with stage I, stage II, or stage III breast cancer who have received chemotherapy within the last year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 4 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Fisetin and Exercise Education Materials</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Handout on the importance of physical activity</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Fisetin and Exercise Program</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Supervised exercise training, 3 sessions every week for 4 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Placebo and Exercise Program</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Supervised exercise training, 3 sessions every week for 4 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4: Placebo and Exercise Education Materials</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for fisetin, by mouth, 3 days every 2 weeks for 4 months</li> <li class="seamTextUnorderedListItem">Handout on the importance of physical activity</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Frailty is marked by low strength, low energy, slowed walking speed, low physical activity, and/or unintentional weight loss.</li> <li class="seamTextUnorderedListItem">In this study, frailty is measured by walking speed.</li> <li class="seamTextUnorderedListItem">Fisetin is a natural substance found in strawberries and other foods and is available as a nutritional supplement.</li> <li class="seamTextUnorderedListItem">Fisetin may help reduce inflammation and improve outcomes in people with breast cancer who are exercising.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06113016' target='_blank'>ClinicalTrials.gov</a> </li></ul>
11
NEAREST SITE: 336 miles
UCLA Kaiser Permanente Center for Health Equity
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05298605
Faith in Action: Church-Based Education and Navigation to Increase Breast Cancer Screening in Korean Women
Faith in Action! A Cluster-Randomized Trial to Evaluate the Efficacy of a Church-based Navigation Model to Increase Breast Cancer Screening Among Korean Women in Los Angeles Scientific Title
Purpose
To study if the Faith in Action cancer screening education and navigation curriculum increases breast cancer screening among Korean American women.
Who is this for?
Korean women at least 45 years old who do not have breast cancer, have not received a screening mammogram in the last 2 years, and are members of participating Korean churches in Los Angeles, California.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Faith in Action cancer screening education and navigation curriculum</li> <li class="seamTextUnorderedListItem">American Cancer Society Screening Guidelines pamphlet</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Presentation on physical activity and nutrition</li> <li class="seamTextUnorderedListItem">American Cancer Society Screening Guidelines pamphlet</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Faith in Action is a curriculum designed to deliver cancer education and increase motivation to participate in breast cancer screening through proven approaches such as one-on-one education, small media, and workshops.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05298605' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://ucla.clinicaltrials.researcherprofiles.org/trial/NCT05298605' target='_blank'>UCLA: Faith in Action</a> </li></ul>
12
NEAREST SITE: 341 miles
Cedars-Sinai Medical Center
Los Angeles,CA
VISITS: 2 visits within 6 months
PHASE: I
NCT ID: NCT06123286
Tart Cherry Concentrate and Fish Oil for Joint Pain Due to Aromatase Inhibitors for Women With Stage I-III Breast Cancer
An Open Label, Randomized, Waitlist Controlled Trial of Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms Scientific Title
Purpose
To study whether Tart Cherry concentrate and fish oil received together have beneficial effects on joint pain and function.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are receiving an aromatase inhibitor, have a BMI >27, and joint pain.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Tart Cherry Concentrate, by mouth, daily for 3 months</li> <li class="seamTextUnorderedListItem">Omega 3 Fish Oil, by mouth, daily for 3 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No supplements</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Tart Cherry concentrate and fish oil after the study is complete (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Joint pain is one side effect of aromatase inhibitors. Aromatase inhibitors are letrozole (Femara®), anastrozole (Arimidex®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Tart Cherry concentrate and fish oil can help with joint stiffness in general.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06123286' target='_blank'>ClinicalTrials.gov</a> </li></ul>
13
NEAREST SITE: 341 miles
Cedars-Sinai Medical Center
West Hollywood,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT04722341
Time-Restricted Eating to Reduce Treatment Side Effects for People with Stage II-III Breast Cancer
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators Scientific Title
Purpose
To study the effects (good and bad) and anti-cancer activity of time-restricted eating (TRE) during treatment before surgery.
Who is this for?
People with stage II or stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time-restricted eating (TRE) schedule, 8 hour daily eating period, 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Regular eating schedule, 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fasting may protect healthy cells from chemotherapy and radiation side effects.</li> <li class="seamTextUnorderedListItem">Time-restricted eating (TRE) involves eating within a period of 10 hours or less, followed by fasting for at least 14 hours daily.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04722341' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/research-news/can-fasting-reduce-recurrence-risk' target='_blank'>Breastcancer.org: Can Fasting 13 Hours or More at Night Reduce Recurrence Risk?</a> </li></ul>
14
NEAREST SITE: 348 miles
USC / Norris Comprehensive Cancer Center
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06422455
Genetic Testing Education for People with Stage 0-IV Breast Cancer
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent Scientific Title
Purpose
To gather feedback about genetic testing education with a computer-generated character as an alternative to standard of care genetic testing education with a human genetic counselor.
Who is this for?
People diagnosed with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer before age 50, people with breast cancer in both breasts, people with triple negative (ER-, PR-, HER2-) breast cancer, or men with breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Genetic testing education with PERLA, computer-generated character, 1 time before testing</li> <li class="seamTextUnorderedListItem">Genetic counseling with genetic counselor, 1 time after testing</li> <li class="seamTextUnorderedListItem">Interview</li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Genetic testing education with genetic counselor, 1 time before testing</li> <li class="seamTextUnorderedListItem">Genetic counseling with genetic counselor, 1 time after testing</li> <li class="seamTextUnorderedListItem">Survey</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The computer-generated character in Group 1 is called a patient-facing relational agent (PERLA).</li> <li class="seamTextUnorderedListItem">Many people with cancer are recommended to receive genetic testing as standard of care.</li> <li class="seamTextUnorderedListItem">Lack of access to genetic counseling and testing is one reason people may not receive genetic testing.</li> <li class="seamTextUnorderedListItem">Education about genetic testing before recieving testing in both English and Spanish may lead to better access to genetic testing.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06422455' target='_blank'>ClinicalTrials.gov</a> </li></ul>
15
NEAREST SITE: 348 miles
USC / Norris Comprehensive Cancer Center
Los Angeles,CA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06297265
Manual Breast Massage to Reduce Treatment Side Effects for Women with Stage 0-III Breast Cancer
Feasibility and Effects of Manual Lymphatic Drainage (MLD) Breast Massage in Breast Cancer Patients Undergoing Adjuvant Radiation Therapy Scientific Title
Purpose
To study the ability of manual lymphatic drainage breast massage to reduce treatment related side effects.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have received a lumpectomy and are planning to receive radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Manual lymphatic drainage breast massage, 2 times every week for 2-3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lumpectomy and radiation can lead to side effects including swelling called lymphedema, pain, reduced quality of life, and poor body image. </li> <li class="seamTextUnorderedListItem">Manual lymphatic drainage is a gentle massage technique used to reduce swelling. It may be a safe and effective way to reduce treatment related side effects after lumpectomy and radiation.</li> <li class="seamTextUnorderedListItem">Manual means you will be giving yourself the massage.</li> <li class="seamTextUnorderedListItem">Each massage is 30-60 minutes.</li> <li class="seamTextUnorderedListItem">You will be asked to complete the massage during radiation and for 1 month after radiation.</li> <li class="seamTextUnorderedListItem">A lumpectomy is sometimes called a partial mastectomy.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06297265' target='_blank'>ClinicalTrials.gov</a> </li></ul>
16
NEAREST SITE: 353 miles
City of Hope Medical Center
Duarte,CA
VISITS: 5 visits in 2 years
PHASE: III
NCT ID: NCT06763328
Metformin for Insulin Resistance After Chemotherapy for Women with Stage I-III Breast Cancer
Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer Scientific Title
Purpose
To study the ability of metformin to help treat insulin resistance after completing chemotherapy.
Who is this for?
Women with stage I, stage II, or stage III estrogen receptor negative (ER-) breast cancer who completed chemotherapy between 1 month and 3 years ago. You must not have diabetes.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Metformin with Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Metformin, by mouth, daily for 1 year</li> <li class="seamTextUnorderedListItem">Healthy diet and exercise handouts</li> <li class="seamTextUnorderedListItem">Blood samples, 5 times in 2 years </li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Healthy diet and exercise handouts</li> <li class="seamTextUnorderedListItem">Blood samples, 5 times in 2 years</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Insulin resistance occurs when cells stop responding to insulin and is a risk factor for developing diabetes and heart disease. </li> <li class="seamTextUnorderedListItem">Higher levels of insulin are related to aggressive breast cancer. </li> <li class="seamTextUnorderedListItem">Metformin decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body's use of the glucose. </li> <li class="seamTextUnorderedListItem">Giving metformin with usual care may be more effective than usual care alone in preventing or reversing insulin resistance in women with stage I-III breast cancer after chemotherapy.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06763328' target='_blank'>ClinicalTrials.gov</a> </li></ul>
17
NEAREST SITE: 353 miles
City of Hope Medical Center
Duarte,CA
VISITS: 2 times within 2 months
PHASE: II
NCT ID: NCT06731894
Phytocannabinoids for Reducing Chemotherapy-Induced Peripheral Neuropathy for Stage I-III Breast Cancer
A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy Scientific Title
Purpose
To study whether phytocannabinoids reduce long-term chemotherapy-induced peripheral neuropathy.
Who is this for?
People with stage I, stage II, or stage III breast cancer who completed treatment with a taxane or platinum chemotherapy at least 6 months ago and who are experiencing neuropathy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">CBD, by mouth, daily for 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">THC:CBD, by mouth, daily for 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Standard of care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo, by mouth, daily for 2 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chemotherapy-induced peripheral neuropathy is pain, tingling, numbness, and motor weakness caused by damage to nerves by some types of chemotherapy. </li> <li class="seamTextUnorderedListItem">Phytocannabinoids are compounds made by the cannabis plant, such as THC and CBD, that can treat chronic pain. Phytocannabinoids may be effective in reducing chronic chemotherapy-induced peripheral neuropathy.</li> <li class="seamTextUnorderedListItem">Taxanes are paclitaxel (Taxol®) and docetaxel (Taxotere®).</li> <li class="seamTextUnorderedListItem">Platinum chemotherapy drugs are cisplatin, oxaliplatin (Eloxatin®), and carboplatin (Paraplatin®).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06731894' target='_blank'>ClinicalTrials.gov</a> </li></ul>
18
NEAREST SITE: 353 miles
City of Hope Medical Center
Duarte,CA
VISITS: 3 visits in 3 months
PHASE: II
NCT ID: NCT06538389
CBD for Joint Pain During Hormone Therapy for Women with Stage 0-III Breast Cancer
High Cannabidiol (CBD) Standardized Extract for Aromatase Inhibitor-Induced Arthralgia - A Randomized Controlled Double Blind Clinical Trial Scientific Title
Purpose
To study the ability of BC-001, a cannabidiol (CBD) plant extract, to reduce joint pain during hormone therapy.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or some stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed treatment. You must be receiving an aromatase inhibitor and experiencing joint pain.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">BC-001, by mouth, daily, up to 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Placebo</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for BC-001, by mouth, daily, up to 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women on aromatase inhibitor (AI) therapy may experience joint stiffness, pain and arthritis symptoms as a side effect of the medication.</li> <li class="seamTextUnorderedListItem">Some women stop AI therapy due to these side effects and do not receive the maximum benefit from the medication.</li> <li class="seamTextUnorderedListItem">BC-001 is an experimental cannabidiol (CBD) plant extract.</li> <li class="seamTextUnorderedListItem">CBD is derived from the same plant family as marijuana but is not associated with a <q>high</q> or mind-altering effect and is not habit-forming.</li> <li class="seamTextUnorderedListItem">CBD might decrease inflammation in joint tissues and may help reduce chronic pain.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06538389' target='_blank'>ClinicalTrials.gov</a> </li></ul>
19
NEAREST SITE: 374 miles
Chao Family Comprehensive Cancer Center, University of California Irvine
Orange,CA
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT06580002
Riluzole to Improve Cognition After Treatment for People with Stage I-III Breast Cancer
Repurposing Riluzole for Augmenting Brain-Derived Neuropathic Factor (BDNF) Levels and Cognitive Function in Breast Cancer Patients Experiencing Cancer-Related Cognitive Impairment: an Interventional Pilot Clinical Trial Scientific Title
Purpose
To study if riluzole (Rilutek®) changes the amount of brain derived neurotrophic factor (BDNF) in your body, which is related to changes in cognition (ability to think).
Who is this for?
People with stage I, stage II, or stage III breast cancer who have cognitive (thinking) issues.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Riluzole (Rilutek®), by mouth, daily for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Placebo</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for riluzole, by mouth, daily for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognition is your ability to think.</li> <li class="seamTextUnorderedListItem">Brain derived neurotrophic factor (BDNF) is a protein that is involved with thinking (cognition) and learning.</li> <li class="seamTextUnorderedListItem">Changing the amount of brain derived neurotrophic factor (BDNF) in your body may improve your cognition.</li> <li class="seamTextUnorderedListItem">Riluzole (Rilutek®) is a drug used to treat ALS (Lou Gehrig's disease), but it may also be helpful to improve cognition. Its use in this trial is considered experimental.</li> <li class="seamTextUnorderedListItem">This trial is also available in Chinese, Korean, Vietnamese, and Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06580002' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mayoclinic.org/drugs-supplements/riluzole-oral-route/description/drg-20065853' target='_blank'>Mayo Clinic: Riluzole (Rilutek®)</a> </li></ul>
20
NEAREST SITE: 441 miles
UCSD
San Diego,CA
VISITS: 2 visits within 4 months
PHASE: NA
NCT ID: NCT07071896
Strong Survivor Virtual Exercise Program for Older Women with Stage 0-III Breast Cancer
Strong Survivors: A Prospective Study of Video-assisted Exercise Program for the Geriatric Breast Cancer Patient Scientific Title
Purpose
To study the effects of the Strong Survivor exercise program on quality of life, fitness, and other physical measurements.
Who is this for?
Women, age 65 and older, with stage 0, stage I, stage II, or stage III breast cancer who received a mastectomy in the last month.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Strong Survivor exercise program, virtual, twice a week for 4 months</li> <li class="seamTextUnorderedListItem">Fitness measurements, 2 times within 4 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Strong Survivor is a 16-week, virtual program with three core components: aerobic fitness, balance and mobility, and muscle strength and power.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07071896' target='_blank'>ClinicalTrials.gov</a> </li></ul>
21
NEAREST SITE: 533 miles
OHSU Knight Cancer Institute
Portland,OR
VISITS: 4 visits within 6 months
PHASE: II
NCT ID: NCT06049355
Exercise Program for Couples to Improve Physical and Mental Health During Radiation for Stage I-III Breast Cancer
EMBark on RAdiation Therapy With a Clinic-based Exercise Program: EXERCISING TOGETHER (EMBRACE) Scientific Title
Purpose
To study how well the Exercising Together program prevents declines in physical and mental health in couples where one partner is receiving radiation.
Who is this for?
People with stage I, stage II, or stage III breast cancer who are planning to receive or receiving radiation and live with a partner who is willing to participate in the study.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercising Together program, 6 months</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests, 4 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational materials about exercise</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Physical tests, 4 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Treatments for cancer including radiation can cause side effects such as fatigue and can put a strain on relationships. </li> <li class="seamTextUnorderedListItem">Exercising Together is an exercise program for both people in the relationship that adds communication, collaboration, and support to the exercise program and is designed to strengthen the relationship and increase the benefits of exercise. </li> <li class="seamTextUnorderedListItem">The Exercising Together program may improve the mental and physical health of couples when one person is receiving radiation treatment for cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06049355' target='_blank'>ClinicalTrials.gov</a> </li></ul>
22
NEAREST SITE: 602 miles
Huntsman Cancer Institute at University of Utah
Salt Lake City,UT
VISITS: Number of visits unavailable
PHASE: III
NCT ID: NCT07166042
Guided Meditation to Reduce Anxiety During Radiation for Stage 0-III Breast Cancer
Med-RT BG: An Interventional Trial Using Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies Scientific Title
Purpose
To study the effect of brief mindfulness-guided meditations during radiation on feelings of anxiety.
Who is this for?
People with stage 0 (DCIS), I, stage II, or stage III breast cancer who are planning to receive 15-25 daily breast radiation treatments. You must not be planning to receive deep inspiration breath hold treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Guided meditation, by audio, 10 to 15 minutes</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No intervention</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The mindfulness-guided meditation recordings teach you several practices aimed at reducing anxiety, including directing non-judgmental attention to different parts of the body, focusing on breathing, accepting negative thoughts, and shifting attention to pleasant thoughts.</li> <li class="seamTextUnorderedListItem">Deep inspiration breath hold treatment is when you hold your breath briefly while the radiation is delivered. Holding your breath protects your heart by moving it out of the way of the radiation.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07166042' target='_blank'>ClinicalTrials.gov</a> </li></ul>
23
NEAREST SITE: 602 miles
University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences
Salt Lake City,UT
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06305312
Referral for Assistance with Basic Needs After an Abnormal Mammogram
Community Services Navigation to Advance Health Equity in Breast Cancer Screening (B-SINCERE) Scientific Title
Purpose
To study if connecting people to assistance with food, housing, utilities, and transportation increases follow-up after an abnormal mammogram result.
Who is this for?
People with an abnormal result after a mammogram who have not been diagnosed with breast cancer and need support with food, housing, utilities, and/or transportation. You must live in or near Salt Lake City, Utah.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Referral to United Way of Salt Lake's community referral services (SINCERE)</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard referral to community resources</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women with greater need for food, housing, utilities, and transportation are about half as likely to follow up after an abnormal mammogram than women without such needs.</li> <li class="seamTextUnorderedListItem">This trial is studying the United Way of Salt Lake's community referral services (SINCERE) intervention, which connects people to assistance with these needs.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06305312' target='_blank'>ClinicalTrials.gov</a> </li></ul>
24
NEAREST SITE: 602 miles
Huntsman Cancer Institute at University of Utah
Salt Lake City,UT
VISITS: Number of visits unavailable, up to 2 years
PHASE: NA
NCT ID: NCT07120100
Non-Invasive Brain Stimulation for Nerve Pain Due to Chemotherapy for Women with Stage I-III Breast Cancer
Repetitive Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Breast and Gynecologic Cancer Survivors: A Pilot Study Scientific Title
Purpose
To study if repetitive transcranial magnetic stimulation (rTMS) can reduce nerve pain due to chemotherapy.
Who is this for?
Women with stage I, stage II, or stage III breast cancer with nerve pain that started within 1 month of receiving certain chemotherapy drugs and has not gotten better with pain medication. You must have completed active treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Repetitive Transcranial Magnetic Stimulation (rTMS), 10 times within 2 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some types of chemotherapy can cause nerve pain due to nerve damage. This is called peripheral neuropathy.</li> <li class="seamTextUnorderedListItem">Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive way to stimulate nerve cells in the brain.</li> <li class="seamTextUnorderedListItem">You must have received at least one of the following chemotherapy drugs: paclitaxel (Taxol®), docetaxel (Taxotere®), cisplatin, oxaliplatin (Eloxatin®), carboplatin (Paraplatin®), vinblastine (Velban®), vincristine (Oncovin®), vinorelbine (Navelbine®), vinflunine (Javlor®).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07120100' target='_blank'>ClinicalTrials.gov</a> </li></ul>
25
NEAREST SITE: 650 miles
Mayo Clinic in Arizona
Phoenix,AZ
VISITS: At least 2 visits within 6 months
PHASE: NA
NCT ID: NCT04816006
Exercise to Improve Thinking Ability After Treatment for Women with Stage I-III Breast Cancer
Enhancing Cognitive Function in Breast Cancer Survivors Through Community-based Exercise Training (BRAIN) Scientific Title
Purpose
To study whether an exercise program improves cognitive function (the ability to think).
Who is this for?
Postmenopausal women with stage I, stage II, or some stage III breast cancer who have completed treatment between 3 months ago and 2 years ago. You must regularly perform at least 20 minutes of exercise up to 2 days every week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised exercise sessions, 20 sessions within 6 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Wear an accelerometer</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions, in-person or virtual, monthly for 9 months</li> <li class="seamTextUnorderedListItem">Education resources and 1 year subscription to Mayo Clinic Health Letter</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Walking test</li> <li class="seamTextUnorderedListItem">Wear an accelerometer</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Free fitness center membership, 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Problems with thinking (cognition) affect daily functioning, quality of life, and long-term health. </li> <li class="seamTextUnorderedListItem">Aerobic exercise may help improve these problems and is generally considered safe, tolerable, and accessible.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, treadmill walking is the primary mode of exercise. However, you will be permitted to use other cardiovascular equipment (e.g., elliptical machines, stationary bicycles) as prescribed by your exercise trainer.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, the sessions will cover cancer support and discussion of cancer-related wellness topics such as stress management and coping.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will receive a free 6 month fitness membership after the study.</li> <li class="seamTextUnorderedListItem">An accelerometer is a device that measures how fast you walk.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04816006' target='_blank'>ClinicalTrials.gov</a> </li></ul>
26
NEAREST SITE: 682 miles
Fred Hutch/University of Washington Cancer Consortium
Seattle,WA
VISITS: At least 2 visits in 1 year
PHASE: NA
NCT ID: NCT05930483
Virtual Weight Loss Program for Latina Women After Treatment
Using a SMART Design to Evaluate Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors Scientific Title
Purpose
To study if a culturally appropriate weight loss program helps Latina breast cancer survivors lose weight.
Who is this for?
Hispanic/Latina women with stage I, stage II, or stage III breast cancer who were diagnosed within the last 5 years and have completed treatment (except hormone therapy). You must have a BMI >30. You must not smoke or have diabetes.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss and exercise program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> <p class="seamTextPara"> After 1 month, participants who do not achieve weight loss will be assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> <li class="seamTextUnorderedListItem">Personalized health coaching sessions, by phone, 14 sessions</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Weight loss, exercise, and health education program, virtual</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Cook for Your Life website</li> <li class="seamTextUnorderedListItem">Personalized health coaching sessions, by phone, 14 sessions</li> <li class="seamTextUnorderedListItem">Receive a bag of groceries, monthly</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Approximately 80% of Latinas in the United States are overweight, which can lead to poor breast cancer outcomes.</li> <li class="seamTextUnorderedListItem">A culturally appropriate program to promote and maintain weight loss in Latina breast cancer survivors is needed.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05930483' target='_blank'>ClinicalTrials.gov</a> </li></ul>
27
NEAREST SITE: 714 miles
Navajo Nation Center for Indigenous Health
Chinle,AZ
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06957535
Virtual Program to Increase Mammography for Native American Women
Community-led Navigation to Address Disparities in Mammography Among Native American Women Scientific Title
Purpose
To increase breast cancer screening with mammography with a program called TEAM.
Who is this for?
American Indian or Alaska Native women, age 40-74 years, who receive care at Chinle Comprehensive HealthCare Facility (Arizona). You must not have a history of breast cancer, and you must not have received a mammogram in the last year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">TEAM, virtual</li> <li class="seamTextUnorderedListItem">Individual navigation support from a Diné peer-navigator</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">TEAM, virtual</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Tablet-based Education to improve the Acceptance of Mammography (TEAM) is a culturally tailored mammography education program.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06957535' target='_blank'>ClinicalTrials.gov</a> </li></ul>
28
NEAREST SITE: 887 miles
Presbyterian Southern Outpatient Rehab
Rio Rancho,NM
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05983380
Hand Exercises for Lymphedema for Women with Stage 0-III Breast Cancer
The Effect of Hand Mobility and Grip Strengthening Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors Scientific Title
Purpose
To determine if hand mobility and grip strengthening exercises with usual care will reduce swelling and improve quality of life, hand mobility, and grip strength.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment in the past 10 years and have untreated lymphedema.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Hand exercises</li> <li class="seamTextUnorderedListItem">Compression, exercise, information about skin hygiene, and massage</li> <li class="seamTextUnorderedListItem">Measurements, 3 times within 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Compression, exercise, information about skin hygiene, and massage</li> <li class="seamTextUnorderedListItem">Measurements, 3 times within 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 2 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is abnormal swelling in the arm, hand, breast, or torso that develops as a side effect of breast cancer treatments like surgery and radiation therapy.</li> <li class="seamTextUnorderedListItem">Lymphedema can affect arm function and quality of life.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05983380' target='_blank'>ClinicalTrials.gov</a> </li></ul>
29
NEAREST SITE: 941 miles
Outpatient CTRC
Aurora,CO
VISITS: 5 visits within 6 months
PHASE: I
NCT ID: NCT06430541
Psilocybin and Psychotherapy to Support Fear of Recurrence for Women with Stage I-II Breast Cancer
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission Scientific Title
Purpose
To study whether psilocybin and psychotherapy can reduce the fear of recurrence (cancer coming back).
Who is this for?
Women with stage I or stage II breast cancer who completed treatment at least 6 months ago. You must have a support person who agrees to take you home after receiving psilocybin.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Psilocybin, 1 time</li> <li class="seamTextUnorderedListItem">Psychotherapy, 4 times</li> <li class="seamTextUnorderedListItem">Surveys, 5 times within 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Psilocybin is a molecule found in psychedelic (magic) mushrooms.</li> <li class="seamTextUnorderedListItem">Psilocybin plus psychotherapy may reduce distress in people with cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling other people with breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06430541' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://nyulangone.org/news/mental-health-benefits-one-dose-psychedelic-drug-last-years-people-cancer' target='_blank'>New York University Langone Health: Psilocybin and Mental Health in People with Cancer</a> </li></ul>
30
NEAREST SITE: 941 miles
University of Colorado Anschutz
Aurora,CO
VISITS: 1 visit
PHASE: NA
NCT ID: NCT07228234
Education About Mammograms for Healthy Women
Evaluating Mammography Communication Approaches Scientific Title
Purpose
To study different methods for communicating about the benefits and harms of breast cancer screening.
Who is this for?
Women, aged 39-49 years, with no history of breast cancer and no known mutation in the BRCA1 or BRCA2 genes.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 5 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Basic information about what mammography screening is</li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Screening outcomes are referred to as <q>harms</q> and <q>benefits</q></li> <li class="seamTextUnorderedListItem">Information about breast cancer survivability</li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Screening outcomes are referred to as <q>harms</q> and <q>benefits</q></li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Screening outcomes are referred to as <q>outcomes that can happen</q></li> <li class="seamTextUnorderedListItem">Information about breast cancer survivability</li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 5: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Screening outcomes are referred to as <q>outcomes that can happen</q></li> <li class="seamTextUnorderedListItem">Survey</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information about the benefit of saving lives, false positives, and overdiagnosis is referred to throughout the communication as either <q>harms</q> and <q>benefits</q> or <q>outcomes that can happen</q>.</li> <li class="seamTextUnorderedListItem">For groups 2 and 4, information about improvements over time in the survivability of breast cancer is provided.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07228234' target='_blank'>ClinicalTrials.gov</a> </li></ul>
31
NEAREST SITE: 1418 miles
University of Nebraska Medical Center
Omaha,NE
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06938581
Plan to Control Pain Due to Lumpectomy Without Opioids for Stage I-III Breast Cancer
The Utility of Enhanced Recovery After Surgery (ERAS) Protocols in Breast Conserving Surgery: A Randomized Control Trial (ERAS) Scientific Title
Purpose
To study whether the ERAS plan reduces the use of opioids after lumpectomy.
Who is this for?
People with stage I, stage II, or stage III breast cancer who are planning to receive a lumpectomy and sentinel lymph node biopsy. You must not have cancer in your lymph nodes as determined with imaging or physical exam. You must not have yet received treatment for your breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental (ERAS Plan)</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Carbohydrate drink, by mouth, twice before surgery</li> <li class="seamTextUnorderedListItem">Acetaminophen (Tylenol®), by mouth, before surgery</li> <li class="seamTextUnorderedListItem">Celecoxib (Celebrex®), by mouth, before surgery</li> <li class="seamTextUnorderedListItem">Acetaminophen (Tylenol®), Scopolamine, Dexamethasone, and/or Ondansetron (optional), after surgery</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acetaminophen (Tylenol®), Scopolamine, Dexamethasone, and/or Ondansetron (optional), after surgery</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Enhanced Recovery After Surgery (ERAS) is a plan that aims to maximize pain control after surgery without the use of opioids.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06938581' target='_blank'>ClinicalTrials.gov</a> </li></ul>
32
NEAREST SITE: 1455 miles
Sanford Worthington Medical Center
Worthington,MN
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT06028022
Reishi Mushroom Extract for Fatigue and Pain for People with Stage 0-III Breast Cancer
Reishi Mushroom Extract for Fatigue and/or Arthralgias in Patients With Breast Cancer on Aromatase Inhibitors: A Randomized Phase II MNCCTN Trial Scientific Title
Purpose
To study the ability of Reishi mushroom extract to reduce fatigue, joint pain, and/or muscle pain.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III estrogen receptor positive (ER+) breast cancer who are receiving an aromatase inhibitor and experiencing fatigue. You must not be receiving a CDK4/6 inhibitor or olaparib (Lynparza®).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reishi mushroom extract, by mouth, daily for the first month</li> <li class="seamTextUnorderedListItem">Placebo for Reishi mushroom extract, by mouth, daily for the second month</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for Reishi mushroom extract, by mouth, daily for the first month</li> <li class="seamTextUnorderedListItem">Reishi mushroom extract, by mouth, daily for the second month</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are a type of hormone therapy commonly used to treat hormone receptor-positive breast cancer. The approved aromatase inhibitors are anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Side effects of aromatase inhibitors may include fatigue, joint pain, and/or muscle pain.</li> <li class="seamTextUnorderedListItem">Studies suggest that Reishi mushroom extract has beneficial effects including reducing fatigue.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06028022' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy/aromatase-inhibitors' target='_blank'>Breastcancer.org: Aromatase Inhibitors and Pain</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancercare.org/questions/11' target='_blank'>Cancer Care: Aromatase Inhibitors and Fatigue</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.healthline.com/nutrition/reishi-mushroom-benefits#TOC_TITLE_HDR_8' target='_blank'>Healthline: Reishi Mushroom Extract</a> </li></ul>
33
NEAREST SITE: 1539 miles
Mayo Clinic Health System in Mankato
Mankato,MN
VISITS: 2 visits
PHASE: NA
NCT ID: NCT05417867
Gut Microbiome and Chemotherapy-Induced Nausea in Women with Stage I-III Breast Cancer
A Pilot Study of the Associations Between Chemotherapy-Induced Nausea in Breast Cancer Patients and Gut Microbiome Composition Profiles Scientific Title
Purpose
To study how changes in bacteria in the gut (microbiome) may be associated with chemotherapy-induced nausea.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy. You must be receiving care at Mayo Clinic Arizona or Mayo Clinic Florida.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will complete the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times</li> <li class="seamTextUnorderedListItem">Complete questionnaires, 2 times</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The microbiome consists of the many bacteria, viruses, and fungi found in the digestive tract. Most of the microbiome consists of bacteria in your digestive system. These bacteria can be beneficial or harmful. The harmful bacteria cause disease, and the beneficial bacteria help keep you healthy.</li> <li class="seamTextUnorderedListItem">Nausea is a common side effect of many types of chemotherapy.</li> <li class="seamTextUnorderedListItem">You will provide stool samples 2 times: 1) When you begin the trial, and 2) 3-5 days after starting chemotherapy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05417867' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.hsph.harvard.edu/nutritionsource/microbiome/' target='_blank'>Harvard University: What is the Microbiome?</a> </li><li class='seamTextUnorderedListItem'><a href='https://breastcancernow.org/about-us/news-personal-stories/can-gut-bacteria-help-treat-breast-cancer' target='_blank'>Breast Cancer Now: Gut Bacteria and Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/nausea' target='_blank'>Breastcancer.org: Nausea</a> </li></ul>
34
NEAREST SITE: 1623 miles
University of Missouri
Columbia,MO
VISITS: Up to 1 visit every week for 3 months
PHASE: NA
NCT ID: NCT06545045
Training to Improve Thinking Ability After Treatment for Women with Stage I-III Breast Cancer
Pilot Testing of Metacognitive Strategy Training to Address Cancer-related Cognitive Impairment in Breast Cancer Scientific Title
Purpose
To study if training can improve cognition (ability to think) and quality of life.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who completed treatment between 6 months and 3 years ago and are having cognitive (thinking) problems.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Training to improve cognition, in person, weekly for 2.5 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Phone call, weekly for 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Most breast cancer survivors have problems with cognition (thinking), which includes planning, problem-solving, multitasking, memory, and processing speed after cancer treatment.</li> <li class="seamTextUnorderedListItem">In this trial, the training includes identifying 5 goals, creating a plan to achieve each goal, carrying out the plan, and checking to see if the plan worked.</li> <li class="seamTextUnorderedListItem">Training sessions are 45 minutes each and are led by a trained occupational therapist.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06545045' target='_blank'>ClinicalTrials.gov</a> </li></ul>
35
NEAREST SITE: 1640 miles
UT Physicians Center for Healthy Aging Bellaire
Bellaire,TX
VISITS: 5 or 6 visits within 1 year
PHASE: II
NCT ID: NCT06478589
Program to Understand Patient Priorities for Survivorship Care for Older Women with Stage 0-III Breast Cancer
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors Scientific Title
Purpose
To study the priorities and health care preferences of older breast cancer survivors.
Who is this for?
Women, 65 years and older, with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed breast cancer treatment (except hormone therapy if recommended) and have other health conditions.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit with trial team member</li> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 1 year</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This program aims to help breast cancer survivors identify what matter most to them, set goals, describe care that is helpful, and discuss priorities with their doctor.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06478589' target='_blank'>ClinicalTrials.gov</a> </li></ul>
36
NEAREST SITE: 1643 miles
The University of Texas M. D. Anderson Cancer Center
Houston,TX
VISITS: Number of visits unavailable, 1 year
PHASE: NA
NCT ID: NCT06885203
Virtual Program to Improve the Quality of Life of Black Women with Stage 0-III Breast Cancer
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI) Scientific Title
Purpose
To study whether the BBCSI course improves the quality of life of Black breast cancer survivors.
Who is this for?
Black women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer that was diagnosed within the last 4 years.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Complete the BBCSI course, virtual, 1 hour per week for 6 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times</li> <li class="seamTextUnorderedListItem">Provide urine sample</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Black Breast Cancer Survivors Intervention (BBCSI) is a community-based and peer-led course developed to help improve the quality of life of Black breast cancer survivors.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06885203' target='_blank'>ClinicalTrials.gov</a> </li></ul>
37
NEAREST SITE: 1643 miles
MD Anderson Cancer Center
Houston,TX
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05694559
Inherited Cancer Genetic Testing for Black Individuals and Families
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics Scientific Title
Purpose
To connect Black individuals and their families to genetic testing and counseling so that they can know their cancer risk and how to decrease it.
Who is this for?
Black or African-American individuals over 18 years of age that live near Houston, Texas.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Saliva collection kit to collect a saliva sample for genetic testing</li> <li class="seamTextUnorderedListItem">Screening form to assess your risk of hereditary breast cancer</li> <li class="seamTextUnorderedListItem">Counseling about genetic testing</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Genetic testing looks for changes, sometimes called mutations or variants, in your DNA.</li> <li class="seamTextUnorderedListItem">You will also receive counseling about what genetic testing is, why you are eligible, how to receive genetic testing, and that you will be connected to a genetic counselor if you have a pathogenic mutation (PV) of a variant of unknown significance (VUS).</li> <li class="seamTextUnorderedListItem">You will also receive resources for family cascade genetic testing.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05694559' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.komen.org/breast-cancer/risk-factor/gene-mutations-genetic-testing/genetic-counseling-for-people-who-do-not-have-breast-cancer/' target='_blank'>Susan G. Komen: Genetic Testing for People Who Do Not Have Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/genetic-testing' target='_blank'>Breastcancer.org: Genetic Testing</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/genomics/disease/cascade_testing/index.htm' target='_blank'>Centers for Disease Control and Prevention: Cascade Testing</a> </li></ul>
38
NEAREST SITE: 1643 miles
UT Health Houston
Houston,TX
VISITS: At least 2 visits within 1 year
PHASE: NA
NCT ID: NCT05349227
Virtual Health Coaching for People with Stage 0-IV Breast Cancer
Comprehensive Outcomes for After Cancer Health (COACH): The Feasibility and Impact of an mHealth Augmented Coaching Program for Self-Management in Cancer Survivors Scientific Title
Purpose
To study the use of virtual health coaching to improve well-being, including management of other health conditions, mental and social wellness, and healthy lifestyle behaviors.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer, and people without a history of breast cancer. If you have stage 0-III breast cancer, you must have completed treatment within the last year. If you have metastatic (stage IV) breast cancer, you must have been diagnosed with metastatic disease within the past year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Immediately Start Coaching</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual health coaching, up to 4 times weekly, during first 6 months</li> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times within 6 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires during second 6 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit, 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Delayed Start Coaching</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires during first 6 months</li> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times within 6 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual health coaching, up to 4 times weekly, during second 6 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit, 1 year</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This program aims to support people's ability to manage their symptoms and their general wellness (including physical, mental, and social well-being, as well as following healthcare recommendations).</li> <li class="seamTextUnorderedListItem">Coaching consists of weekly calls and information about exercise, physical health, emotional health, and financial health.</li> <li class="seamTextUnorderedListItem">This study is also studying the relationship between symptoms and gut health and if coaching improves gut health.</li> <li class="seamTextUnorderedListItem">People that live in your household who do not have cancer will also be eligible to participate in this study.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05349227' target='_blank'>ClinicalTrials.gov</a> </li></ul>
39
NEAREST SITE: 1643 miles
M D Anderson Cancer Center
Houston,TX
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05928325
Education and Support Program to Improve the Health of Older Adults with Stage I-III Breast Cancer
Implementation of a Geriatric Care Survivorship Intervention in Older Adults Who Have Completed Curative Intent Therapy for Early-Stage Breast Cancer Scientific Title
Purpose
To study the ability of an education and support survivorship program to improve the overall health of older adults who have completed breast cancer treatment.
Who is this for?
People at least 65 years old with stage I, stage II, or stage III breast cancer who are within 3 months of completing chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health assessments, 3 times within 1 year</li> <li class="seamTextUnorderedListItem">Education about survivorship</li> <li class="seamTextUnorderedListItem">Wearable device, 1 year</li> <li class="seamTextUnorderedListItem">Supportive therapy</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The health assessment asks about your physical, mental, and emotional health.</li> <li class="seamTextUnorderedListItem">Wearable devices such as FitBits are used to track your physical activity.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05928325' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.bcrf.org/blog/breast-cancer-elderly-treating-growing-patient-population/?psafe_param=1&utm_source=google&utm_medium=cpc&gclid=Cj0KCQjwuZGnBhD1ARIsACxbAVgxOj7KCm21Zmg5TCplhMCDhvola-e-h9IoQWD0A-pi9eLpEHWIIfgaAsz1EALw_wcB' target='_blank'>Breast Cancer Research Foundation: Older Adults and Breast Cancer</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mycarg.org/?page_id=437' target='_blank'>Cancer and Aging Resource Group: Improving the Care of Older Adults with Cancer</a> </li></ul>
40
NEAREST SITE: 1643 miles
Baylor College of Medicine
Houston,TX
VISITS: At least 3 visits in 4 months
PHASE: NA
NCT ID: NCT05323409
Oncology Nurse Navigator to Help Manage Other Health Conditions for People with Stage I-III Breast Cancer
Optimise: Improving Comprehensive Care of Cancer Patients With Comorbidities Scientific Title
Purpose
To study if the OPTIMISE program improves care, health outcomes, and quality of life for people with other health conditions transitioning from receiving care from an oncologist to a primary care physician (PCP).
Who is this for?
People with stage I, stage II, or some stage III breast cancer who have not started treatment or started treatment less than 3 months ago. You must have other health conditions and receive care at Harris Health in Houston, Texas.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: OPTIMISE Program</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Work with oncology nurse navigator, 3 times in 4 months</li> <li class="seamTextUnorderedListItem">Create survivorship care plan</li> <li class="seamTextUnorderedListItem">Reminders to follow up with primary care physician</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Create survivorship care plan</li> <li class="seamTextUnorderedListItem">Meet with nurse about survivorship care plan</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many people with cancer have other health conditions that also have to be managed after cancer treatment ends.</li> <li class="seamTextUnorderedListItem">Primary care physicians (PCPs) typically manage other non-cancer health conditions.</li> <li class="seamTextUnorderedListItem">The OPTIMISE program is designed to improve your ability to manage other health conditions and coordinate the transition of care from oncologists to PCPs from diagnosis through the first year after cancer treatment.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other kinds of cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05323409' target='_blank'>ClinicalTrials.gov</a> </li></ul>
41
NEAREST SITE: 1643 miles
M D Anderson Cancer Center
Houston,TX
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05649072
Genetic Testing and Counseling for Women in Texas
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. Scientific Title
Purpose
To provide genetic testing and counseling to underserved women at risk for breast cancer.
Who is this for?
Women ages 40 to 74 who live in Texas, do not have health insurance, and are planning to receive a mammogram through the Project VALET program.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Genetic testing and counseling</li> <li class="seamTextUnorderedListItem">Questionnaire</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will provide a saliva sample for genetic testing when you arrive at your Project VALET mammogram appointment.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05649072' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mdanderson.org/about-md-anderson/business-legal/office-of-health-policy/project-valet.html#:~:text=Project%20VALET%20(Providing%20Valuable%20Area,are%20patients%20in%20participating%20clinics.' target='_blank'>MD Anderson Cancer Center: Project VALET Mammogram Screening</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/genetic-testing' target='_blank'>Breastcancer.org: Genetic Testing</a> </li></ul>
42
NEAREST SITE: 1683 miles
The University of Texas Medical Branch, Galveston
Galveston,TX
VISITS: 2 visits in 3 months
PHASE: NA
NCT ID: NCT06395506
Exercise and Creatine Supplement to Increase Strength of Women After Chemotherapy
An Open-label Randomized Trial of Exercise ± Creatine Supplementation to Augment the Adaptations of Exercise Training in Cancer Survivors (THRIVE) Scientific Title
Purpose
To study if creatine supplements can help people with breast cancer respond more quickly to exercise and improve strength.
Who is this for?
Women with stage I, stage II, and stage III breast cancer who have completed chemotherapy in the last 6 months, and women who have not been diagnosed with breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Creatine and Exercise</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Creatine, by mouth, daily for 3 months</li> <li class="seamTextUnorderedListItem">Exercise sessions, virtual, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Strength and walking tests, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times in 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Exercise Only</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise sessions, virtual, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Strength and walking tests, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">DEXA scan, 2 times in 3 months</li> <li class="seamTextUnorderedListItem">MRI scan, 2 times in 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is comparing information from women who have never had breast cancer to women who have completed chemotherapy for breast cancer.</li> <li class="seamTextUnorderedListItem">Creatine is a supplement that may help you improve strength and physical function.</li> <li class="seamTextUnorderedListItem">A Fitbit is device you wear on your wrist that tracks your physical activity.</li> <li class="seamTextUnorderedListItem">DEXA scans use x-ray energy to measure bone density (thickness and strength of bones).</li> <li class="seamTextUnorderedListItem">A magnetic resonance imaging (MRI) scan produces body pictures created by using magnetic energy rather than x-ray energy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06395506' target='_blank'>ClinicalTrials.gov</a> </li></ul>
43
NEAREST SITE: 1711 miles
Duke University
Durham,NC
VISITS: Up to 5 visits within 5 months
PHASE: NA
NCT ID: NCT06795529
Improving Communication and End-of-Life Care for People With Metastatic Breast Cancer Near the End of Life
Randomized Trial of a Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer Scientific Title
Purpose
To study a palliative care intervention designed to improve communication with the care team and the quality of end-of-life care.
Who is this for?
People with metastatic (stage IV) breast cancer who are at risk of dying within 1 year. You must not have received an outpatient palliative care visit within the last 6 months or be receiving hospice care.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">TARGET-PC, monthly for 5 months</li> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">People with MBC who are nearing the end of their life often have distressing symptoms and may be in the hospital.</li> <li class="seamTextUnorderedListItem">Sometimes, communication with care teams about their wishes is poor. Patients may not receive palliative or hospice services.</li> <li class="seamTextUnorderedListItem">The program in this study is called TARGET-PC. It focuses on coping with advanced cancer, understanding the illness, treatment decision-making, and end-of-life care planning. TARGET-PC includes 5 monthly visits from a palliative care specialist.</li> <li class="seamTextUnorderedListItem">For usual care, doctors will receive an electronic message to encourage them to discuss their patients' health care preferences.</li> <li class="seamTextUnorderedListItem">This study is also enrolling caregivers.</li> <li class="seamTextUnorderedListItem">Participants will be followed for up to 5 years.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06795529' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/from-the-experts/palliative-care-2/' target='_blank'>Metastatic Trial Talk: Palliative Care</a> </li></ul>
44
NEAREST SITE: 1739 miles
Washington University School of Medicine
St Louis,MO
VISITS: 2 visits within 2 months
PHASE: NA
NCT ID: NCT06864754
Video to Improve Understanding and Decrease Anxiety About DIEP Flap Breast Reconstruction Surgery for Women with Stage I-III Breast Cancer
WashU DIEP Flap Video and Patient Understanding Improvement Scientific Title
Purpose
To study whether a video affects a person's understanding and anxiety about DIEP flap breast reconstruction.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are planning to receive DIEP flap breast reconstruction after a mastectomy at Barnes Jewish Hospital (St. Louis, MO).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch a video about DIEP flap breast reconstruction</li> <li class="seamTextUnorderedListItem">Surveys, 3 times within 2 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">DIEP flap breast reconstruction is breast reconstruction surgery after a mastectomy that is done using tissue from your belly.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06864754' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/autologous-flap/diep' target='_blank'>Breastcancer.org: DIEP Flap Breast Reconstruction Surgery</a> </li></ul>
45
NEAREST SITE: 1739 miles
Washington University School of Medicine
St Louis,MO
VISITS: 1 or 2 visits
PHASE: NA
NCT ID: NCT06981208
Artificial Intelligence-Generated Education About Breast Reconstruction for Stage 0-III Breast Cancer or People at High Risk for Breast Cancer
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction Scientific Title
Purpose
To study the usefulness of artificial intelligence-generated patient education about breast reconstruction options.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer, or people at high risk for breast cancer, who are planning to receive a mastectomy and a consultation about breast reconstruction surgery options.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education generated by ChatGPT about breast reconstruction </li> <li class="seamTextUnorderedListItem">Survey</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard education about breast reconstruction</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">For the experimental group, participants will receive ChatGPT-generated patient-tailored education about breast reconstruction options.</li> <li class="seamTextUnorderedListItem">For the control group, participants will receive standard patient education that includes a description of breast reconstruction options, including which option is most suitable, as well as a description of the risk of complications and expected recovery after surgery.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06981208' target='_blank'>ClinicalTrials.gov</a> </li></ul>
46
NEAREST SITE: 1814 miles
Rush University College of Nursing
Sugar Grove,IL
VISITS: 2 visits within 6 months
PHASE: NA
NCT ID: NCT06827704
Dance Program to Improve Physical Health and Reduce the Risk of Breast Cancer for South Asian Indian Immigrant Women
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in South Asian Indian Immigrant Women (MetS-BC) Scientific Title
Purpose
To improve physical activity and outcomes related to high blood pressure, diabetes, abnormal lipid levels, and obesity for reducing the risk of breast cancer in South Asian Indian immigrant women.
Who is this for?
South Asian Indian immigrant women, age 40-65 years, who do not have breast cancer, are physically inactive, and speak Hindi.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 4 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Treatment plan to increase physical activity</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Body measurements, 2 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Bollywood-style group dance, virtual, 1-hour sessions, twice a week for 6 months</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Body measurements, 2 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Treatment plan to increase physical activity</li> <li class="seamTextUnorderedListItem">Bollywood-style group dance, virtual, 1-hour sessions, twice a week for 6 months</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Body measurements, 2 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No intervention</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times within 6 months</li> <li class="seamTextUnorderedListItem">Body measurements, 2 times within 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Breast cancer develops an average of 5-10 years earlier in South Asian Indian immigrant women than in white women.</li> <li class="seamTextUnorderedListItem">The risk of breast cancer is more than twice as high in South Asian Indian immigrant women with high blood pressure, diabetes, abnormal lipid levels, and obesity than in white women with these conditions.</li> <li class="seamTextUnorderedListItem">This study aims to use a culturally appropriate exercise program to improve physical activity, blood pressure, diabetes, lipid levels, and obesity to reduce the risk of breast cancer in South Asian Indian immigrant women.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06827704' target='_blank'>ClinicalTrials.gov</a> </li></ul>
47
NEAREST SITE: 1832 miles
Medical College of Wisconsin
Milwaukee,WI
VISITS: 3 visits in 1 year
PHASE: NA
NCT ID: NCT03824145
Every Day Counts Lifestyle Program to Improve Quality of Life for Women with Metastatic Breast Cancer
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer Scientific Title
Purpose
To study whether the Every Day Counts lifestyle program improves the quality of life of women with metastatic breast cancer.
Who is this for?
Women with metastatic (stage IV) breast cancer that is currently stable and who live in Milwaukee, Wisconsin or Chicago, Illinois.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Every Day Counts lifestyle program, 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Home/work organization intervention, 4 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Every Day Counts lifestyle program</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Every Day Counts lifestyle program promotes nutritional and physical activity changes based on the American Cancer Society nutrition and physical activity guidelines.</li> <li class="seamTextUnorderedListItem">The Every Day Counts lifestyle program consists of: 1) a curriculum binder covering weekly topics and including self-monitoring tools to support adherence; 2) lifestyle coaching for 16-weeks, with in-person or virtual supervised exercise sessions and telephone-based sessions; 3) exercise supplies (Fitbit, resistance bands), 4) twice weekly text messaging targeting self-efficacy and social support; and 5) attendance to cooking classes emphasizing plant-based eating.</li> <li class="seamTextUnorderedListItem">The home/work organization intervention consists of: 1) a book with overview of home/work organization program with 16 weekly topics with an overview of each chapter, 2) virtual or weekly phone calls with a home organization coach with standard prompts, 3) text messages supporting home/work organization.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03824145' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://redcap.mcw.edu/surveys/?s=84MA4DRTTTA8FRCD' target='_blank'>Medical College of Wisconsin: Trial Information Brochure</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/healthy/eat-healthy-get-active/acs-guidelines-nutrition-physical-activity-cancer-prevention/guidelines.html' target='_blank'>American Cancer Society: Guideline for Diet and Physical Activity</a> </li></ul>
48
NEAREST SITE: 1832 miles
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee,WI
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06106477
Intermittent Fasting to Improve Quality of Life for People with Stage I-III ER+, HER2- Breast Cancer
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer Scientific Title
Purpose
To study if intermittent fasting improves health-related quality of life.
Who is this for?
People with stage I, stage II, or stage III estrogen receptor positive (ER+ or ER low), HER2 negative (HER2- or HER2 low) breast cancer who are planning to receive hormone therapy after surgery (adjuvant). You must have a body mass index (BMI) of at least 25.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Intermittent fasting, daily, 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">In this trial, intermittent fasting (not eating) means that you are allowed to eat during a 10 hour period, with the last meal of the day between 5:00 PM and 9:00 PM.</li> <li class="seamTextUnorderedListItem">In this trial, HER2 low is defined as IHC 1+ or IHC 2+/FISH-.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06106477' target='_blank'>ClinicalTrials.gov</a> </li></ul>
49
NEAREST SITE: 1832 miles
Medical College of Wisconsin
Wauwatosa,WI
VISITS: At least 3 visits in 1 year
PHASE: NA
NCT ID: NCT05223322
Exercise to Reduce Side Effects During Treatment for Women with Stage I-III Breast Cancer
DECODE Heartland: Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction Scientific Title
Purpose
To study if exercise improves side effects caused by chemotherapy and anti-HER2 targeted therapy.
Who is this for?
Black/African American or non-Hispanic White women with stage I, stage II, or stage III breast cancer who are receiving chemotherapy with doxorubicin (Doxil®) or anti-HER2 targeted therapy with trastuzumab (Herceptin®), pertuzumab (Perjeta®), tucatinib (Tukysa®), neratinib (Nerlynx®), margetuximab (Margenza®), trastuzumab deruxtecan (Enhertu®, T-DXd), and/or trastuzumab emtansine (Kadcyla®, T-DM1).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, up to 2.5 hours every week for 4-5 months</li> <li class="seamTextUnorderedListItem">Exercise information, resistance bands, and activity tracker</li> <li class="seamTextUnorderedListItem">Physical tests, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Ultrasound, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Blood tests and biopsies, 3 times in 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supportive text messages, weekly</li> <li class="seamTextUnorderedListItem">Physical tests, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Ultrasound, 3 times in 1 year</li> <li class="seamTextUnorderedListItem">Blood tests and biopsies, 3 times in 1 year</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise information, resistance bands, and activity tracker (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some cancer medications such as chemotherapy and anti-HER2 targeted therapy may harm blood vessels.</li> <li class="seamTextUnorderedListItem">Harm to blood vessels may negatively affect physical health.</li> <li class="seamTextUnorderedListItem">Exercise may improve these negative effects.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05223322' target='_blank'>ClinicalTrials.gov</a> </li></ul>
50
NEAREST SITE: 1835 miles
Carle Health
Urbana,IL
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT05484973
AMMA Portable Scalp Cooling to Prevent Hair Loss During Chemotherapy for Women with Stage I-III Breast Cancer
A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III. Scientific Title
Purpose
To study the ability of the AMMA portable scalp cooling system to prevent hair loss in women receiving chemotherapy.
Who is this for?
Women at least 21 years old with stage I, stage II, or stage III breast cancer who are planning to receive or receiving paclitaxel (Taxol®), nab-paclitaxel (Abraxane®), or docetaxel (Taxotere®) chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">AMMA portable scalp cooling device during chemotherapy sessions</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will wear the AMMA scalp cooling device 30 minutes before, during, and for at least 2.5 hours after each chemotherapy session.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05484973' target='_blank'>ClinicalTrials.gov</a> </li></ul>
51
NEAREST SITE: 1853 miles
University of Illinois Health
Chicago,IL
VISITS: 3 visits
PHASE: NA
NCT ID: NCT05841355
Empowering Latina Women to Receive Breast Cancer Screening
Empowering Latinas to Obtain Guideline Concordant Screenings Scientific Title
Purpose
This trial will study a new way to educate Latina women about the importance of breast cancer screening.
Who is this for?
Latina women 50-74 years old who have not had a mammogram in the last 2 years and have not been diagnosed with breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">New breast cancer screening education, 3 sessions</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard breast cancer screening education, 3 sessions</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Please contact research site for trial schedule</i></p>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Latina women are less likely than other groups to receive breast cancer screening.</li> <li class="seamTextUnorderedListItem">Education sessions cover topics such as breast cancer information, screening, personal stories, lifestyle factors, role playing, and individual action plans.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05841355' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.bcrf.org/blog/hispanic-latina-breast-cancer-facts-statistics/' target='_blank'>Breast Cancer Research Foundation: Breast Cancer and Screening in Latina Women</a> </li></ul>
52
NEAREST SITE: 1853 miles
University of Illinois Chicago
Chicago,IL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06504914
Healthy Cooking and Eating for Black Women with Stage 0-III Breast Cancer, High Blood Pressure, and Obesity
Developing FIM-BCS: A Lifestyle Modification for African-American Breast Cancer Survivors With Cardiovascular Risk Factors Scientific Title
Purpose
To study the ability of the Real Nourishment and Cooking Healthy Food is Rx program to improve nutritious eating habits and blood pressure control.
Who is this for?
Black and African American women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment. You must have high blood pressure, a BMI of at least 30, and live in Chicago, Illinois.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Real Nourishment and Cooking Healthy Food is Rx program, in person, 3 months</li> <li class="seamTextUnorderedListItem">Interviews and surveys, 3 times within 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High blood pressure and obesity are risk factors for heart disease.</li> <li class="seamTextUnorderedListItem">The Real Nourishment and Cooking Healthy Food is Rx program involves grocery delivery, cooking classes, and nutrition education and is designed to improve nutritious eating habits and blood pressure control.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06504914' target='_blank'>ClinicalTrials.gov</a> </li></ul>
53
NEAREST SITE: 1853 miles
University of Illinois Chicago
Chicago,IL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05259410
Time Restricted Eating During Chemotherapy for Women with Stage I-III Breast Cancer
The Safety and Efficacy of Time Restricted Eating Combined With Chemotherapy During Breast Cancer Treatment Scientific Title
Purpose
To study whether time restricted eating during chemotherapy improves treatment-related outcomes and quality of life and limits treatment-related side effects and weight gain.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy after surgery.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time restricted eating, 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No time restricted eating, 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time restricted eating, a form of intermittent fasting, is eating all food within the hours of 10:00am and 6:00pm, with water fasting the remaining hours of the day.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05259410' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/research-news/intermittent-fasting-may-help-cancer-treatments-work-better' target='_blank'>Breastcancer.org: Intermittent Fasting May Help Cancer Treatments Work Better</a> </li></ul>
54
NEAREST SITE: 1856 miles
Northwestern University
Chicago,IL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06271356
Coaching Program and Materials to Support Starting Treatment After Surgery for Women with Stage I-III Breast Cancer
Effect of a Navigation Intervention on Care Equity for Women of Color Diagnosed with Breast Cancer: a Feasibility Study Scientific Title
Purpose
To study the ability of a patient navigation and coaching program and its website/mobile app to help women start adjuvant (after surgery) treatment.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who have completed surgery and are planning to receive chemotherapy after surgery (adjuvant). You must be receiving care at Northwestern Medicine in Chicago, IL.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following through the Breast Cancer-Navigate program: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Patient navigation and coaching program, 3 months</li> <li class="seamTextUnorderedListItem">Website and mobile app, 3 months</li> <li class="seamTextUnorderedListItem">Interview, 1 time</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Chrysalis Initiative has designed a patient navigation and coaching program and website/mobile app called Breast Cancer-Navigate.</li> <li class="seamTextUnorderedListItem">These materials are designed to guide Women of Color through adjuvant (after surgery) treatment according to the timeline recommended by their care team.</li> <li class="seamTextUnorderedListItem">Women of all races and ethnicities may participate in this study.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06271356' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://thechrysalisinitiative.org/' target='_blank'>The Chrysalis Initiative</a> </li></ul>
55
NEAREST SITE: 2054 miles
University of Michigan Comprehensive Cancer Center
Ann Arbor,MI
VISITS: Number of visits unavailable, up to 1 year
PHASE: NA
NCT ID: NCT07291414
Virtual Platform to Track Medication Safety and Concerns for Stage 0-IV Breast Cancer
Patient Engagement in Using the Technology for Self-Tracking Medication Safety Events Scientific Title
Purpose
To study the usefulness of a self-monitoring platform for tracking medication safety events and concerns.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are receiving treatment for their cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use of the online platform to track your experiences or concerns about taking your medications, including symptoms, for 6 months</li> <li class="seamTextUnorderedListItem">Educational materials and resources, virtual, for 6 months</li> <li class="seamTextUnorderedListItem">Follow-up from a nurse practitioner, virtual, as needed over the 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Patients receiving cancer treatment by mouth often have challenges with managing complex treatments, side effects, and interactions with food or other drugs at home.</li> <li class="seamTextUnorderedListItem">In this study, patients go online to track their experiences or concerns about taking their medications, including symptoms. This online platform may help people take better care of their health.</li> <li class="seamTextUnorderedListItem">This study is enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07291414' target='_blank'>ClinicalTrials.gov</a> </li></ul>
56
NEAREST SITE: 2054 miles
University of Michigan
Ann Arbor,MI
VISITS: At least 3 visits within 6 months
PHASE: NA
NCT ID: NCT06100263
Supervised Exercise Program After Treatment for Black Women with Stage 0-III Breast Cancer
Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study Scientific Title
Purpose
To study how a supervised resistance exercise program affects the physical and social health of Black women after breast cancer treatment.
Who is this for?
Black, African American, and/or Afro-Latina women with stage 0 (DCIS), stage I, stage II, or some stage III breast cancer who have completed treatment within the last 5 years. You must exercise less than 2 times every week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised resistance exercise program, 4 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information about physical activity for people with cancer</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised exercise may improve a person's ability to exercise correctly, attitude about exercise, and physical and social health.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, each exercise session will be 35-45 minutes.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06100263' target='_blank'>ClinicalTrials.gov</a> </li></ul>
57
NEAREST SITE: 2088 miles
Barbara Ann Karmanos Cancer Institute
Detroit,MI
VISITS: 1 visit
PHASE: NA
NCT ID: NCT04766190
DISCO App to Improve Financial Knowledge for People with Breast Cancer
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer Scientific Title
Purpose
To study the ability of the DISCO app to improve financial knowledge and reduce financial toxicity.
Who is this for?
People newly diagnosed with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have not yet received treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">2 surveys during visit</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">2 surveys during visit</li> <li class="seamTextUnorderedListItem">DISCO app</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">2 surveys during visit</li> <li class="seamTextUnorderedListItem">DISCO app</li> </ul> <p class="seamTextPara"> followed 2 months later by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Email reminder about information from DISCO app</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Additional Procedures</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">4 surveys within 1 year</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The DISCO (DIScussions of COst) app is designed to improve your treatment cost knowledge and ability to manage financial toxicity (financial distress and hardship).</li> <li class="seamTextUnorderedListItem">The app includes a short video and asks questions about your financial concerns. The app will give you a list of questions you may want to ask your oncologist.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04766190' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.youtube.com/watch?v=KuO8qp1XJTA' target='_blank'>Association of Community Cancer Centers (Video): The DISCO App: A Patient-Focused Tool to Reduce Financial Toxicity</a> </li></ul>
58
NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH
VISITS: 8 visits within 9 months
PHASE: NA
NCT ID: NCT05984888
MIND Diet and Nutrition Counseling to Improve Brain Function for People with Stage II-IV HR+ Breast Cancer
Protecting the Brain From Toxic Side Effects of Chemotherapy: a Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer Scientific Title
Purpose
To study the impact of the Neurodegenerative Delay (MIND) diet on your cognition (ability to think).
Who is this for?
Postmenopausal women 45 to 75 years old with stage II, stage III, or stage IV (metastatic) hormone receptor positive (ER+ and/or PR+) breast cancer who are planning to begin treatment within 1 month.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition counseling about the MIND diet, 8 in-person sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General health (non-diet) counseling, 8 in-person sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer treatment can lead to cognition (ability to think) problems and low quality of life.</li> <li class="seamTextUnorderedListItem">The Neurodegenerative Delay (MIND) diet is high in anti-inflammatory nutrients (omega-3, carotenoids, B vitamins, etc.) and limits foods that are not healthy for the brain (butter, cheese, red meat, fried foods, sugar, etc.).</li> <li class="seamTextUnorderedListItem">The MIND diet may help improve brain function during cancer treatment.</li> <li class="seamTextUnorderedListItem">Cognition is your ability to think.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05984888' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.osu.edu/wellness/exercise-and-nutrition/the-mind-diet' target='_blank'>Ohio State University: The MIND Diet and Brain Health</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/diseases/21032-chemo-brain' target='_blank'>Cleveland Clinic: Chemotherapy and Brain Function Problems</a> </li></ul>
59
NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06666192
Cancer Screening and Education for Women in Central Ohio
A Multi-Level Intervention for Improving Screening Rates of Breast, Cervical and Colorectal Cancer in Women in Low-Income Communities Scientific Title
Purpose
To study how well the SCREEN Community Program increases cancer screening for low income and un/underinsured women in Central Ohio.
Who is this for?
Women who live in Central Ohio who are low income and do not have insurance (uninsured) or do not have enough insurance (underinsured).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following as part of the SCREEN Community Program: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer screening and follow-up</li> <li class="seamTextUnorderedListItem">Cancer screening educational materials</li> <li class="seamTextUnorderedListItem">Screening recommendations, by mail and during in-person visits</li> <li class="seamTextUnorderedListItem">Access to educational website</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial involves screening for breast, cervical, and colorectal cancer.</li> <li class="seamTextUnorderedListItem">Cancer screening can detect cancer when treatment is less intensive and more successful.</li> <li class="seamTextUnorderedListItem">However many low income and un/underinsured women do not have access to health care and screenings.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06666192' target='_blank'>ClinicalTrials.gov</a> </li></ul>
60
NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH
VISITS: 2 visits in 2.5 months
PHASE: NA
NCT ID: NCT05677802
Stress Management Therapy for Women with Stage I-III Triple Negative Breast Cancer
Examining the Feasibility of Implementing a Biobehavioral Stress Reduction Program in Triple Negative Breast Cancer Patients Scientific Title
Purpose
To study if stress management therapy reduces stress and addresses health-related social needs.
Who is this for?
Women with newly diagnosed stage I, stage II, or stage III triple negative (ER-, PR-, HER2-) breast cancer who have not yet received treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stress management therapy, 10 sessions in 2.5 months</li> <li class="seamTextUnorderedListItem">Blood tests, 2 times in 2.5 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The stress management therapy includes progressive muscle relaxation, coping, problem solving, communication, and social support.</li> <li class="seamTextUnorderedListItem">Health related social needs (such as utilities and transportation) will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05677802' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://breastcancernow.org/information-support/facing-breast-cancer/living-beyond-breast-cancer/life-after-breast-cancer-treatment/coping-emotionally/managing-stress-anxiety#:~:text=After%20a%20diagnosis%20of%20breast,and%20cope%20better%20with%20anxiety' target='_blank'>Breast Cancer Now: Coping with Stress Following a Breast Cancer Diagnosis</a> </li></ul>
61
NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH
VISITS: 7-9 visits within 3 months
PHASE: NA
NCT ID: NCT06635005
Low Insulin Diet to Reduce Breast Cancer Risk in High Risk Women
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women Scientific Title
Purpose
To study whether a diet that leads to low insulin levels can reduce the risk of breast cancer.
Who is this for?
Women at least 45 years old or postmenopausal women with a BMI of 25-35 who are at high risk for breast cancer. You must receive care at the Ohio State University Comprehensive Cancer Center (OSUCCC) Stefanie Spielman Comprehensive Breast Center (SSCBC) high risk breast clinic.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition education sessions, weekly for 1.5 months</li> <li class="seamTextUnorderedListItem">Nutrition counseling, in person or virtual, 3 times within 3 months</li> <li class="seamTextUnorderedListItem">Wear an activity tracker</li> <li class="seamTextUnorderedListItem">Blood, stool, and urine samples</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The diet in this study is designed to lower insulin levels.</li> <li class="seamTextUnorderedListItem">The diet is moderately low in total fat and saturated fat, low in protein from animal foods but high in protein from plant sources, high in fruits and vegetables, high in whole grains, and high in dietary fiber.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06635005' target='_blank'>ClinicalTrials.gov</a> </li></ul>
62
NEAREST SITE: 2108 miles
The Ohio State University
Columbus,OH
VISITS: 3 visits every week for 4 months
PHASE: NA
NCT ID: NCT05193149
Training to Strengthen Breathing Muscles and Exercise Program After Treatment for Overweight Women with Stage 0-III Breast Cancer
Reducing Exercise Intolerance Through Inspiratory Muscle Training in Obese Breast Cancer (IMOCS) Scientific Title
Purpose
To study the ability of training to strengthen breathing muscles to improve the ability to exercise.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment between 6 months to 5 years ago. You must have a BMI of at least 30 kg/m2 and exercise less than 1.5 hours every week. You may still be receiving hormone therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Training to strengthen breathing muscles, 3 times every week for 1 month</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise training, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Exercise, strength, and fatigue tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo training to strengthen breathing muscles, 3 times every week for 1 month</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise training, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Exercise, strength, and fatigue tests</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Training to strengthen the muscles used for breathing may improve the ability to exercise.</li> <li class="seamTextUnorderedListItem">Aerobic exercise includes cycling, walking, and using the elliptical.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05193149' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.lung.org/lung-health-diseases/wellness/breathing-exercises' target='_blank'>American Lung Association: Breathing Exercises to Strengthen Breathing Muscles</a> </li></ul>
63
NEAREST SITE: 2108 miles
Ohio State University Comprehensive Cancer Center
Columbus,OH
VISITS: 1 day
PHASE: NA
NCT ID: NCT07227038
Interview and Survey About a Support Program for People With Advanced Breast Cancer
Living Well With Advanced Breast Cancer Scientific Title
Purpose
To study the use of supportive care to better understand what has helped people, what has been hard, and what kind of help they still need.
Who is this for?
People with advanced (some stage III) or metastatic (stage IV) breast cancer and their caregivers.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Survey</li> <li class="seamTextUnorderedListItem">Interview</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Living Well with Advanced Breast Cancer is a program at Ohio State that aims to address the physical, social, emotional and spiritual concerns of people living with advanced breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07227038' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/cancers-conditions-and-treatment/cancer-types/breast-cancer/specialty-clinics-and-programs/living-well-with-advanced-breast-cancer' target='_blank'>Ohio State University: Living Well with Advanced Breast Cancer</a> </li></ul>
64
NEAREST SITE: 2135 miles
Emory Saint Joseph's Hospital
Atlanta,GA
VISITS: Up to 1-2 visits every week for 3 months
PHASE: NA
NCT ID: NCT06534125
Acupuncture or Acupressure to Prevent Joint Pain from Hormone Therapy for Postmenopausal Non-Hispanic Black Women with Stage I-III HR+, HER2- Breast Cancer
Preventing Aromatase Inhibitor-Associated Arthralgias Among Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer Scientific Title
Purpose
To compare the ability of in-person acupuncture and at-home acupressure to prevent joint pain from hormone therapy.
Who is this for?
Postmenopausal non-Hispanic Black women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who completed treatment at least 2 weeks ago and are planning to receive letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor. You must not have received or be currently receiving palbociclib (Ibrance®), ribociclib (Kisqali®), or abemaciclib (Verzenio®) CDK4/6 inhibitor.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acupuncture, in person, every 1-2 weeks for 3 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acupressure, at home, every 1-2 weeks for 3 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No acupuncture or acupressure</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors prolong life in postmenopausal women with HR+ breast cancer.</li> <li class="seamTextUnorderedListItem">However, non-Hispanic Black women are more likely to experience side effects such as joint pain and stop their hormone therapy compared to non-Hispanic white women.</li> <li class="seamTextUnorderedListItem">Acupuncture involves inserting thin needles through the skin at specific points on the body to control pain.</li> <li class="seamTextUnorderedListItem">Acupressure uses the application of pressure or localized massage to specific sites on the body to control symptoms such as pain.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06534125' target='_blank'>ClinicalTrials.gov</a> </li></ul>
65
NEAREST SITE: 2137 miles
Emory University Hospital Midtown
Atlanta,GA
VISITS: 1 visit every day for 2 weeks
PHASE: NA
NCT ID: NCT05368428
Transcutaneous Electrical Nerve Stimulation for Chemotherapy Induced Peripheral Neuropathy in People with Stage I-III Breast Cancer
Single-Institution Trial Investigating the Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in Taxane Induced Peripheral Neuropathy (CIPN) in Patients With Early Stage Breast Cancer Scientific Title
Purpose
To determine if transcutaneous electrical nerve stimulation (TENS) reduces chemotherapy induced peripheral neuropathy (CIPN).
Who is this for?
People with stage I, stage II, or stage III breast cancer who are receiving chemotherapy and have chemotherapy induced peripheral neuropathy (CIPN).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Transcutaneous electrical nerve stimulation (TENS), daily for 2 weeks</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chemotherapy induced peripheral neuropathy (CIPN) is nerve pain in your hands and feet as a side effect of chemotherapy.</li> <li class="seamTextUnorderedListItem">Neuropathy is pain from nerve damage.</li> <li class="seamTextUnorderedListItem">Transcutaneous electrical nerve stimulation (TENS) involves mild electric currents applied to some areas of your skin to potentially improve neuropathy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05368428' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/treatments/15840-transcutaneous-electrical-nerve-stimulation-tens' target='_blank'>Cleveland Clinic: Transcutaneous Electrical Nerve Stimulation (TENS)</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/neuropathy' target='_blank'>Breastcancer.org: Neuropathy</a> </li></ul>
66
NEAREST SITE: 2139 miles
Emory University Hospital/Winship Cancer Institute
Atlanta,GA
VISITS: 1-2 visits in up to 6 years
PHASE: NA
NCT ID: NCT06760507
Education and Screening for Cancers Related to BRCA for Women in Southwest Georgia
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics (RSPH5973-23) Scientific Title
Purpose
To study the ability of the GA CORE family history screening program to increase screening for cancers related to the BRCA gene.
Who is this for?
Women at least 25 years old who receive care in southwest Georgia.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education about breast cancer risk</li> <li class="seamTextUnorderedListItem">Follow up to encourage cancer screening (if recommended)</li> <li class="seamTextUnorderedListItem">Standard genetic testing results and follow up</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Interviews</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Help from nurses about screening</li> <li class="seamTextUnorderedListItem">Standard genetic testing results and follow up</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Interviews</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Simple, low cost family history screening can identify families at high risk for cancers related to the BRCA gene.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06760507' target='_blank'>ClinicalTrials.gov</a> </li></ul>
67
NEAREST SITE: 2168 miles
Case Western Reserve University/University Hospitals Cleveland
Cleveland,OH
VISITS: At least 2 visits within 2-7 months
PHASE: NA
NCT ID: NCT05535192
Exercise and Nutrition Support During Chemotherapy for Older Women with Stage I-III Breast Cancer
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients (THRIVE-65) Scientific Title
Purpose
To study if exercise plus support to increase protein intake will make it easier for older women to receive chemotherapy as prescribed.
Who is this for?
Women at least 65 years old with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Exercise and Nutrition Support</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, 1 session in person, then 2 sessions at home every week during chemotherapy</li> <li class="seamTextUnorderedListItem">Meeting with dietician, virtual</li> <li class="seamTextUnorderedListItem">Diet journal</li> <li class="seamTextUnorderedListItem">Body and memory tests, 2 times</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Health Education</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health educational materials on tablet during chemotherapy appointments</li> <li class="seamTextUnorderedListItem">Body and memory tests, 2 times</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">If you are in Group 1, you will work with an exercise coach to perform muscle strengthening exercises and aerobic exercises. </li> <li class="seamTextUnorderedListItem">If you are in Group 1, you will also meet with a dietitian to make sure you are eating enough protein during chemotherapy. You will keep a daily protein checklist and share this with the exercise coach each week.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will receive a tablet with information about meditation, stretching and gentle movement, relaxation, and creative arts during chemotherapy appointments.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05535192' target='_blank'>ClinicalTrials.gov</a> </li></ul>
68
NEAREST SITE: 2260 miles
Allegheny General Hospital
Pittsburgh,PA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT07023887
Exercise After Treatment for Women with Stage 0-III Breast Cancer
EXERT-BCHC: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning Scientific Title
Purpose
To study the effect of four exercise programs on body measurements.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have received treatment for their breast cancer and have been prescribed exercise. You must not currently be receiving chemotherapy or radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 4 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program in which 3 exercises are performed consecutively with minimal rest</li> <li class="seamTextUnorderedListItem">Body measurements, monthly for 5 months</li> <li class="seamTextUnorderedListItem">Questionnaires, monthly for 5 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program in which 6 exercises are performed consecutively with no rest between sets</li> <li class="seamTextUnorderedListItem">Body measurements, monthly for 5 months</li> <li class="seamTextUnorderedListItem">Questionnaires, monthly for 5 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program in which 5 repetitions are performed, followed by resting for 20 seconds</li> <li class="seamTextUnorderedListItem">Body measurements, monthly for 5 months</li> <li class="seamTextUnorderedListItem">Questionnaires, monthly for 5 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program in which 5 repetitions are performed, followed by resting for 20 seconds, plus additional repetitions</li> <li class="seamTextUnorderedListItem">Body measurements, monthly for 5 months</li> <li class="seamTextUnorderedListItem">Questionnaires, monthly for 5 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise is often recommended for people who have completed treatment for breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07023887' target='_blank'>ClinicalTrials.gov</a> </li></ul>
69
NEAREST SITE: 2260 miles
Allegheny General Hospital
Pittsburgh,PA
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06858449
Exercise Program and Protein Supplement to Improve Strength During Chemotherapy for Women with Stage I-III Breast Cancer
NeoChemoPRT: a Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer Scientific Title
Purpose
To study if an exercise program and high dose of protein supplement will improve body composition and strength for people receiving chemotherapy before surgery (neoadjuvant).
Who is this for?
Women with stage I, stage II, or some stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Exercise with Low Dose of Protein</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance (strength) exercise program, 6 months</li> <li class="seamTextUnorderedListItem">20 grams of protein supplement, after each exercise session</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Exercise with High Dose of Protein</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance (strength) exercise program, 6 months</li> <li class="seamTextUnorderedListItem">60 grams of protein supplement, after each exercise session</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistence training is a type of exercise aimed at improving muscular strength and endurance.</li> <li class="seamTextUnorderedListItem">Protein supplements can help your body build muscle.</li> <li class="seamTextUnorderedListItem">In this study, the protein is made of whey, which is a dairy product.</li> <li class="seamTextUnorderedListItem">The whey is non-GMO, grass-fed, soy and gluten free, unflavored, and unsweetened.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06858449' target='_blank'>ClinicalTrials.gov</a> </li></ul>
70
NEAREST SITE: 2260 miles
Allegheny General Hospital
Pittsburgh,PA
VISITS: 3 times per week for 3 months
PHASE: NA
NCT ID: NCT06115486
Exercise to Improve Muscle Mass After Treatment for Stage 0-III Breast Cancer
EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy Scientific Title
Purpose
To compare the ability of 2 group exercise programs to increase muscle mass for women after breast cancer treatment.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistance training in a small group, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Strength measurements</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Strength and conditioning training in a small group, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Strength measurements</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise to build muscle mass in people who have been treated for breast cancer may reduce toxicity from treatment, increase time to tumor progression, and prolong survival.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06115486' target='_blank'>ClinicalTrials.gov</a> </li></ul>
71
NEAREST SITE: 2273 miles
West Virginia University Cancer Institute
Morgantown,WV
VISITS: At least 2 visits in 2 weeks
PHASE: II
NCT ID: NCT05013255
Pioglitazone to Reduce Fatigue for Women with Stage 0-III HR+, HER2- Breast Cancer
Pioglitazone Therapy Targeting Fatigue in Breast Cancer Scientific Title
Purpose
To study if pioglitazone (Actos®) can reduce fatigue.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who are planning to receive a mastectomy. You must not have received any treatments except chemotherapy, and you must not have diabetes.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Low dose of pioglitazone (Actos®), by mouth, daily for 2 weeks </li> <li class="seamTextUnorderedListItem">Body weight measurements, 2 times in 2 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High dose of pioglitazone (Actos®), by mouth, daily for 2 weeks </li> <li class="seamTextUnorderedListItem">Body weight measurements, 2 times in 2 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No drug</li> <li class="seamTextUnorderedListItem">Body weight measurements, 2 times in 2 weeks</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fatigue is common in people with cancer and is difficult to treat.</li> <li class="seamTextUnorderedListItem">Chemotherapy, radiation, and surgery can make fatigue worse.</li> <li class="seamTextUnorderedListItem">Pioglitazone (Actos®) is an FDA-approved drug that is used to treat insulin resistance in people with diabetes.</li> <li class="seamTextUnorderedListItem">Pioglitazone may improve fatigue.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05013255' target='_blank'>ClinicalTrials.gov</a> </li></ul>
72
NEAREST SITE: 2299 miles
Roswell Park Cancer Institute
Buffalo,NY
VISITS: 1 visit
PHASE: NA
NCT ID: NCT06456411
Brain Scan and Virtual Reality to Decrease Pain for People with Stage 0-IV Breast Cancer
Real-Time Evaluation of Severity of Perceived Pain in Patients With Cancer by Using Functional Near-Infrared Spectroscopy (fNIRS), and Investigation of Pain Relief Utilizing Virtual Reality Technologies Scientific Title
Purpose
To study whether a virtual reality relaxation program can decrease pain and if this can be seen in the brain with a functional near-infrared spectroscopy scan.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are experiencing pain from treatment, and people who do not have breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Virtual Reality and Scan</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy scan, 1 time</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual reality, 1 time, at least 15 minutes</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Scan Only</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy scan, 1 time</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Functional near-infrared spectroscopy is a non-invasive type of imaging scan that can show pictures of the brain and brain activity.</li> <li class="seamTextUnorderedListItem">Virtual reality (VR) is a computer-generated experience that simulates the 3D environment.</li> <li class="seamTextUnorderedListItem">Virtual reality relaxation programs may help relieve pain in people with cancer who are receiving treatment. Relief of pain may be seen on a functional near-infrared spectroscopy scan.</li> <li class="seamTextUnorderedListItem">Results from people who do not have breast cancer will be compared to results from people with breast cancer.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06456411' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.techtarget.com/whatis/definition/virtual-reality' target='_blank'>Tech Target: What is Virtual Reality?</a> </li></ul>
73
NEAREST SITE: 2299 miles
Roswell Park Cancer Institute
Buffalo,NY
VISITS: Weekly for up to 1 year
PHASE: NA
NCT ID: NCT06833255
Support Services for Black Survivors of Stage 0-III Breast Cancer in Western New York
Thriving Beyond Breast Cancer: Post-Treatment Supportive Services Programming for Black Women to Alleviate Disparities During Survivorship Scientific Title
Purpose
To study whether a post-treatment supportive service program helps Black women transition into survivorship.
Who is this for?
Black or African American people with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who live in western New York and have completed breast cancer treatment (except hormone therapy if recommended) within the last year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group support and peer mentoring sessions, in person, 2-hour sessions, weekly for up to 1 year</li> <li class="seamTextUnorderedListItem">Interview</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The post-treatment supportive service program combines group support sessions and one-on-one peer mentoring sessions. The group support sessions include traditional support groups, education, activities, such as cooking lessons, celebrations, or facility tours, and guest speakers. The peer mentoring sessions are held with a long-term breast cancer survivor mentor who helps the mentee perform monthly self-assessments, create plans to help improve modifiable risk factors, and connect the mentee to providers or resources as needed.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06833255' target='_blank'>ClinicalTrials.gov</a> </li></ul>
74
NEAREST SITE: 2299 miles
Roswell Park Comprehensive Cancer Center
Buffalo,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06350500
Navigation to Provide Access to Support Services for Women with Stage 0-4 Breast Cancer
Addressing Disparities in Breast Cancer Care: An Approach to Health Equity Scientific Title
Purpose
To study a program that helps women with breast cancer receive and manage breast cancer care.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Support from patient navigator</li> <li class="seamTextUnorderedListItem">Interview</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The patient navigator will help connect you with support services, manage obstacles to care, and support your ability to manage cancer treatment.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06350500' target='_blank'>ClinicalTrials.gov</a> </li></ul>
75
NEAREST SITE: 2314 miles
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem,NC
VISITS: 3 visits within 2 years
PHASE: NA
NCT ID: NCT05309655
Impact of Hormone Therapy on Heart Health in Women with Stage I-III Breast Cancer
The Cardiac Outcomes With Near-Complete Estrogen Deprivation (CROWN) Study Scientific Title
Purpose
To study the effect of near complete estrogen deprivation (NCED) hormone therapy on heart health.
Who is this for?
Premenopausal women 18-55 years old with stage I, stage II, or stage III breast cancer. If you have hormone receptor positive (ER+ and/or PR+) breast cancer, you must be planning to receive or receiving treatment with an aromatase inhibitor or selective estrogen receptor degrader (SERD) hormone therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MRI scans, 3 times</li> <li class="seamTextUnorderedListItem">CT scans, 2 times</li> <li class="seamTextUnorderedListItem">Electrocardiogram (ECG or EKG), 2 times</li> <li class="seamTextUnorderedListItem">Blood tests, 3 times</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Near complete estrogen deprivation (NCED) is treatment with an aromatase inhibitor or selective estrogen receptor degrader (SERD) hormone therapy.</li> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">A magnetic resonance imaging (MRI) scan produces body pictures created by using magnetic energy rather than x-ray energy.</li> <li class="seamTextUnorderedListItem">A computed tomography (CT) scan produces body pictures created by x-ray energy.</li> <li class="seamTextUnorderedListItem">An electrocardiogram (ECG) test records electrical signals in your heart.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with hormone receptor negative (ER- and/or PR-) breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05309655' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.dukehealth.org/clinical-trials/directory/pro00110774' target='_blank'>Duke Health: Trial Information Page</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.lbbc.org/about-breast-cancer/side-effects/heart-health' target='_blank'>Living Beyond Breast Cancer: Heart Health</a> </li></ul>
76
NEAREST SITE: 2314 miles
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem,NC
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05595577
Exercise to Improve Heart and Brain Function for Stage I-III Breast Cancer
Improving Exercise Capacity With a Tailored Physical Activity Intervention in Lymphoma and Breast Cancer Patients Undergoing Treatment (PALS) Scientific Title
Purpose
To study if an exercise program helps improve exercise capability, heart function, memory, and quality of life compared to health classes.
Who is this for?
People with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy, trastuzumab (Herceptin®), immunotherapy, or radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, 1-2 sessions every week for 6 months</li> <li class="seamTextUnorderedListItem">Heart tests, 2 times</li> <li class="seamTextUnorderedListItem">Heart MRI scan</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health classes, virtual or in person, 12 sessions within 6 months</li> <li class="seamTextUnorderedListItem">Heart tests, 2 times</li> <li class="seamTextUnorderedListItem">Heart MRI scan</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some cancer treatments can harm the heart.</li> <li class="seamTextUnorderedListItem">Exercise may improve heart and brain function and improve quality of life.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, the exercise sessions include an aerobic warm-up, strength training, aerobic exercise of increasing intensity, and cool-down with elastic bands.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, the control health classes provide information about nutrition, stress management, sleep, and a healthy lifestyle.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05595577' target='_blank'>ClinicalTrials.gov</a> </li></ul>
77
NEAREST SITE: 2351 miles
University of Florida
Gainesville,FL
VISITS: Up to 4 visits in 6 months
PHASE: NA
NCT ID: NCT06461650
Program to Stop Nicotine Use Before Surgery for Women with Stage 0-III Breast Cancer
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction Scientific Title
Purpose
To study the effect of an education program designed to help women stop using nicotine products.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who are planning to receive reconstruction during surgery and who currently use nicotine products.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education program designed to help people stop using nicotine, up to 4 sessions in 2-6 months</li> <li class="seamTextUnorderedListItem">Surveys, 3 times</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nicotine use in people with breast cancer is associated with worse survival and more surgery problems compared to people who do not use nicotine.</li> <li class="seamTextUnorderedListItem">People who use nicotine are not usually able to receive reconstruction during surgery, which can be emotionally challenging.</li> <li class="seamTextUnorderedListItem">Being able to receive reconstruction during surgery may motivate people to quit nicotine.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06461650' target='_blank'>ClinicalTrials.gov</a> </li></ul>
78
NEAREST SITE: 2352 miles
University of Rochester
Rochester,NY
VISITS: 6 visits over 3-5 months
PHASE: NA
NCT ID: NCT03137095
Memory Problems During Chemotherapy in People with Stage I-III Breast Cancer
Longitudinal Pilot Mechanistic Study of the Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients and Non-Cancer Control Participants Scientific Title
Purpose
To study if and how your cognitive functioning skills, like memory and concentration, change as you receive chemotherapy.
Who is this for?
Women with newly diagnosed stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy, and women who do not have breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will undergo the following over 3-5 months: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">6 cognitive tests, during chemotherapy and 1 month after chemotherapy</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognitive tests study your cognition, which is your ability to think.</li> <li class="seamTextUnorderedListItem">Women without breast cancer will also be enrolled for comparison.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03137095' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/cancer/managing-cancer/side-effects/changes-in-mood-or-thinking/chemo-brain.html' target='_blank'>American Cancer Society: What is Chemo Brain?</a> </li></ul>
79
NEAREST SITE: 2354 miles
Integrative Cardiovasculal Physiology Laboratory, University of Florida
Gainesville,FL
VISITS: 3 visits every week for 3 months
PHASE: NA
NCT ID: NCT05848141
Rowing for Heart Health After Treatment for Women with Stage I-III Breast Cancer
Indoor Rowing as a Novel Exercise Therapy for Cardiovascular Rehabilitation in Middle-Aged and Older Breast Cancer Survivors Following Chemotherapy Scientific Title
Purpose
To study how rowing exercise affects heart health for breast cancer survivors.
Who is this for?
Women 40 to 80 years old with stage I, stage II, or stage III breast cancer who completed primary treatment between 6 months and 2 years ago. You must not have heart disease.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise with indoor rowing machine after study completion (optional)</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise with indoor rowing machine, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">People who have received chemotherapy and some other types of breast cancer treatment have a higher risk for heart disease that people who have not.</li> <li class="seamTextUnorderedListItem">Exercise may decrease the risk of heart disease.</li> <li class="seamTextUnorderedListItem">Each rowing exercise is about 50 minutes.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05848141' target='_blank'>ClinicalTrials.gov</a> </li></ul>
80
NEAREST SITE: 2354 miles
Integrative Cardiovascular Physiology Laboratory, University of Florida
Gainesville,FL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05913713
Exercise for Heart Health After Chemotherapy for Women with Stage I-III Breast Cancer
High Intensity Interval Training: Optimizing Exercise Therapy to Mitigate Cardiovascular Disease Risk Following Breast Cancer Chemotherapy Scientific Title
Purpose
To study the ability of high intensity or moderate intensity exercise to improve heart health after chemotherapy.
Who is this for?
Women 18 to 85 years old with stage I, stage II, or stage III breast cancer who completed chemotherapy between 6 months and 1.5 years ago. You must currently exercise less than 2.5 hours every week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High intensity exercise using a stationary bike, at home, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Moderate intensity exercise using a stationary bike, at home, 3 days every week for 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Continue routine exercise, 3 months</li> <li class="seamTextUnorderedListItem">Heart tests</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High or moderate intensity exercise using a stationary bike, at home, 3 days every week for 3 months (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">People who have received chemotherapy have a higher risk for heart disease that people who have not received chemotherapy.</li> <li class="seamTextUnorderedListItem">Exercise may decrease the risk of heart disease.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05913713' target='_blank'>ClinicalTrials.gov</a> </li></ul>
81
NEAREST SITE: 2354 miles
University of Florida
Gainesville,FL
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT05507879
Registry to Study Heart Problems from Chemotherapy in People with Stage I-III Breast Cancer
Characterization of TRPC6 to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure (Prospective Study) Scientific Title
Purpose
To study the TRPC6 biomarker to predict and prevent chemotherapy-related cardiac toxicity.
Who is this for?
People with stage I, stage II, or stage III breast cancer who are receiving or are planning to receive chemotherapy or trastuzumab (Herceptin®).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will provide the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Blood samples</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">Understanding how the TRPC6 biomarker is involved in these changes may allow early intervention against cardiac toxicity and also identify new biomarkers to protect long-term cardiac health.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05507879' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/diseases/16858-chemotherapy--the-heart-cardiotoxicity#:~:text=Cardiotoxicity%20is%20a%20term%20for,radiation%20therapy%20to%20the%20chest.' target='_blank'>Cleveland Clinic: Cardiotoxicity and Cancer Treatment</a> </li></ul>
82
NEAREST SITE: 2354 miles
University of Florida
Gainesville,FL
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT06327490
Imaging to Improve Manual Lymphatic Drainage for Lymphedema for People with Stage 0-III Breast Cancer
A Pilot Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer Scientific Title
Purpose
To study the use of lymphatic mapping with ICG to improve manual lymphatic drainage for people with lymphedema.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who are planning to receive axillary lymph node dissection and lymphatic system mapping with indocyanine green (ICG).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Manual lymphatic drainage, using images from lymphatic mapping with ICG, at home, daily for 2 years</li> <li class="seamTextUnorderedListItem">Arm measurements</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Manual lymphatic drainage, using standard methods, at home, daily for 2 years</li> <li class="seamTextUnorderedListItem">Arm measurements</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is abnormal swelling in the arm, hand, breast, or torso that develops as a side effect of breast cancer treatments like surgery and radiation therapy.</li> <li class="seamTextUnorderedListItem">1 in 5 people treated for breast cancer will develop lymphedema after treatment.</li> <li class="seamTextUnorderedListItem">Arm massage and manual lymphatic drainage are currently used to treat lymphedema.</li> <li class="seamTextUnorderedListItem">This trial is studying manual lymphatic drainage guided by the individual patient's anatomy as seen with ICG, a tracer used for imaging scans.</li> <li class="seamTextUnorderedListItem">A tracer, like ICG, helps doctors see and follow where something goes, like the flow of lymph fluid, during tests or surgery.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06327490' target='_blank'>ClinicalTrials.gov</a> </li></ul>
83
NEAREST SITE: 2354 miles
University of Florida
Gainesville,FL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT07042243
Digital Tool and Patient Navigators to Improve Access to Healthy Food for Stage 0-IV Breast Cancer
The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT) Scientific Title
Purpose
To study whether the MyCarePulse digital tool and ASCENT patient navigator program can help people get access to healthy food.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer whose diagnosis was within the last year, speak English or Spanish, and live in Florida.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">Standard of care</li> <li class="seamTextUnorderedListItem">MyCarePulse</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li> <li class="seamTextUnorderedListItem">MyCarePulse</li> <li class="seamTextUnorderedListItem">ASCENT patient navigator</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MyCarePulse is a digital tool that assesses the need for food assistance. </li> <li class="seamTextUnorderedListItem">The ASCENT patient navigator program is designed to improve access to nutritious food, improve one's confidence in eating a healthy diet, and improve diet quality compared to standard of care.</li> <li class="seamTextUnorderedListItem">Patient navigators can provide individualized support and connect people with community resources to promote healthy eating.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07042243' target='_blank'>ClinicalTrials.gov</a> </li></ul>
84
NEAREST SITE: 2354 miles
Integrative Cardiovasculal Physiology Laboratory, University of Florida
Gainesville,FL
VISITS: At least 1 visit
PHASE: NA
NCT ID: NCT04914663
Exercise to Reduce Heart Problems During Chemotherapy for Women with Stage I-III Breast Cancer
All-extremity Exercise as a Novel Strategy for Optimizing Cardiovascular Function During Chemotherapy for Breast Cancer Scientific Title
Purpose
To study if 2 different types of exercise reduce heart problems during chemotherapy.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy. You must not be receiving a CDK4/6 inhibitor, PARP inhibitor, or radiation during chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Full body exercise, at home, 3 months</li> <li class="seamTextUnorderedListItem">Physical function tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Treadmill exercise, at home, 3 months</li> <li class="seamTextUnorderedListItem">Physical function tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Physical function tests</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments, such as chemotherapy, can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">Exercise may help reduce these heart problems.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04914663' target='_blank'>ClinicalTrials.gov</a> </li></ul>
85
NEAREST SITE: 2354 miles
Institute on Aging; University of Florida
Gainesville,FL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05684367
Walking to Reduce Fatigue for Older Women After Treatment
Center-Based and Home-Based Walking Exercise Intervention to Reduce Fatigue in Older Breast Cancer Survivors (EXERGISE) Scientific Title
Purpose
To study if walking can reduce fatigue.
Who is this for?
Women at least 60 years old with stage I, stage II, or stage III breast cancer who completed treatment between 3 months and 1 year ago. You must be experiencing fatigue (feeling tired).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking at research center, 30 minutes per session, 3 days every week for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking at home, 30 minutes per session, 5 days every week for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many people experience fatigue (feeling tired) after cancer treatment.</li> <li class="seamTextUnorderedListItem">Older breast cancer survivors experience more fatigue than younger survivors.</li> <li class="seamTextUnorderedListItem">Aerobic exercise (such as walking) can improve fatigue in younger breast cancer survivors, but these effects are not as strong in older people. New methods are needed to reduce fatigue in older breast cancer survivors.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05684367' target='_blank'>ClinicalTrials.gov</a> </li></ul>
86
NEAREST SITE: 2382 miles
Scotland Health Care System
Laurinburg,NC
VISITS: Number of visits unavailable, 3 months
PHASE: NA
NCT ID: NCT06529120
Virtual Program to Improve Sleep Problems and Symptoms for Women With Stage 0-IV Breast Cancer
Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas Scientific Title
Purpose
To study a virtual mindfulness-based program called Nite2Day that is designed to improve sleep and help people manage symptoms.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer who received their diagnosis within the last year and who are having trouble sleeping.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nite2Day program, virtual, 45- to 60-minute sessions, weekly for 1.5 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women with breast cancer often experience trouble sleeping, fatigue, stress, and pain.</li> <li class="seamTextUnorderedListItem">In this study, participants will learn strategies to help them cope with trouble sleeping and daytime symptoms of fatigue, stress, and pain.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06529120' target='_blank'>ClinicalTrials.gov</a> </li></ul>
87
NEAREST SITE: 2383 miles
Mayo Clinic in Florida
Jacksonville,FL
VISITS: At least 2 visits
PHASE: NA
NCT ID: NCT06401889
Improving Skin and Quality of Life During Hormone Therapy for Women with Stage 0-III Breast Cancer
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy Scientific Title
Purpose
To study changes in skin quality and self-esteem during hormone therapy after meeting with an aesthetician.
Who is this for?
Postmenopausal women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who are planning to receive one of the following aromatase inhibitors: letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®). You must not have received chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visits with aesthetician</li> <li class="seamTextUnorderedListItem">Skin photos and measurements</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Skin quality may change after beginning to receive an aromatase inhibitor, such as letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Skin changes may affect a person's self-esteem.</li> <li class="seamTextUnorderedListItem">Aestheticians are skin care professionals. </li> <li class="seamTextUnorderedListItem">Meeting with an aesthetician may improve skin quality and therefore self-esteem.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06401889' target='_blank'>ClinicalTrials.gov</a> </li></ul>
88
NEAREST SITE: 2383 miles
Mayo Clinic in Florida
Jacksonville,FL
VISITS: 5 visits in 6 months
PHASE: NA
NCT ID: NCT06831838
Pain Management Program During Hormone Therapy for Stage 0-III Breast Cancer
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors Scientific Title
Purpose
To study if a pain management program reduces pain from hormone therapy, improves quality of life, and increases the chance that people will receive hormone therapy as recommended.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who are receiving letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor and experiencing pain.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Pain management program, 2 days</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 6 months</li> </ul> <p class="seamTextPara"> followed 6 months later by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Pain management program, 2 days (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The pain management program is a 2 day class that uses cognitive behavioral therapy (CBT) and focuses on skills to improve pain control, fatigue, sleep problems, thinking problems, and stress.</li> <li class="seamTextUnorderedListItem">The program also educates you about the effectiveness of aromatase inhibitors in prolonging survival without cancer coming back.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06831838' target='_blank'>ClinicalTrials.gov</a> </li></ul>
89
NEAREST SITE: 2383 miles
Mayo Clinic in Florida
Jacksonville,FL
VISITS: 1 visit
PHASE: NA
NCT ID: NCT07126522
HERCaRE Virtual App to Improve Survivorship for Black Women with Stage 0-III Breast Cancer
Advancing Survivorship Support Through Virtual Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) Scientific Title
Purpose
To study how well a virtual support platform called the Health Equity Resources for Breast Cancer Responsive Education (HERCaRE) app works to improve survivorship.
Who is this for?
Black women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed surgery, chemotherapy, and/or radiation and who live near the Mayo Clinic Florida (Jacksonville). Women currently receiving hormone therapy may participate.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">HERCaRE app, virtual, for 4-6 weeks</li> <li class="seamTextUnorderedListItem">Interview</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">HERCaRE is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help patients better understand and manage survivorship after breast cancer treatment.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07126522' target='_blank'>ClinicalTrials.gov</a> </li></ul>
90
NEAREST SITE: 2383 miles
Mayo Clinic in Florida
Jacksonville,FL
VISITS: 7 visits within 1 year 3 months
PHASE: II
NCT ID: NCT07044310
WBF-038 Prebiotic and Probiotic to Prevent Bone Loss for Women with Stage 0-III HR+ Breast Cancer Who Are Receiving an Aromatase Inhibitor
Phase 2 Trial of 5-Strain Probiotic Formulation in Hormone Receptor-Positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss Scientific Title
Purpose
To study how well WBF-038 probiotic and prebiotic works to prevent bone loss in women who are starting to receive an aromatase inhibitor.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who plan to begin receiving an aromatase inhibitor.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">WBF-038, by mouth, daily for 1 year</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Bone density tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are a type of hormone therapy commonly used to treat hormone receptor-positive breast cancer. The approved aromatase inhibitors are anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Aromatase inhibitors can lead to reduced bone density.</li> <li class="seamTextUnorderedListItem">WBF-038 is a combination of prebiotics (food for healthy bacteria) and probiotics (healthy bacteria).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07044310' target='_blank'>ClinicalTrials.gov</a> </li></ul>
91
NEAREST SITE: 2388 miles
Duke Cancer Network
Durham,NC
VISITS: 3 visits in 4 months
PHASE: NA
NCT ID: NCT06555588
ENGAGE Telehealth Program to Reduce Symptoms and Improve Quality of Life for People with Metastatic Breast Cancer
Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients With Advanced Cancer Scientific Title
Purpose
To study the ability of ENGAGE, a telehealth program, to reduce pain, fatigue, and distress and improve quality of life for people with metastatic breast cancer.
Who is this for?
People with metastatic (stage IV) breast cancer who are experiencing pain, fatigue, and/or distress. You must be receiving care at a Duke Cancer Network (DCN) clinic.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ENGAGE program, virtual, 4 sessions</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Supportive Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supportive care program, virtual, 4 sessions</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times in 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ENGAGE sessions use Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT) approaches to manage pain, fatigue, and distress.</li> <li class="seamTextUnorderedListItem">Supportive care sessions focus on education, support, and resources focused on common cancer-related concerns, such as education on symptoms, body image concerns, and financial concerns.</li> <li class="seamTextUnorderedListItem">All sessions (Group 1 and Group 2) are led by trained therapists and are 45-60 minutes long.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06555588' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.nami.org/treatment/how-i-use-act-and-cbt-to-help-people-cope-with-health-conditions/' target='_blank'>National Alliance on Mental Illness: Using ACT and CBT to Help People Cope with Health Conditions</a> </li></ul>
92
NEAREST SITE: 2395 miles
Moffitt Cancer Center
Tampa,FL
VISITS: 2 times within 3 months
PHASE: NA
NCT ID: NCT07018986
The MIND Diet to Improve Thinking Problems for Women with Stage I-III Breast Cancer
The MIND-BC Study: MIND Diet for Breast Cancer Cognition Scientific Title
Purpose
To study the safety and effects (good and bad) of the MIND diet for cognitive problems (thinking problems).
Who is this for?
Women with stage I, stage II, or stage III breast cancer who completed cancer treatment 6 months to 3 years ago and have cancer-related cognitive problems (thinking problems).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Consume the MIND diet, for 3 months</li> <li class="seamTextUnorderedListItem">Check in with a diet coach and dietitian, weekly</li> <li class="seamTextUnorderedListItem">Questionnaires and cognitive tests, 2 times within 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual diet</li> <li class="seamTextUnorderedListItem">Check-in sessions will be about general health (e.g., healthy hair, skin, eyesight), not diet</li> <li class="seamTextUnorderedListItem">Questionnaires and cognitive tests, 2 times within 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The MIND diet is a combination of the Mediterranean and DASH diets and emphasizes eating high-nutrient, plant-based foods such as green leafy vegetables, nuts, berries, fish, and olive oil while limiting intake of foods high in saturated fat, pre-processed snacks, sugar, red and processed meat.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07018986' target='_blank'>ClinicalTrials.gov</a> </li></ul>
93
NEAREST SITE: 2395 miles
Moffitt Cancer Center
Tampa,FL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05645471
Together After Cancer: Online Program to Support Latinas and Their Partners After Treatment
Comparative Effectiveness of Together After Cancer Among Breast Cancer Survivors and Their Intimate Partners Scientific Title
Purpose
To evaluate the impact of OurRelationship, an online self-help relationship intervention, with coach calls for Latina breast cancer survivors and their partners.
Who is this for?
Latina/Hispanic people diagnosed with breast cancer within the last 5 years who have completed treatment, are in a committed relationship for at least 6 months, and live in Florida. Your partner must also be willing to participate in the trial.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">OurRelationship online program, 1-2 months</li> <li class="seamTextUnorderedListItem">Coach calls, by phone or Zoom</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Screening to assess relationship/intimacy issues</li> <li class="seamTextUnorderedListItem">Referrals to various support groups (if needed)</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">In the OurRelationship online program, partners complete the majority of the program on their own and come together for 2-3 key conversations with their partner.</li> <li class="seamTextUnorderedListItem">The coach calls serve several purposes: a) helping couples stay on schedule; b) addressing any technical questions; and c) collecting research data.</li> <li class="seamTextUnorderedListItem">Couples-based psychosocial programs improve the quality of life and emotional and physical health of cancer survivors and their partners.</li> <li class="seamTextUnorderedListItem">Researchers are interested in learning if couples assigned to the OurRelationship online program report changes in their relationship functioning, psychological functioning (depression, anxiety, and perceived stress), and cancer-related quality of life (pain, fatigue, body image, and quality of life).</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05645471' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life' target='_blank'>Breastcancer.org: Managing Life With Cancer</a> </li></ul>
94
NEAREST SITE: 2406 miles
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Chapel Hill,NC
VISITS: 3 visits within 1 year
PHASE: II
NCT ID: NCT06727773
Memantine and Exercise to Improve Thinking During Chemotherapy for Women with Stage I-III Breast Cancer
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer Scientific Title
Purpose
To study the safety and effects (good and bad) of memantine (Namenda®) and a cancer exercise program called MEM+EX in addressing cancer-related thinking problems and biomarkers.
Who is this for?
Women, age 50 and older, with stage I, stage II, or stage III breast cancer who have received at least one cycle of chemotherapy and are experiencing cognitive problems. You must not have received other cancer treatments including radiation, hormone therapy, or immunotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Memantine (Namenda®), by mouth</li> <li class="seamTextUnorderedListItem">MEM plus EX supervised exercise program, virtual, 3 times per week</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 1 year</li> <li class="seamTextUnorderedListItem">Blood tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Memantine (Namenda®), by mouth</li> <li class="seamTextUnorderedListItem">Access to exercise videos</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 1 year</li> <li class="seamTextUnorderedListItem">Blood tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo, by mouth</li> <li class="seamTextUnorderedListItem">Access to exercise videos</li> <li class="seamTextUnorderedListItem">Questionnaires, 3 times within 1 year</li> <li class="seamTextUnorderedListItem">Blood tests</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognitive problems, which are problems with thinking, are common in people who have received breast cancer treatment.</li> <li class="seamTextUnorderedListItem">Memantine (Namenda®), which is approved to treat cognitive problems in people with dementia, is a promising medication to address cognitive problems in people with breast cancer.</li> <li class="seamTextUnorderedListItem">Exercise may enhance the effects of memantine (Namenda®).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06727773' target='_blank'>ClinicalTrials.gov</a> </li></ul>
95
NEAREST SITE: 2406 miles
University of North Carolina at Chapel Hill
Chapel Hill,NC
VISITS: Number of visits unavailable, up to 15 years
PHASE: NA
NCT ID: NCT07214610
Behavioral Program to Improve Communication With Your Healthcare Team for Women With Stage I-IV Breast Cancer
Carolina Breast Cancer Study: Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes in the Carolina Breast Cancer Study, Phase 4 Scientific Title
Purpose
To study whether a behavioral intervention increases confidence in a person's ability to communicate with their healthcare team about health concerns.
Who is this for?
Women with newly diagnosed stage I, stage II, stage III, or stage IV (metastatic) breast cancer who live in North Carolina.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Interview</li> <li class="seamTextUnorderedListItem">Provide blood or saliva sample</li> <li class="seamTextUnorderedListItem">Behavioral program, 1 year</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The behavioral program includes self-assessments, symptom reporting tools, interactions with nurses and educators, webinars and newsletters, and educational materials. Participants will learn about the study results.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07214610' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/resources-support/prepare-for-visit/' target='_blank'>Metastatic Trial Talk: Communicating With Your Healthcare Team</a> </li></ul>
96
NEAREST SITE: 2406 miles
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill,NC
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT04073966
Studying Brain Function Changes During Radiation in People with Brain Metastases
Magnetic Resonance Imaging Biomarkers for Radiation-Induced Neurocognitive Decline Following Stereotactic Radiosurgery of Newly Diagnosed Brain Metastases: An Observational Pilot Study Scientific Title
Purpose
To study why radiation causes brain function changes to help doctors predict and prevent brain function changes.
Who is this for?
People with metastatic (stage IV) breast cancer that has spread to the brain (brain metastasis) who are receiving stereotactic radiosurgery (SRS). You must not have received surgery to the lesion receiving SRS or any radiation to the brain or head.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MRI scans</li> <li class="seamTextUnorderedListItem">Neurocognitive function tests</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Please contact research site for trial schedule</i></p>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stereotactic radiosurgery (SRS) is a type of radiation therapy that delivers a high dose of radiation only to the areas of cancer in the brain and avoids the surrounding normal brain tissue.</li> <li class="seamTextUnorderedListItem">A magnetic resonance imaging (MRI) scan produces body pictures created by using magnetic energy rather than x-ray energy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04073966' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://mbcbrainmets.org/' target='_blank'>MBCBrainMets.org</a> </li></ul>
97
NEAREST SITE: 2430 miles
Virginia Commonwealth University
Richmond,VA
VISITS: 3 visits within 4 months
PHASE: NA
NCT ID: NCT05130606
Video Versus Fact Sheet to Increase Genetic Counseling and Testing for Latina Women With Stage 0-IV Breast Cancer or High-Risk Women
Testing a Narrative Intervention to Enhance Genetic Counseling and Testing (CONTIGO) Scientific Title
Purpose
To compare a culturally targeted video and a Spanish-language fact sheet for enhancing genetic counseling, increasing genetic testing, and improving psychosocial outcomes.
Who is this for?
Latina women with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer or healthy women with a family history of cancer that suggests hereditary breast and ovarian cancer who speak Spanish. You must not have received genetic counseling or testing.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch the video: <q>Is My Cancer Hereditary? Rosa Visits a Genetic Counselor,</q> virtual</li> <li class="seamTextUnorderedListItem">Surveys, 3 times within 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Read a fact sheet, virtual</li> <li class="seamTextUnorderedListItem">Surveys, 3 times within 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The culturally targeted video is in Spanish with English subtitles. It provides education about genetic counseling and testing and hereditary breast and ovarian cancer to at-risk Latinas.</li> <li class="seamTextUnorderedListItem">The fact sheet includes information about genes, breast cancer, risk factors for hereditary breast and ovarian cancer, genetic counseling and testing, and resources.</li> <li class="seamTextUnorderedListItem">All participants will be offered genetic counseling and testing.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05130606' target='_blank'>ClinicalTrials.gov</a> </li></ul>
98
NEAREST SITE: 2433 miles
Sibley Memorial Hospital
Washington D.C.,DC
VISITS: 4 visits within 1 year 2 months
PHASE: NA
NCT ID: NCT05780814
Improving Sleep Problems and Weight Loss for Women After Treatment
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer (COIN) Scientific Title
Purpose
To study the ability of a cognitive behavioral therapy (CBT) program to improve sleep problems before losing weight.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who were diagnosed within the last 10 years and have completed treatment (except hormone therapy). You must also be overweight (BMI > 25), planning to lose weight, and experiencing sleep problems.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cognitive behavioral therapy (CBT) sessions to improve sleep, virtual, 6 times within 2 months</li> <li class="seamTextUnorderedListItem">Videos about weight loss, 19 videos</li> <li class="seamTextUnorderedListItem">Electronic sleep diary, 1 week</li> <li class="seamTextUnorderedListItem">Body measurements, 4 times</li> <li class="seamTextUnorderedListItem">DEXA scans, 2 times</li> <li class="seamTextUnorderedListItem">Smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires, 5 times</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions about sleep and cancer, virtual, 6 times within 2 months</li> <li class="seamTextUnorderedListItem">Body measurements, 4 times</li> <li class="seamTextUnorderedListItem">DEXA scans, 2 times</li> <li class="seamTextUnorderedListItem">Smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires, 5 times</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The cognitive behavioral therapy (CBT) program combines education and behavioral techniques to reduce sleep problems (insomnia).</li> <li class="seamTextUnorderedListItem">Cognitive behavioral therapy (CBT) is a type of therapy that focuses on the relationship between thoughts, feelings, and behaviors.</li> <li class="seamTextUnorderedListItem">All participants will follow a program with the goals of increasing physical activity, improving diet, and losing weight.</li> <li class="seamTextUnorderedListItem">Wearable devices such as smart watches and FitBits are used to track your physical activity.</li> <li class="seamTextUnorderedListItem">A DEXA scan measures fat, muscle, and bone density.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05780814' target='_blank'>ClinicalTrials.gov</a> </li></ul>
99
NEAREST SITE: 2433 miles
Sibley Memorial Hospital
Washington D.C.,DC
VISITS: 1 visit every week for 1 month
PHASE: NA
NCT ID: NCT06536881
Fasting to Improve Adherence to Chemotherapy for Women with Stage I-III Breast Cancer
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming (GAMMER) Study in Early Stage Breast Cancer Receiving Chemotherapy Scientific Title
Purpose
To study if fasting (not eating) for 1-2 days during chemotherapy helps women continue receiving chemotherapy as prescribed.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are planning to receive one of the following chemotherapy treatments: dose dense doxorubicin (Doxil®) and cyclophosphamide (Cytoxan®) (called ddAC) or docetaxel (Taxotere®) and cyclophosphamide (Cytoxan®) (called TC).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fast (not eat, except for water) for 1-2 days during chemotherapy</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, weekly for 3 weeks</li> <li class="seamTextUnorderedListItem">Blood samples, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Questionnaires, weekly for 1 month</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Previous research suggests that fasting during chemotherapy is safe and can prevent some toxic effects of chemotherapy without causing chronic weight loss.</li> <li class="seamTextUnorderedListItem">Fasting may allow people to experience less issues during chemotherapy (tolerance) and receive chemotherapy as prescribed (adherence).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06536881' target='_blank'>ClinicalTrials.gov</a> </li></ul>
100
NEAREST SITE: 2434 miles
Medstar Georgetown University Hospital
Washington D.C.,DC
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05334732
Sisters Informing Sisters Coaching Program to Improve Treatment Adherence in Black Women with Stage I-III Breast Cancer
Improving Communication and Adherence in Black Breast Cancer Survivors Scientific Title
Purpose
To study if the Sisters Informing Sisters coaching program increases adherence to treatment.
Who is this for?
Black women with newly diagnosed stage I, stage II, or stage III breast cancer who received surgery less than 1 month ago and are planning to begin chemotherapy or hormone therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sisters Informing Sisters coaching program</li> <li class="seamTextUnorderedListItem">Workbook </li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">National Cancer Institute treatment information booklet</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Please contact research site for trial schedule</i></p>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sisters Informing Sisters is a peer-based, culturally-tailored, positive role-modeling coaching program.</li> <li class="seamTextUnorderedListItem">In Sisters Informing Sisters, Black cancer survivors educate Black women with breast cancer about how to communicate with their doctors and the importance of completing treatment.</li> <li class="seamTextUnorderedListItem">The National Cancer Institute treatment information booklet provides women with national-level recommendations regarding treatment recommendations.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05334732' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://richmondmagazine.com/life-style/health/going-for-the-moon-shot/' target='_blank'>Richmond Magazine: Sisters Informing Sisters</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/latest-news/breast-cancer-death-rates-are-highest-for-black-women-again.html#:~:text=Black%20women%20have%20the%20lowest%205%2Dyear%20relative%20breast%20cancer,and%20every%20breast%20cancer%20subtype.&text=There%20is%20a%206%25%20t' target='_blank'>American Cancer Society: Black Women and Breast Cancer</a> </li></ul>
101
NEAREST SITE: 2434 miles
Georgetown University
Washington D.C.,DC
VISITS: 1 month
PHASE: NA
NCT ID: NCT06892275
Education About Decision-Making for a Screening Breast MRI Scan for Black and/or Latina Women at High Risk for Breast Cancer
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI Scientific Title
Purpose
To study decision support methods about breast MRI.
Who is this for?
Black and/or Latina women with no personal history of breast cancer who have received a mammogram at Ralph Lauren Center (Washington, DC) and are at high risk for breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Letter, by mail</li> <li class="seamTextUnorderedListItem">Decision aid, by email or mail</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Letter, by mail</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women at high risk for breast cancer may benefit from a breast MRI scan in addition to a mammogram.</li> <li class="seamTextUnorderedListItem">This study provides information needed to help a woman decide about having a breast MRI scan.</li> <li class="seamTextUnorderedListItem">All participants will receive a letter with their estimated lifetime risk for breast cancer, information about screening breast MRI, and instructions for contacting a nurse practitioner.</li> <li class="seamTextUnorderedListItem">The decision aid in this study describes two different breast cancer screening plans: (1) yearly mammogram only; and (2) yearly mammogram plus yearly breast MRI. The decision aid provides balanced information about breast MRI, including its risks, limitations, and benefits. The decision aid will emphasize that there is no 'correct' decision and women should pick the plan that is right for them. </li> <li class="seamTextUnorderedListItem">Study materials are available in English and Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06892275' target='_blank'>ClinicalTrials.gov</a> </li></ul>
102
NEAREST SITE: 2437 miles
Adventhealth
Orlando,FL
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT07231159
Understanding Barriers to Follow-Up After a Positive Breast Cancer Screening Result
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots Scientific Title
Purpose
To study a community-based outreach program for screening, diagnosis, and treatment of breast cancer.
Who is this for?
Women, age 40-74 years, who received a result of "positive" for breast cancer following screening.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Referral for follow-up after receiving a <q>positive</q> breast cancer screening result</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is looking at differences between adults who accept or decline follow-up after a <q>positive</q> cancer screening result. The researchers are looking for factors that prevent or make it easier for someone to receive cancer screening, diagnosis, treatment, and clinical trial screening. They are also seeking to understand people's feelings towards navigators who may help people receive these services.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people who were screened for other cancers.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07231159' target='_blank'>ClinicalTrials.gov</a> </li></ul>
103
NEAREST SITE: 2452 miles
Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore,MD
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT07032545
Broccoli Microgreens for Obese Women with Stage I-III Breast Cancer
Metabotyping of a Functional Food, Broccoli Microgreen, in Obese Breast Cancer Survivors Scientific Title
Purpose
To study if people can stick to a diet that includes broccoli microgreens (BMG) every day and how their bodies respond.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who completed cancer treatment at least 2 months and no more than 5 years ago and who are obese (BMI >30 kg/m²).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">One cup of broccoli microgreens (BMG), by mouth, daily for 2 weeks</li> <li class="seamTextUnorderedListItem">Blood test</li> <li class="seamTextUnorderedListItem">Provide stool (poop) sample</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Obesity can increase the risk of cancer coming back.</li> <li class="seamTextUnorderedListItem">Broccoli microgreens (BMG) are young broccoli plants that may help prevent cancer and improve health.</li> <li class="seamTextUnorderedListItem">Results from this study may help create new diet strategies to improve health and reduce cancer risk in patients who are overweight or obese.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07032545' target='_blank'>ClinicalTrials.gov</a> </li></ul>
104
NEAREST SITE: 2454 miles
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore,MD
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05386719
Screening for Diabetes, High Cholesterol, and Heart Disease in People with Breast Cancer After Treatment
A Cardiometabolic Screening Program for Breast Cancer Survivors Scientific Title
Purpose
To study a screening program for prediabetes, diabetes, high cholesterol, and heart disease in breast cancer survivors, as well as a program to direct people to resources for management.
Who is this for?
People with stage I, stage II, or stage III breast cancer who completed treatment at least 3 months ago. You must be receiving care at Johns Hopkins Medical Institute; Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD; Green Spring Station in Lutherville-Timonium, MD; or Sibley Memorial Hospital in Washington, DC.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Blood tests, 1-2 times in 1 year</li> <li class="seamTextUnorderedListItem">Referral to primary care, nutrition, exercise, hormone health, and/or heart health provider(s) based on risk factors</li> <li class="seamTextUnorderedListItem">Educational handouts based on risk factors</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Prediabetes, diabetes, high cholesterol, and being overweight/obese are common in people with early stage breast cancer.</li> <li class="seamTextUnorderedListItem">The Healthful Eating, Activity and Weight Program (HEAWP) and Cardiovascular Disease Prevention Program are designed to help people manage these conditions.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05386719' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.hopkinsmedicine.org/gim/clinical/lifestyle-weight/' target='_blank'>Johns Hopkins: Healthful Eating, Activity and Weight Program</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.hopkinsmedicine.org/health/wellness-and-prevention/preventing-cardiovascular-diseases' target='_blank'>Johns Hopkins: Preventing Cardiovascular Diseases</a> </li></ul>
105
NEAREST SITE: 2519 miles
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia,PA
VISITS: 1 visit every 2-3 weeks for 4 months
PHASE: NA
NCT ID: NCT05327608
Intermittent Fasting During Chemotherapy for People with Stage 0-III and Oligometastatic HER2- Breast Cancer
Intermittent Fasting for Patients With HER2- Negative and ER/PR <10% Breast Cancer and Body Mass Index >= 25 Receiving Neoadjuvant Chemotherapy Scientific Title
Purpose
To study the ability of intermittent fasting to improve breast cancer outcomes, prevent weight gain, and reduce chemotherapy side effects.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, some stage III, or some oligometastatic (stage IV) HER2 negative (HER2-) breast cancer who are planning to receive AC-T chemotherapy before surgery (neoadjuvant). You must have a BMI between 25 and 40.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Intermittent fasting, daily for 4 months</li> <li class="seamTextUnorderedListItem">Questionnaires, every 2-3 weeks for 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Time-restricted eating, a form of intermittent fasting, is eating all food within an 8-10 hour window each day and fasting (not eating) the remaining hours of the day.</li> <li class="seamTextUnorderedListItem">Doxorubicin (Adriamycin®) and cyclophosphamide (Cytoxan®) followed by paclitaxel (Taxol®), nab-paclitaxel (Abraxane®), or docetaxel (Taxotere®) is often called the AC-T chemotherapy regimen.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05327608' target='_blank'>ClinicalTrials.gov</a> </li></ul>
106
NEAREST SITE: 2531 miles
Virtua Health
Voorhees Township,NJ
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05704842
Exercise to Reduce Fatigue During Chemotherapy for Women with Stage I-III Breast Cancer
Pilot Study to Evaluate the Impact of a Home-Based Exercise Program on Cancer-Related Fatigue in Breast Cancer Patients Undergoing Curative-Intent Chemotherapy Scientific Title
Purpose
To study if exercise reduces fatigue during treatment with chemotherapy.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who plan to receive chemotherapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit with physical therapist</li> <li class="seamTextUnorderedListItem">Complete home-based exercise program</li> <li class="seamTextUnorderedListItem">Complete online surveys, weekly</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard Treatment</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Complete online surveys, weekly</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The home-based exercise program includes exercises such as: core stabilization, core extension, leg extensions, squats with and without weights, shoulder exercises, and arm exercises.</li> <li class="seamTextUnorderedListItem">The online surveys will assess your symptoms and fatigue.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05704842' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/fatigue' target='_blank'>Breastcancer.org: Cancer Fatigue</a> </li></ul>
107
NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge,NJ
VISITS: 5 visits, over 2 years
PHASE: NA
NCT ID: NCT02743858
Learning Why Some Women Develop Lymphedema After Surgery and Others Do Not
A Prospective Surveillance Program for Assessment and Treatment of Breast Cancer-Related Lymphedema After Axillary Lymph Node Dissection Scientific Title
Purpose
To study why some women develop lymphedema after breast cancer surgery that includes an axillary lymph node dissection (ALND).
Who is this for?
Women recently diagnosed with stage I, stage II or stage III breast cancer. You must be planning to have a breast cancer surgery at Memorial Sloan Kettering Cancer Center that includes the removal of nearby lymph nodes under the arm (ALND)
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> Over 2 years, you will receive: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">5 arm measurements</li> <li class="seamTextUnorderedListItem">5 height and weight measurements</li> <li class="seamTextUnorderedListItem">5 quality of life questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Breast tissue taken during surgery will be studied for signs of inflammation, which may increase a woman's risk for lymphedema.</i></p>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is a painful swelling of the hand, wrist and/or arm that can occur after breast cancer surgery.</li> <li class="seamTextUnorderedListItem">The surgery that removes lymph nodes from your underarm area is called an axillary lymph node dissection (ALND).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02743858' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-pdq' target='_blank'>NCI: Lymphedema PDQ</a> </li></ul>
108
NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge,NJ
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05910294
Preventing and Improving Sexual Health Concerns for People with DCIS and Stage I-III Breast Cancer
Randomized Pilot Prevention Trial to Improve Sexual and Vulvovaginal Health Concerns in Premenopausal Female Breast Cancer Patients Receiving Ovarian Suppression Scientific Title
Purpose
To study whether sexual health counseling and using a non-hormonal vaginal moisturizer at the start of hormone therapy may prevent or reduce sexual side effects.
Who is this for?
Premenopausal or perimenopausal women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who are receiving or planning to receive hormone therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive recommendations for vaginal moisturizers</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sexual health counseling</li> <li class="seamTextUnorderedListItem">Receive non-hormonal moisturizers, 3-5 times per week</li> <li class="seamTextUnorderedListItem">Consultation with pelvic floor physical therapist</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">If you are in group 1, you will receive recommendations for vaginal moisturizers but will purchase the moisturizers at your local pharmacy.</li> <li class="seamTextUnorderedListItem">If you are in group 2, you will receive non-hormonal vaginal moisturizers, such as: Hyalogyn, Replens, Liquibeads, or Vitamin E capsules.</li> <li class="seamTextUnorderedListItem">Sexual side effects include vaginal dryness and sexual dysfunction.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05910294' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/sex-intimacy' target='_blank'>Breastcancer.org: Sexual Health During and After Breast Cancer</a> </li></ul>
109
NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge,NJ
VISITS: 2 visits within 2 months
PHASE: IV
NCT ID: NCT07042581
Revaree Plus Vaginal Suppository for Women with Stage 0-III HR+ Breast Cancer and Vaginal Dryness
Evaluation of Revaree Plus in Women With Breast Cancer Scientific Title
Purpose
To study whether Revaree Plus vaginal suppository improves vaginal health for women with vaginal dryness due to breast cancer treatment.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who have completed chemotherapy and radiation (if recommended) and are currently receiving an aromatase inhibitor or tamoxifen (Nolvadex®) and experiencing vaginal dryness.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Revaree Plus, by vaginal suppository</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 2 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Vaginal dryness is a common side effect of hormone therapy, which includes aromatase inhibitors and tamoxifen (Nolvadex®).</li> <li class="seamTextUnorderedListItem">Aromatase inhibitors are letrozole (Femara®), anastrozole (Arimidex®), and exemestane (Aromasin®).</li> <li class="seamTextUnorderedListItem">Revaree Plus is a medicine called hyaluronic acid that is delivered by insertion into the vagina with a suppository.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07042581' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://hellobonafide.com/products/revaree-plus' target='_blank'>Bonafide: Revaree Plus</a> </li></ul>
110
NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Consent Only)
Basking Ridge,NJ
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT06721065
Language Translation During Appointments for People With Stage I-IV Breast Cancer
RSMI HEALS (Health Equity Advances Through Language Solutions) (AI) Scientific Title
Purpose
To measure 3 different ways of translating medical conversations from English to Spanish or Mandarin.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer that was diagnosed within the last 2 months and whose preferred language is Spanish or Mandarin. You must be receiving care at Memorial Sloan Kettering Cancer Center in New York City, NY.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Translation of medical conversation in real time, audio only</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Translation of medical conversation after the speaker has stopped talking, audio only</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Translation of medical conversation after the speaker has stopped talking, audio and video</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">People who do not speak English well can better understand medical conversations that are conducted in or translated to their preferred language.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06721065' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.interprefy.com/resources/how-remote-simultaneous-interpretation-works#:~:text=Remote%20Simultaneous%20Interpretation%20(RSI)%20is,no%20equipment%20and%20no%20barriers.' target='_blank'>Interprefy: Remote Simultaneous Interpretation</a> </li><li class='seamTextUnorderedListItem'><a href='https://interpreter.io/Blog/understanding-consecutive-interpretation-a-simple-guide.html#:~:text=In%20consecutive%20interpretation%2C%20the%20interpreter,to%20jot%20down%20key%20points.' target='_blank'>Interpreter.io: Remote Consecutive Interpretation</a> </li></ul>
111
NEAREST SITE: 2539 miles
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge,NJ
VISITS: Number of visits unavailable
PHASE: III
NCT ID: NCT06144164
Managing Lymphedema After Lymph Node Surgery for Women with Stage I-III Breast Cancer
A Prospective Cohort Study of Patients Undergoing ALND for Treatment of Breast Cancer: The Efficacy of a Comprehensive Prevention Program in Decreasing the Incidence of Lymphedema and Improving Quality of Life Scientific Title
Purpose
To study the ability of a lymphedema prevention program to help lymph fluid drain out of the arm, prevent lymphedema, and improve quality of life.
Who is this for?
Women 18-75 years old with stage I, stage II, or stage III breast cancer who are planning to receive axillary lymph node dissection or sentinel lymph node biopsy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Immediate lymphatic reconstruction (ILR) during lymph node surgery</li> <li class="seamTextUnorderedListItem">Lymphatic massage, at home, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Compression garments, daily for 3 months</li> <li class="seamTextUnorderedListItem">Arm measurements, up to 2 years</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Lymphedema is the build up of fluid and abnormal swelling of the arm (in the case of axillary lymph node dissection or sentinel lymph node biopsy surgery).</li> <li class="seamTextUnorderedListItem">Lymphedema is caused by damage to the lymphatic system and inability to drain excess lymph fluid.</li> <li class="seamTextUnorderedListItem">Immediate Lymphatic Reconstruction (ILR) is a procedure to rebuild damaged lymphatic system.</li> <li class="seamTextUnorderedListItem">Lymphatic massage may help reduce swelling in your body.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06144164' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mskcc.org/cancer-care/patient-education/about-your-immediate-lymphatic-reconstruction-ilr-procedure#:~:text=ILR%20is%20a%20procedure%20to,your%20axillary%20lymph%20node%20dissection.' target='_blank'>Memorial Sloan Kettering Cancer Center: About Your Immediate Lymphatic Reconstruction (ILR) Procedure</a> </li></ul>
112
NEAREST SITE: 2541 miles
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton
Hamilton,NJ
VISITS: Number of visits unavailable
PHASE: II
NCT ID: NCT05559164
Reducing Treatment-Related Heart Problems From Anti-HER2 Targeted Therapy
STACIE: Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted Therapy Scientific Title
Purpose
To study whether atorvastatin (Lipitor®) reduces treatment delays or early discontinuations of anti-HER2 targeted therapy due to treatment-related heart problems.
Who is this for?
Women with stage I, stage II, or stage III HER2 positive (HER2+) breast cancer who are planning to receive treatment with anti-HER2 targeted therapy. You must not currently be receiving any cholesterol drugs.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Atorvastatin (Lipitor®), by mouth, daily</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 1.25 years</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some breast cancer treatments including anti-HER2 targeted therapy can cause or increase the risk of heart problems, which is called cardiotoxicity. </li> <li class="seamTextUnorderedListItem">Atorvastatin (Lipitor®) is a cholesterol drug called a statin. Statins lower <q>bad cholesterol</q> which may reduce the risk of heart problems.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05559164' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/targeted-therapy/what-are-anti-her2-therapies' target='_blank'>Breastcancer.org: Anti-HER2 Targeted Therapy</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/statins/art-20045772' target='_blank'>Mayo Clinic: Statins Including Atorvastatin (Lipitor®)</a> </li></ul>
113
NEAREST SITE: 2567 miles
Memorial Sloan Kettering Cancer Center
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT04458532
Aerobic Exercise to Improve Cardiovascular Health in Post-Menopausal Women After Breast Cancer Treatment
A Randomized Trial to Minimize Non-Response to Aerobic Training in Post-Menopausal Women With Early Stage Breast Cancer Scientific Title
Purpose
To study how different amounts of aerobic exercise improves cardiovascular health after breast cancer treatment.
Who is this for?
Postmenopausal women with stage I, stage II, or stage III breast cancer who have completed treatment with surgery and radiation, chemotherapy, or trastuzumab (Herceptin®) within the past 1-5 years.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 4 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 5 hours/week for 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 2.5 hours/week for 8 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 5 hours/week for 8 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised aerobic exercise, 2.5 hours/week for 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic exercise is physical activity of light-to-moderate intensity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for at least 10 minutes.</li> <li class="seamTextUnorderedListItem">The researchers will study the effects of different exercise programs on your cardiovascular health, which is how well your body uses oxygen, how well your heart pumps blood, how well your lungs function, and how healthy your blood vessels are.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04458532' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise</a> </li></ul>
114
NEAREST SITE: 2567 miles
Memorial Sloan Kettering Cancer Center
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06037954
Improving Mental Health for Older Adults with Breast Cancer
Mental Health Care Initiation Intervention for Older Adults With Cancer Scientific Title
Purpose
To study the ability of the Open Door for Cancer (OD-C) approach to improve mental health for older adults with breast cancer.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who were diagnosed at age 65 or older and are currently receiving treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Open Door for Cancer (OD-C) approach, by phone or videoconference, 3 sessions within 1.5 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mental health screening</li> <li class="seamTextUnorderedListItem">Referrals to support resources</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Open Door for Cancer (OD-C) approach includes the following: 1) Provide education about depression and treatment options; 2) Identify treatment preferences and a personal goal achievable with mental health care; 3) Assess barriers to starting treatment; 4) Referrals to additional support; 5) Address barriers to accessing care.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06037954' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/taking-care-of-mental-health/how-breast-cancer-affects-mental-health' target='_blank'>Breastcancer.org: How Breast Cancer Can Affect Mental Health</a> </li></ul>
115
NEAREST SITE: 2568 miles
NYU Langone Health
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05742178
Support from a Community Health Worker to Increase Breast Cancer Screening in New York City
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation Randomized Controlled Trial (NYC CONNECT) Scientific Title
Purpose
To study the effects of education materials and/or information delivered by community health workers to increase breast cancer screening.
Who is this for?
Women 50-74 years old with no history of breast cancer, who have not had a mammogram in the last 2 years, and who live in New York City.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information from a community health worker about social services and breast cancer screening</li> <li class="seamTextUnorderedListItem">Education materials about cancer</li> <li class="seamTextUnorderedListItem">Surveys, 3 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information from a community health worker about social services</li> <li class="seamTextUnorderedListItem">Education materials about cancer</li> <li class="seamTextUnorderedListItem">Surveys, 3 times within 6 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information from a community health worker about breast cancer screening (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Information delivered by a community health worker about breast cancer screening may increase screening.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish, Haitian-Creole, and Chinese Mandarin.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05742178' target='_blank'>ClinicalTrials.gov</a> </li></ul>
116
NEAREST SITE: 2569 miles
Mount Sinai
New York,NY
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT04983875
Sharing Breast Arterial Calcification Results After Mammograms
Enhancing the Public Health Benefits of Mammography Screening by Informing Women of Both Breast Cancer and Breast Arterial Calcification Results: A Randomized Trial to Promote Cardiovascular Health Scientific Title
Purpose
To study the potential benefits of adding breast arterial calcification (BAC) results to the standard results letter women receive after mammography.
Who is this for?
Women at least 40 years old who are planning to receive a mammogram at a Mount Sinai breast radiology clinic.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive a letter after your mammogram with your breast arterial calcification (BAC) status</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive standard of care letter after your mammogram without your breast arterial calcification (BAC) status</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 6 months</li> </ul> <p class="seamTextPara"> followed 6 months later by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive information about BAC status</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">In addition to detecting potential breast cancer, mammograms can also detect the presence of calcifications within the breast arteries (blood vessels). </li> <li class="seamTextUnorderedListItem">Those calcifications, called BAC, can be associated with a disease of the heart and blood vessels called coronary artery disease.</li> <li class="seamTextUnorderedListItem">Currently, women are not routinely told whether or not they have BAC.</li> <li class="seamTextUnorderedListItem">Previous research has suggested that patients would like to be informed about their BAC status.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04983875' target='_blank'>ClinicalTrials.gov</a> </li></ul>
117
NEAREST SITE: 2569 miles
Columbia University Irving Medical Center
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05351424
Video or Brochure to Educate Non-English Speaking Latinx Women with Breast Cancer About Radiation Therapy and Cancer Clinical Trials
Audiovisual Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment (ADELANTE) Study in Radiation Oncology Scientific Title
Purpose
To develop educational materials to prepare Latinx Spanish-speaking people for radiation therapy and to improve understanding about participating in cancer clinical trials.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who are Spanish speakers of Latinx background (from Mexican, Puerto Rican, Cuban, Dominican, Central or South American ancestry) and who are planning to receive radiation therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to Group 1 or 2: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch a video with educational information about radiation therapy.</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive a brochure with written information about radiation therapy.</li> </ul> <p class="seamTextPara"> You will also be randomly assigned to Group 3 or 4: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch a video with educational information about cancer clinical trials.</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive a brochure with written information about cancer clinical trials.</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Low understanding of health information and language barriers can lead to low trial enrollment in minority and/or non-English speakers and produce trial results that don't reflect this population.</li> <li class="seamTextUnorderedListItem">Culturally appropriate audiovisual materials may improve knowledge about radiotherapy and increase chances of completing treatment, as well as improve knowledge about clinical trials and increase enrollment in Latinx/Spanish-speaking people.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05351424' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.astro.org/Patient-Care-and-Research/Provider-Resources/Patient-Brochures' target='_blank'>American Society for Radiation Oncology: Patient Brochures</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.gov/publications/patient-education/cancer-treatment-research-studies' target='_blank'>National Cancer Institute: Taking Part in Cancer Research Studies</a> </li></ul>
118
NEAREST SITE: 2569 miles
Mount Sinai Hospital
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT06405828
Community Navigator to Provide Support Services to Black and Latina Women with Metastatic Breast Cancer
Project ACCESS: A Pilot Randomized Controlled Trial of a Navigator Delivered Model to Enhance Access to Supportive Services for Women of Color With Metastatic Breast Cancer Scientific Title
Purpose
To study the ability of a community navigator to provide supportive care for Black and Latina women with metastatic breast cancer.
Who is this for?
African American/Black and Latina women with stage IV (metastatic) breast cancer who live in New York City, NY.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Coaching sessions with community navigator, in-person or virtual, weekly for 1.5 months</li> <li class="seamTextUnorderedListItem">Phone call check-ins, monthly for 4 months</li> <li class="seamTextUnorderedListItem">Support with scheduling supportive care visits (optional)</li> <li class="seamTextUnorderedListItem">Referrals to community resources (optional)</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Phone calls, weekly for 1.5 months</li> <li class="seamTextUnorderedListItem">Phone call check-ins, monthly for 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Black and Latina women experience unequal access to support services and care.</li> <li class="seamTextUnorderedListItem">If you are in group 1, the navigator sessions will focus on health coaching. You have the choice to receive support with scheduling supportive care visits and/or referrals to support groups, educational workshops, and healthy lifestyle services.</li> <li class="seamTextUnorderedListItem">If you are in group 2, the phone calls will include reviewing breast cancer supportive and palliative care resources in NYC and online.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06405828' target='_blank'>ClinicalTrials.gov</a> </li></ul>
119
NEAREST SITE: 2569 miles
Columbia University Medical Center
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05496829
Improving Adherence to Hormone Therapy and Heart Disease Medication for People with Stage I-III Breast Cancer
IMPACT Trial: Intervention to iMProve AdherenCe Equitably Scientific Title
Purpose
To study whether a patient portal and smartphone reminder app help people adhere to treatment with hormone therapy and heart disease medication.
Who is this for?
People with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who are receiving treatment with hormone therapy and at least 1 medication for high blood pressure or high cholesterol to prevent heart disease. You must self-report that you do not take your medication as frequently as prescribed. You must receive care from a primary care provider or cardiologist within the New York Presbyterian Health System.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Access to patient portal with training from pharmacist</li> <li class="seamTextUnorderedListItem">Access to smartphone reminder app</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No access to patient portal or smartphone reminder app</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Additional Procedures</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Hormone therapy is a common treatment for hormone receptor positive (HR+) breast cancer.</li> <li class="seamTextUnorderedListItem">Antihypertensive medications are used to treat high blood pressure and statins are used to treat high cholesterol to prevent heart disease.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05496829' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy' target='_blank'>Breastcancer.org: Hormone Therapy</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/treatments/21811-antihypertensives' target='_blank'>Cleveland Clinic: Antihypertensive Medications</a> </li><li class='seamTextUnorderedListItem'><a href='https://my.clevelandclinic.org/health/treatments/22282-statins' target='_blank'>Cleveland Clinic: Statins</a> </li></ul>
120
NEAREST SITE: 2569 miles
Herbert Irving Comprehensive Cancer Care Center
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT05146297
Clinical Trial Education and Navigation for People with Stage I-IV Breast Cancer
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials Scientific Title
Purpose
To study whether a list of clinical trials, clinical trial educational materials, and clinical trial patient navigators (CTPN) increase participation in clinical trials, especially in the Black, Indigenous, and People of Color (BIPOC) community.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">List of matched clinical trials</li> <li class="seamTextUnorderedListItem">Clinical trial educational materials</li> <li class="seamTextUnorderedListItem">Clinical trial patient navigator (CTPN)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will receive a list of matched clinical trials and educational materials designed to inform and empower you to consider clinical trials.</li> <li class="seamTextUnorderedListItem">You will also work with a clinical trial patient navigator (CTPN) to further educate you about clinical trials.</li> <li class="seamTextUnorderedListItem">This trial is available in English and Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05146297' target='_blank'>ClinicalTrials.gov</a> </li></ul>
121
NEAREST SITE: 2570 miles
Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities)
New York,NY
VISITS: Number of visits unavailable
PHASE: NA
NCT ID: NCT04751435
Developing Genetic Testing Education for Diverse Groups of People with Breast Cancer
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients Scientific Title
Purpose
To develop educational materials about genetic testing for people that speak different languages and have diverse cultural backgrounds.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Interview</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Genetic testing is a type of test that detects changes to the genes, the DNA instructions that are passed on from the mother and father.</li> <li class="seamTextUnorderedListItem">The results of a genetic test can confirm whether the participant has a genetic disorder, which is a disease caused in whole or in part by changes to the genes. Genetic testing can also help determine a person's chance of getting or passing on a genetic disorder.</li> <li class="seamTextUnorderedListItem">The information gathered from your interview will be used to develop educational materials about genetic testing.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04751435' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/genomics/gtesting/genetic_testing.htm' target='_blank'>Centers for Disease Control and Prevention: Genetic Testing</a> </li></ul>
122
NEAREST SITE: 2574 miles
Montefiore Medical Center
The Bronx,NY
VISITS: Coincides with surgery
PHASE: NA
NCT ID: NCT06524895
Reiki Before Surgery for Women with Stage 0-III Breast Cancer Who Live in Bronx County, NY
Pilot Study of Medical Reiki for Women Undergoing Surgery for Breast Cancer: Impact on Quality of Life, Medical Recovery Metrics, and Cortisol Scientific Title
Purpose
To study the impact of reiki before surgery on surgery recovery, quality of life, and stress.
Who is this for?
Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who are planning to receive a mastectomy. You must live in Bronx County, New York.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reiki, before surgery</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Placebo</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Placebo for reiki, before surgery</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Reiki is a form of energy therapy involving light touch. It is a process of targeting the energy fields around the patient's body and is believed to stimulate the patient's natural ability to heal itself.</li> <li class="seamTextUnorderedListItem">Reiki is a safe treatment that emphasizes spirituality in healing and wellness whose origins are rooted in ancient Tibetan traditions.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06524895' target='_blank'>ClinicalTrials.gov</a> </li></ul>
123
NEAREST SITE: 2574 miles
Montefiore Medical Center
The Bronx,NY
VISITS: At least 2 visits
PHASE: NA
NCT ID: NCT05213936
Improving Scalp Cooling and Reducing Hair Loss During Chemotherapy for Stage I-III Breast Cancer
Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color: A Clinical and Mechanistic Study Scientific Title
Purpose
To determine if hairstyles can improve the ability of a scalp cooling cap to decrease hair loss.
Who is this for?
People with stage I, stage II, or stage III breast cancer with type 3 (curly) or type 4 (kinky-curly) hair who are planning to receive paclitaxel (Taxol®) or docetaxel (Taxotere®) chemotherapy. You must not have received or be planning to receive doxorubicin (Doxil®).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Scalp Cooling with Hairstyles</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear scalp cooling cap with braids, twists, or cornrows</li> <li class="seamTextUnorderedListItem">Hair samples and examinations</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Scalp Cooling with Water and Conditioner</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear scalp cooling cap with water and conditioner on the hair and scalp</li> <li class="seamTextUnorderedListItem">Hair samples and examinations</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: No Scalp Cooling</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No scalp cooling</li> <li class="seamTextUnorderedListItem">Hair samples and examinations</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Scalp cooling helps prevent hair loss due to chemotherapy.</li> <li class="seamTextUnorderedListItem">Scalp cooling may be less effective in people of color because their hair type can prevent the scalp cooling cap from making contact with the scalp.</li> <li class="seamTextUnorderedListItem">Hairstyles such as cornrows, braids, or twists or the use of water and conditioner on the hair and scalp may increase contact of the scalp cooling cap with the scalp, help the cap work better, and may therefore help prevent hair loss.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, you can choose from receiving braids, twists, or cornrows.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with lung cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05213936' target='_blank'>ClinicalTrials.gov</a> </li></ul>
124
NEAREST SITE: 2591 miles
University of Miami
Miami,FL
VISITS: Coincides with routine care
PHASE: NA
NCT ID: NCT04650256
Chinese Herbal Product to Reduce Pain and Itching from Radiation for Women with Stage II-III Breast Cancer
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences Scientific Title
Purpose
To study a Chinese herbal product for the temporary relief of pain and itching after radiation.
Who is this for?
Women with stage II or some stage III breast cancer who have received a mastectomy and are planning to receive radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will complete the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Rub product on your chest skin, daily for 4.5 months</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Chinese herbal product in this study is an over the counter (available without a prescription) product with 1% menthol.</li> <li class="seamTextUnorderedListItem">You will apply the product to your skin 2 times every day during radiation and continue for up to 3 months after radiation is complete.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04650256' target='_blank'>ClinicalTrials.gov</a> </li></ul>
125
NEAREST SITE: 2591 miles
University of Miami
Miami,FL
VISITS: 2 visits in 2-3 months
PHASE: NA
NCT ID: NCT05721976
Improving Physical Activity and Diet for Hispanic Women After Treatment
Pilot Study of a Multigenerational Digital Lifestyle Intervention for Hispanic Female Cancer Survivors and Their Families Scientific Title
Purpose
To study the ability of the With Love, Grandma (Con Carino, Abuelita) digital lifestyle program to improve the physical activity and diet of Hispanic women cancer survivors and their adult daughters.
Who is this for?
Hispanic women with stage I, stage II, or stage III breast cancer who have completed treatment, are a grandmother with an adult daughter, own a smartphone, and live in South Florida. You must be overweight or engage in no more than 2.5 hours of physical activity per week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">With Love, Grandma (Con Carino, Abuelita) digital lifestyle program, 2-3 months</li> <li class="seamTextUnorderedListItem">Video meetings with coach, weekly for 2-3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard Treatment</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care intervention</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The With Love, Grandma (Con Carino, Abuelita) digital lifestyle program includes 8 modules on healthy lifestyle behaviors for cancer prevention and control, family behavior change content for setting weekly goals and self-monitoring health behaviors, and family communication and positive parenting/grandparenting.</li> <li class="seamTextUnorderedListItem">Your daughter will also participate in this trial.</li> <li class="seamTextUnorderedListItem">Each family will virtually meet with a coach for 15-30 minutes per week.</li> <li class="seamTextUnorderedListItem">This trial is available in English and Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05721976' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/exercise' target='_blank'>Breastcancer.org: Exercise</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life/diet-nutrition' target='_blank'>Breastcancer.org: Diet and Nutrition</a> </li></ul>
126
NEAREST SITE: 2591 miles
University of Miami
Miami,FL
VISITS: Up to 1-2 visits every week for 2 months
PHASE: NA
NCT ID: NCT06534918
Diet and Exercise Program to Improve Healthy Behavior for People with Stage 0-III Breast Cancer
Precise Oncology Interventions in Nutrition and Training (OnPoint) Scientific Title
Purpose
To study if breast cancer survivors who receive a personal referral to a nutrition and exercise program will eat a healthier diet and be more physically active.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or some stage III breast cancer who completed treatment at least 6 months ago. You must exercise less than 2.5 hours every week and/or not eat a healthy diet.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 4 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Checklist to monitor diet and exercise, 1 time</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 2 months</li> <li class="seamTextUnorderedListItem">Text or phone call, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Nutrition class, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 2 times every week for 2 months</li> <li class="seamTextUnorderedListItem">Meeting with dietician, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Meeting with exercise expert, weekly for 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Personal sessions with diet and exercise experts may help people treated for breast cancer live healthier lifestyles.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06534918' target='_blank'>ClinicalTrials.gov</a> </li></ul>
127
NEAREST SITE: 2614 miles
Yale University
New Haven,CT
VISITS: 2 visits within 6 months
PHASE: NA
NCT ID: NCT07066189
Exercise and Nutrition to Improve Response to Chemotherapy and Immunotherapy Before Surgery for Women with Stage II-III Triple Negative Breast Cancer
Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in Triple Negative Breast Cancer (TNBC) Scientific Title
Purpose
To study whether a nutrition and exercise program can improve pathologic complete response (pCR), meaning that no cancer is seen in the breast after chemotherapy.
Who is this for?
Women with stage II or stage III triple negative (ER-, PR-, HER2-) breast cancer who are planning to receive chemotherapy and immunotherapy before surgery (neoadjuvant). You must not have received more than one cycle of chemotherapy. You must not currently exercise more than 150 min/week or consume more than 7 fruits and vegetable/week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Physical ability tests</li> <li class="seamTextUnorderedListItem">DEXA scan</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise counseling, virtual, 10 30-minute sessions weekly</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Physical ability tests</li> <li class="seamTextUnorderedListItem">DEXA scan</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise counseling will take place during the same time period you are receiving chemotherapy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07066189' target='_blank'>ClinicalTrials.gov</a> </li></ul>
128
NEAREST SITE: 2619 miles
Dartmouth-Hitchcock Medical Center
Lebanon,NH
VISITS: 2 visits within 2 weeks
PHASE: NA
NCT ID: NCT07040514
Understanding the Value of a Meeting Between a Pathologist and Patient for Stage I-IV Breast Cancer
24GUT540: Opportunity for Breast Cancer Patients to Meet With a Pathologist to Review the Pathology Slides of Their Breast Samples Scientific Title
Purpose
To study the usefulness of patient-pathologist visits in which pathologists review pathology slides with patients.
Who is this for?
People with stage I, stage II, stage III, or stage IV breast cancer who have completed their initial diagnosis visit with an oncologist or surgeon.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meet with pathologist</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Very little is known about the value of patient-pathologist meetings. Patients generally report that the experience was positive and helpful.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07040514' target='_blank'>ClinicalTrials.gov</a> </li></ul>
129
NEAREST SITE: 2619 miles
Dartmouth-Hitchcock Clinic
Lebanon,NH
VISITS: At least 2 visits within 3 months
PHASE: NA
NCT ID: NCT06258993
Promoting Exercise After Treatment for People With Stage 0-III Breast Cancer
Increasing Physical Activity Among Breast Cancer Survivors: Use of the ORBIT Model to Refine and Test a Novel Approach to Exercise Promotion Based on Affect-regulation (Study 2) Scientific Title
Purpose
To study the ability of 2 exercise programs to increase physical activity for breast cancer survivors.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who have completed treatment within the last 5 years. You must exercise less than 1 hour every week over the last 6 months.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Affect-Based Exercise</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit to discuss exercise program, 2 times</li> <li class="seamTextUnorderedListItem">Exercise program</li> <li class="seamTextUnorderedListItem">Affect-based exercise, up to 2.5 hours every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Effort-Based Exercise</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Visit to discuss exercise program, 2 times</li> <li class="seamTextUnorderedListItem">Exercise program</li> <li class="seamTextUnorderedListItem">Effort-based exercise, up to 2.5 hours every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a smart watch</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise may improve fatigue, pain, quality of life, and sleep in people treated for breast cancer.</li> <li class="seamTextUnorderedListItem">The exercise program includes definitions of exercise, guidelines for safe exercise, and strategies to overcome barriers to exercise. You will also be asked to describe your previous exercise and will be given an exercise plan.</li> <li class="seamTextUnorderedListItem">If you are in Group 1, you will be asked to <q>select a pace of exercise that makes you feel as good as possible.</q></li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will be asked to <q>select a pace that would make it challenging for you to carry on more than a short conversation.</q></li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06258993' target='_blank'>ClinicalTrials.gov</a> </li></ul>
130
NEAREST SITE: 2626 miles
Cheshire Medical Center
Keene,NH
VISITS: 3 visits within 1 month
PHASE: NA
NCT ID: NCT06522568
Virtual Mammogram Decision Tool for Healthy Women Age 39-49 Years
Toward Optimization of a Mammography Decision Aid and Clinician Communication Intervention Trial for Rural Settings Scientific Title
Purpose
To study the effectiveness of a virtual breast cancer screening decision aid called MyMammogram.
Who is this for?
Women, age 39-49 years, who are planning to visit their primary care doctor in the next month. You must not have breast cancer or have had a mammogram in the last year.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use MyMammogram before doctor's appointment</li> <li class="seamTextUnorderedListItem">Surveys, 3 times</li> <li class="seamTextUnorderedListItem">Interview</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use MyMammogram before doctor's appointment</li> <li class="seamTextUnorderedListItem">Your doctor will receive information from MyMammogram about your breast cancer risk</li> <li class="seamTextUnorderedListItem">Surveys, 3 times</li> <li class="seamTextUnorderedListItem">Interview</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">No intervention</li> <li class="seamTextUnorderedListItem">Surveys, 3 times</li> <li class="seamTextUnorderedListItem">Interview</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MyMammogram is a virtual education tool that can help you learn about your breast cancer risk and the role of mammograms in screening for breast cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06522568' target='_blank'>ClinicalTrials.gov</a> </li></ul>
131
NEAREST SITE: 2691 miles
Massachusetts General Hospital
Boston,MA
VISITS: Coincides with standard follow-up care
PHASE: NA
NCT ID: NCT01521741
Impact of Lymphedema on Quality of Life After Breast Cancer
Prospective Analysis of Symptoms, Functionality and Quality of Life Questionnaires to Evaluate Lymphedema in Patients Following Treatment for Breast Cancer. Scientific Title
Purpose
To determine how the symptoms and functional disability that accompany lymphedema can impact breast cancer survivors' quality of life.
Who is this for?
Women with breast cancer without axillary lymph node malignancy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> All participants will complete the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires and arm measurements</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Breast cancer treatments can result in long-term, painful swelling of the arm and hand, a condition called lymphedema.</li> <li class="seamTextUnorderedListItem">To be eligible, participants must be planning to have surgery and receive follow-up care for breast cancer at Massachusetts General Hospital.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT01521741' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/lymphedema' target='_blank'>BreastCancer.org: Lymphedema</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.gov/about-cancer/treatment/side-effects/lymphedema/lymphedema-pdq#section/all' target='_blank'>National Cancer Institute: Lymphedema</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/lymphedema.html' target='_blank'>American Cancer Society: Lymphedema</a> </li></ul>
132
NEAREST SITE: 2693 miles
Brigham and Women's Hospital
Boston,MA
VISITS: At least 3 visits in 9 months
PHASE: NA
NCT ID: NCT04724499
Exercise to Improve Brain and Heart Health During Chemotherapy for Women with Stage I-III Breast Cancer
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (The CLARITY Trial) Scientific Title
Purpose
To study if a high-intensity exercise program will improve brain health, heart function, and quality of life.
Who is this for?
Women newly diagnosed with stage I, stage II, or stage III breast cancer who are planning to receive chemotherapy before surgery (neoadjuvant). You must exercise less than 1 hour every week.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High-intensity exercise on stationary bike, in person or virtual, 3 times every week, 4 months</li> <li class="seamTextUnorderedListItem">MRI scans, 3 times within 9 months</li> <li class="seamTextUnorderedListItem">Bone scans</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Fitness tests</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Stretching, at home, 4 months</li> <li class="seamTextUnorderedListItem">MRI scans, 3 times in 9 months</li> <li class="seamTextUnorderedListItem">Bone scans</li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">Fitness tests</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">High-intensity exercise on stationary bike, in person or virtual, 3 times every week, 4 months (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Some people experience problems with brain function after chemotherapy.</li> <li class="seamTextUnorderedListItem">Some breast cancer treatments, such as chemotherapy, can cause or increase the risk of heart problems, which is called cardiotoxicity.</li> <li class="seamTextUnorderedListItem">Exercise may help improve brain function and heart function.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04724499' target='_blank'>ClinicalTrials.gov</a> </li></ul>
133
NEAREST SITE: 2693 miles
Dana Farber Cancer Institute
Boston,MA
VISITS: At least 2 visits within 4 months
PHASE: NA
NCT ID: NCT06322888
Exercise to Reduce the Risk of Breast Cancer for Women With Dense Breasts
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) Scientific Title
Purpose
To study how exercise might lower the risk of developing breast cancer by studying changes that occur in breast tissue and blood.
Who is this for?
Women 18-59 years old with dense breasts on a mammogram within the past year and exercise less than 1 hour every week. You must not have a history of breast cancer, be pregnant or breastfeeding, or be receiving hormonal birth control or hormone replacement therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, in person or virtual, 3 times every week for 3 months</li> <li class="seamTextUnorderedListItem">Exercise journal</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Biopsy, 2 times within 3 months</li> <li class="seamTextUnorderedListItem">Blood test, 2 times within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2 : Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Biopsy, 2 times within 3 months</li> <li class="seamTextUnorderedListItem">Blood test, 2 times within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> followed 3 months later by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, 3 months (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Greater physical activity is associated with a lower risk of breast cancer.</li> <li class="seamTextUnorderedListItem">Exercise may change markers in blood and breast tissue that play a role in breast cancer development.</li> <li class="seamTextUnorderedListItem">If you are in group 1, the exercise program includes aerobic and resistance training exercise with a certified exercise trainer.</li> <li class="seamTextUnorderedListItem">If you are in group 1, a FitBit activity tracker, resistance bands, hand weights, and stationary bike will be provided to you. Hand weights will be returned at end of study.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06322888' target='_blank'>ClinicalTrials.gov</a> </li></ul>
134
NEAREST SITE: 2694 miles
MGH Institute of Health Professions
Boston,MA
VISITS: 5 visits within 5 months
PHASE: NA
NCT ID: NCT06052488
Group Exercise After Completing Treatment for Women with Stage I-III Breast Cancer
Strength After Breast Cancer: Clinical Implementation of an Evidence-based Group Exercise Intervention for Breast Cancer Survivors (SABC) Scientific Title
Purpose
To study if a group exercise program called Strength After Breast Cancer can be completed in a physical therapy clinic to improve physical function for women after breast cancer treatment.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who have completed treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Individual physical therapy evaluation, 1 time</li> <li class="seamTextUnorderedListItem">Group exercise sessions, in person, 4 times within 5 months</li> <li class="seamTextUnorderedListItem">Surveys</li> <li class="seamTextUnorderedListItem">Interviews</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise in people who have been treated for breast cancer may reduce toxicity from treatment, increase time to tumor progression, and prolong survival.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06052488' target='_blank'>ClinicalTrials.gov</a> </li></ul>
135
Tools to Improve Nutrition and Physical Activity After Treatment for People with Stage I-III Breast Cancer
Optimizing Intervention Tools to Improve Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) (TTBF) Scientific Title
Purpose
To study how 4 different support tools impact body weight, nutrition, and physical activity.
Who is this for?
People with stage I, stage II, or stage III breast cancer who have completed treatment (except for hormone therapy).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive a personalized report at the start of the study and then be randomly assigned to receive one or more of the following tools for approximately 1 year: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">A digital health tool kit or a food and exercise logbook</li> <li class="seamTextUnorderedListItem">Text messages</li> <li class="seamTextUnorderedListItem">Health coaching sessions</li> <li class="seamTextUnorderedListItem">Health coaching sessions for your support person</li> </ul> <p class="seamTextPara"> You will complete surveys on your background and health at the start of the study and update your health information a few times throughout the study.</p>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">People with a history of cancer whose nutrition and physical activity habits are consistent with the American Cancer Society's guidelines may live longer without cancer coming back (recurrence).</li> <li class="seamTextUnorderedListItem">The four components of the program being studied may help people with a history of cancer adopt recommended health behaviors after they have completed treatment.</li> <li class="seamTextUnorderedListItem">A support person of your choice will also participate in this study.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05056077' target='_blank'>ClinicalTrials.gov</a> </li></ul>
136
Virtual Mindfulness Approaches for Women With Depression Who Are Survivors of Stage 0-III Breast Cancer
Harnessing E-Mindfulness Approaches for Living After Breast Cancer-HEAL-ABC Scientific Title
Purpose
To study if a digital mindfulness meditation-based program can improve the mental health and well-being of younger breast cancer survivors with depression.
Who is this for?
Women who were age 18 to 50 years old when diagnosed with stage 0 (DCIS), stage I, stage II, or stage III breast cancer, who have completed breast cancer treatment (except hormone therapy or trastuzumab if recommended) 6 months to 5 years ago, and have symptoms of depression.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness, live virtual sessions, 2-hour sessions weekly for 6 weeks</li> <li class="seamTextUnorderedListItem">Practice mindfulness techniques, 5-20 minutes daily</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness, virtual sessions by app</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Guided audio mindfulness meditations, virtual sessions by app</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness meditation programs provided in person are helpful for younger breast cancer survivors. This study will compare different digital approaches for mindfulness training to see which is the most effective.</li> <li class="seamTextUnorderedListItem">Mindfulness delivered live provides structured lessons and guided exercises in mindfulness as well as opportunities for reflection and group discussion.</li> <li class="seamTextUnorderedListItem">Mindfulness delivered by app provides sequential new content and exercises that build on previous sessions. Lessons and other materials are gradually unlocked as participants progress through the program.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06748222' target='_blank'>ClinicalTrials.gov</a> </li></ul>
137
Virtual Intervention to Improve the Well-Being of Black Women With Stage 0-IV Breast Cancer
Project SOAR Awakenings: Randomized Controlled Trial for Black American Women Diagnosed With Breast Cancer Scientific Title
Purpose
To promote well-being and decrease depression and fatigue.
Who is this for?
Black women with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Project SOAR Gatherings, virtual, 1.5- to 2-hour discussions, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Questionnaires, virtual, 3 times within 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive materials by mail for use on your own</li> <li class="seamTextUnorderedListItem">Questionnaires, virtual, 3 times within 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Project SOAR sessions are based on books and articles that participants will receive. The sessions aim to help Black women accept their emotions, care for themselves, accept help from others, and manage stress.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07208084' target='_blank'>ClinicalTrials.gov</a> </li></ul>
138
Questionnaire and Medical Records Review for Breast Cancer Screening as Recommended for Women at Moderate Risk for Breast Cancer
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer Scientific Title
Purpose
To assess breast cancer screening as recommended for women at moderately increased risk for developing breast cancer and to determine factors that promote or prevent screening.
Who is this for?
Women, age 30-75 years old, with a mutation in the genes ATM, CHEK2, BARD1, RAD51C, or RAD51D, or a lifetime breast cancer risk estimate between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model. You must not have breast cancer or have received a mastectomy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaire</li> <li class="seamTextUnorderedListItem">Review of your medical records</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Breast cancer risk can be estimated by genetic mutation status and models that use responses to questions about personal and family health.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07076147' target='_blank'>ClinicalTrials.gov</a> </li></ul>
139
Studying the Gut Microbiome During Neoadjuvant Treatment for Stage I-III Triple Negative Breast Cancer
Impacts of Diet, Activity, and Mood on a Dynamic Gut Microbiota During Treatment for Triple-negative Breast Cancer Scientific Title
Purpose
To study changes in the gut microbiome during neoadjuvant (before surgery) treatment for triple negative breast cancer.
Who is this for?
People with stage I, stage II, or stage III triple negative (ER-, PR-, HER2-) breast cancer. You must not be receiving before surgery (neoadjuvant) treatment or prebiotics or probiotics.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nutrition counseling, virtual, 3 sessions</li> <li class="seamTextUnorderedListItem">Surveys, 4 times in 6 months</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, 4 times in 6 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Educational handout</li> <li class="seamTextUnorderedListItem">Surveys, 4 times in 6 months</li> <li class="seamTextUnorderedListItem">Stool (poop) samples, 4 times in 6 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The gut microbiome is made up of bacteria, viruses, and other organisms that live in the digestive tract and help keep us healthy. </li> <li class="seamTextUnorderedListItem">The gut microbiome changes in response to treatments for triple negative breast cancer, and this may lead to worse outcomes. </li> <li class="seamTextUnorderedListItem">The gut microbiome can be changed by changing the diet.</li> <li class="seamTextUnorderedListItem">To encourage participation and retention, you will be given a $40 gift certificate per stool sample with up to $200 total compensation.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06610097' target='_blank'>ClinicalTrials.gov</a> </li></ul>
140
Group Therapy to Manage Joint Pain From Hormone Therapy for Women with Stage I-III HR+ Breast Cancer
Enhanced Pain Coping in Cancer (EPIC) Scientific Title
Purpose
To study if group therapy can help breast cancer survivors manage joint pain caused by aromatase inhibitors.
Who is this for?
Women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who completed treatment at least 1 month ago. You must be receiving letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor and be planning to continue for at least 1 year. You must have joint pain.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes mindfulness and other coping strategies, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Practice learned skills, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes discussion on chronic pain and cancer survivorship, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Write in a journal, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Joint pain is common in people taking aromatase inhibitors. This pain can make some people decide to stop taking their medication. </li> <li class="seamTextUnorderedListItem">This study will look at the effects of 2 different types of group therapy on your cancer-related symptoms (such as pain, fatigue, and anxiety), your ability to continue taking aromatase inhibitors on a regular schedule, and your quality of life.</li> <li class="seamTextUnorderedListItem">All sessions in Group 1 and Group 2 are 2 hours each.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06728579' target='_blank'>ClinicalTrials.gov</a> </li></ul>
141
Support Improving Treatment Completion for People in Rural Counties with Stage I-III Breast Cancer
Improving the Timeliness and Quality of Care for Rural Patients With Solid Tumors Scientific Title
Purpose
To study if the CARES intervention improves the time to start and complete treatment for people living in rural counties.
Who is this for?
People with stage I, stage II, or stage III breast cancer who live in a rural county and are planning to receive treatment at University of Colorado Health System. You must have no insurance or not enough insurance.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive CARES navigation and counseling, virtually or in person, up to 20 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive list of resources</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The CARES (Cancer Advocacy, Resources, Education and Support) intervention includes up to 10 navigation and 10 counseling sessions provided by oncology nurses and counselors. </li> <li class="seamTextUnorderedListItem">CARES sessions will be scheduled during key treatment transition points.</li> <li class="seamTextUnorderedListItem">This study is also enrolling people with other types of cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04916990' target='_blank'>ClinicalTrials.gov</a> </li></ul>
142
Chabot for Follow-up After a Mammogram for Healthy Women
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study Scientific Title
Purpose
To study a digital tool called a chatbot that provides education about mammograms on a tablet, computer, or phone.
Who is this for?
Healthy women who have received a screening mammogram with the University of Utah and who speak English or Spanish.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care follow-up</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Chatbot</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Follow-up, by chatbot</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chatbots are used in various healthcare situations and can be easily accessed with a smartphone, tablet, or computer. Chatbots have advantages for sending messages, including providing interactive education and information, providing information in small segments, and allowing a person to choose how much information they receive at a time. </li> <li class="seamTextUnorderedListItem">How useful chatbots are for follow-up after a mammogram is unknown.</li> <li class="seamTextUnorderedListItem">In this study, the chatbot will be used after a mammogram for follow-up, to answer patient questions, and to provide information.</li> <li class="seamTextUnorderedListItem">Some participants will be asked to join a focus group.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07029490' target='_blank'>ClinicalTrials.gov</a> </li></ul>
143
Fasting at Night to Improve Cognition After Chemotherapy for People with Stage I-IV Breast Cancer
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors (RESTORE) Scientific Title
Purpose
To study how fasting at night affects health, quality of life, and cognitive ability.
Who is this for?
Women with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who completed chemotherapy at least 3 months ago and who are having cognitive (thinking) problems.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fast at night, 6 nights every week for 2 months</li> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">When you are fasting, you are still allowed to drink water, coffee, and tea.</li> <li class="seamTextUnorderedListItem">Cognitive problems are problems with thinking (cognition).</li> <li class="seamTextUnorderedListItem">This trial's enrollment will be racially diverse (at least 50% of participants will be Black, Hispanic, and/or Native American).</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06938555' target='_blank'>ClinicalTrials.gov</a> </li></ul>
144
Counseling by Phone to Help Manage Side Effects of Immunotherapy for Stage II-IV Breast Cancer
Adaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors Scientific Title
Purpose
To study whether telephone-based counseling will improve your ability to manage immunotherapy side effects.
Who is this for?
People with stage II, stage III, or stage IV (metastatic) breast cancer who have begun treatment with an immune checkpoint inhibitor within the past 3 months. You must be experiencing at least mild psychological distress.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Counseling, by phone call, weekly</li> <li class="seamTextUnorderedListItem">Handbook about managing side effects</li> <li class="seamTextUnorderedListItem">Assessment of side effects, weekly</li> <li class="seamTextUnorderedListItem">Interviews, 2 times within 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Assessment of side effects, weekly</li> <li class="seamTextUnorderedListItem">Interviews, 2 times within 4 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Immunotherapies are drugs that trigger the immune system to see, go after, and kill cancer cells.</li> <li class="seamTextUnorderedListItem">Side effects from immunotherapy are common.</li> <li class="seamTextUnorderedListItem">The ability to manage the side effects you experience from immunotherapy may reduce your distress, prevent treatment interruption, and lead to fewer visits to your doctor.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05715255' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/cancer/types/breast-cancer/treatment/immunotherapy.html#:~:text=Possible%20side%20effects%20of%20immune,reaction%20while%20getting%20these%20drugs.' target='_blank'>American Cancer Society: Immune Checkpoint Inhibitors for Breast Cancer and Their Side Effects</a> </li></ul>
145
Virtual Classes to Improve Symptoms and Physical Activity During Radiation for People with Stage 0-III Breast Cancer
Multicenter Pilot Study: Leveraging Digital Health to Promote Evidence-Based Physical Activity to Improve Symptoms Among Patients Undergoing Radiation for Breast Cancer (PRO-ACTIVE) Scientific Title
Purpose
To study if the Integrative Medicine at Home (IM@Home) program improves symptoms and physical activity during radiation.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who are planning to receive or receiving radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">IM@Home program, virtual, 3 sessions every week for 3 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit, 3 months</li> <li class="seamTextUnorderedListItem">Surveys, every 2 weeks for 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Wear a Fitbit, 3 months</li> <li class="seamTextUnorderedListItem">Surveys, every 2 weeks for 3 months</li> </ul> <p class="seamTextPara"> followed by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">IM@Home program, virtual, 3 sessions every week for 3 months (optional)</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer-related fatigue is common and impacts quality of life during and after treatment.</li> <li class="seamTextUnorderedListItem">Mind-body interventions including physical activity (exercise) and yoga may help treat fatigue and other symptoms.</li> <li class="seamTextUnorderedListItem">The IM@Home program consists of virtual mind-body and fitness classes that include yoga, tai chi, dance, cardio, guided meditation, and music therapy.</li> <li class="seamTextUnorderedListItem">The sessions are between 30 minutes and 1 hour.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06772181' target='_blank'>ClinicalTrials.gov</a> </li></ul>
146
Online Meditation to Reduce Anxiety and Depression After Treatment for Women with Stage I-III Breast Cancer
The SUPORT Project: Leveraging Social Connection by Including Informal Caregivers in an Internet Video Conference-based Compassion Meditation Intervention to Reduce Psychological Distress in Breast Cancer Survivors Scientific Title
Purpose
To study if meditation with or without caregivers will reduce depression and anxiety in breast cancer survivors.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who completed treatment between 3 months and 5 years ago. You may still be receiving hormone therapy or trastuzumab (Herceptin®). You must have a partner or caregiver who lives with you and is willing to participate.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 3 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions without your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Health Education</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many breast cancer survivors (around 70%) experience depression and/or anxiety after finishing cancer treatments.</li> <li class="seamTextUnorderedListItem">Meditation may reduce feelings of anxiety and depression.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05676255' target='_blank'>ClinicalTrials.gov</a> </li></ul>
147
Remote Exercise Program to Reduce Fatigue for Stage 0-III Breast Cancer Survivors Living in Rural Areas
Effects of a Telehealth Exercise Program for Rural Cancer Survivors With Cancer-related Fatigue Including Integrated Longitudinal Assessments of Objective Physical Function and Fatty Acid Oxidation Scientific Title
Purpose
To study whether a virtual exercise program reduces cancer-related fatigue.
Who is this for?
People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment that included hormone therapy, radiation, chemotherapy, and/or immunotherapy within the last 5 years. You may currently be receiving hormone therapy. You must live in a rural area and have moderate or worse fatigue.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, virtual, for 3 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times per month</li> <li class="seamTextUnorderedListItem">Blood samples, by self collection, 2 times per month</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Waitlist Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surveys, 2 times per month</li> <li class="seamTextUnorderedListItem">Blood samples, by self collection, 2 times per month</li> </ul> <p class="seamTextPara"> followed by (3 months later): </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, virtual, for 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise may help improve cancer-related fatigue.</li> <li class="seamTextUnorderedListItem">The exercise program in this study includes virtual exercise sessions with cancer exercise specialists, additional exercise programming delivered by an app, and regular symptom monitoring by emailed surveys.</li> <li class="seamTextUnorderedListItem">The study includes 2 optional visits to the study site for laboratory-based exercise assessment before and after the program.</li> <li class="seamTextUnorderedListItem">This study is also enrolling people with prostate cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07001241' target='_blank'>ClinicalTrials.gov</a> </li></ul>
148
Virtual Occupational Therapy Program to Increase Exercise for People with Stage I-III Breast Cancer
Digitally Mediated Occupational Therapy Program to Increase Physical Activity in Urban and Rural Breast Cancer Survivors Who Have Undergone Breast-conserving Surgery or Mastectomy (SDOTS) Scientific Title
Purpose
To study the ability of a virtual occupational therapy program to increase physical activity and muscle strength.
Who is this for?
People with stage I, stage II, or stage III breast cancer who have received surgery in the last year. You must not be receiving radiation or chemotherapy, and you must not exercise regularly.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Occupational therapy, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Wear a Fitbit</li> <li class="seamTextUnorderedListItem">Interviews</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surgery for breast cancer can lead to arm problems, decreased strength, and limited mobility, which can limit the ability to exercise.</li> <li class="seamTextUnorderedListItem">Most breast cancer survivors do not exercise as recommended, and many are unsure how to begin.</li> <li class="seamTextUnorderedListItem">Occupational therapy helps people return to their normal activities and may help people learn how to start exercising.</li> <li class="seamTextUnorderedListItem">Physical activity is expected to improve physical functioning, sleep, and fitness, as well as reduce anxiety, depression, and pain.</li> <li class="seamTextUnorderedListItem">Sessions are 1 hour each.</li> <li class="seamTextUnorderedListItem">Wearable devices such as FitBits are used to track your physical activity.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06671730' target='_blank'>ClinicalTrials.gov</a> </li></ul>
149
Studying Alopecia During Hormone Therapy in Women with Breast Cancer
Endocrine Therapy-Induced Alopecia Natural History Evaluation Among Female Breast Cancer Survivors Scientific Title
Purpose
To study the incidence, timing, duration, and severity of alopecia (hair loss) during hormone therapy.
Who is this for?
Women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who are receiving or planning to receive hormone therapy.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires, every 3 months for 2 years</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">While alopecia (hair loss) is a well-known side effect of many chemotherapy drugs, it has also been reported by women undergoing hormone therapy.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05612100' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/hair-loss' target='_blank'>Breastcancer.org: Alopecia/Hair Loss</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy' target='_blank'>Breastcancer.org: Hormone Therapy</a> </li></ul>
150
Online Pain and Depression Support Program for Asian Women with Stage I-IV Breast Cancer
Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors (CAI) Scientific Title
Purpose
To study if an online pain and depression management program can support Asian women with breast cancer.
Who is this for?
Chinese, Korean, or Japanese women who were diagnosed with breast cancer in the past and are experiencing pain and depression.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: CAI (Web App Based, Individualized Coaching and Support Program for Cancer Pain)</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Personalized information and support program, online</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: CAPA (Web App Based Information and Coaching/Support Program for Cancer Pain Management)</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General information and support program, online</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem"> The pain and depression management program provides web-based information, coaching, and support that is culturally tailored to Asian American women with breast cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Mandarin (simplified or traditional), Korean, and Japanese.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06085313' target='_blank'>ClinicalTrials.gov</a> </li></ul>
151
Virtual Reminders to Increase Physical Activity for People With Stage I-III Breast Cancer and Chronic Pain
An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial Scientific Title
Purpose
To study the best time to deliver a message to increase physical activity and how often participants experience pain in the 24 hours after receiving a message to increase physical activity.
Who is this for?
People, 65 years and older, with stage I, stage II, or stage III breast cancer.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Messages to report pain, virtual, 4 times a day for 1 month</li> <li class="seamTextUnorderedListItem">Messages to increase physical activity, virtual, 4 times a day for 1 month</li> <li class="seamTextUnorderedListItem">Wear activity monitor, 1 month</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial is studying the best time to send a message to promote physical activity by cancer survivors who experience chronic pain.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07227077' target='_blank'>ClinicalTrials.gov</a> </li></ul>
152
Empowerment and Navigation Sessions for Latina Women Ages 30+ with Breast Cancer or a Family History of Breast/Ovarian Cancer
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care Scientific Title
Purpose
To compare the impact of empowerment and navigation sessions with standard of care sessions on whether Latina women decide to receive genetic testing and/or genetic counseling.
Who is this for?
Latina women ages 30+ with stage I, stage II, stage III, or stage IV (metastatic) breast cancer or with a family history of breast or ovarian cancer. You must have one social determinant of health risk factor, such as: perceived financial struggles, transportation difficulties, exposure to violence, housing challenges, social isolation/challenges. You must not have received genetic testing or genetic counseling.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Empowerment and navigation sessions, by phone, 3 times within 3 weeks</li> <li class="seamTextUnorderedListItem">Personalized educational materials</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care sessions, by phone, 3 times within 3 weeks</li> <li class="seamTextUnorderedListItem">Personalized educational materials</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Empowerment and navigation sessions will discuss social determinants of heath, genetic risk factors, individual behavior change action plans, breast cancer screening, and diet and physical activity for breast cancer prevention.</li> <li class="seamTextUnorderedListItem">Standard of care sessions will discuss social determinants of heath, genetic risk factors, individual behavior change action plans, how to share breast cancer information, and testimonials and include role playing activities and group discussions.</li> <li class="seamTextUnorderedListItem">You can receive up to $100 for participation.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05483283' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-prevention-and-early-detection-facts-and-figures/making-the-case-for-health-equity.pdf' target='_blank'>American Cancer Society: Health Equity and Social Determinants of Health</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.gov/healthypeople/priority-areas/social-determinants-health' target='_blank'>US Department of Health and Human Services: Social Determinants of Health</a> </li></ul>
153
Coaching Program to Reduce Stress and Promote Resilience for People with Metastatic Breast Cancer
Promoting Resilience in Stress Management for Metastatic Breast Cancer (PRISM-MBC PRISMMBC) Scientific Title
Purpose
To study the ability of the PRISM program to reduce stress and improve resilience for people with metastatic breast cancer.
Who is this for?
People with stage IV (metastatic) breast cancer who were diagnosed with metastatic disease in the last 6 months.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Promoting Resilience in Women with Breast Cancer (PRISM) program, virtual, 4 sessions in 1-2 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Promoting Resilience in Women with Breast Cancer (PRISM) program helps improve 4 areas of resilience: stress management, goal setting, cognitive reframing, and meaning-making.</li> <li class="seamTextUnorderedListItem">This study will compare the resilience of Black women to non-Black women.</li> <li class="seamTextUnorderedListItem">It also includes an optional family session.</li> <li class="seamTextUnorderedListItem">Each session is 30-60 minutes every 1-2 weeks.</li> <li class="seamTextUnorderedListItem">Black women with MBC have worse outcomes than white women with MBC because of social determinants of health (SDOH).</li> <li class="seamTextUnorderedListItem">Social determinants of health (SDOH) describe non-medical factors that influence your health, such as race, gender identity, education, occupation, transportation, food and health access, medication affordability, safety at home, housing, and financial stability.</li> <li class="seamTextUnorderedListItem">Reducing stress and improving resilience during MBC treatment may improve quality of life and even improve disease outcomes.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06855654' target='_blank'>ClinicalTrials.gov</a> </li></ul>
154
Virtual Tool to Help Make Chemotherapy Decisions for People with Stage I-IV Breast Cancer
CIPN Decision Aid to Improve Neurotoxic Chemotherapy Decision Making Scientific Title
Purpose
To see if a virtual tool that informs people about chemotherapy-induced peripheral neuropathy (CIPN) helps people make decisions about chemotherapy.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are receiving paclitaxel (Taxol®), nab-paclitaxel (Abraxane®), or docetaxel (Taxotere) chemotherapy and are experiencing peripheral neuropathy (nerve pain, discomfort, sensation changes, or weakness).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual chemotherapy decision tool</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Neuropathy is pain, discomfort, sensation changes, and weakness from nerve damage.</li> <li class="seamTextUnorderedListItem">Chemotherapy-induced peripheral neuropathy (CIPN) is neuropathy in your hands and feet as a side effect of chemotherapy.</li> <li class="seamTextUnorderedListItem">Around half of people who develop CIPN still have it 3 years later.</li> <li class="seamTextUnorderedListItem">A virtual decision tool that provides information about permanent CIPN and prepares patients for a discussion with their doctor may lead to improvements in treatment decision-making.</li> <li class="seamTextUnorderedListItem">This trial is enrolling virtually and does not require any in person visits.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06915168' target='_blank'>ClinicalTrials.gov</a> </li></ul>
155
Healthy Eating and Nutrition Counseling to Improve Cognition During Chemotherapy for Women with Stage II-III Triple Negative Breast Cancer
Food for Thought - Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Triple Negative Breast Cancer (MIND-TNBC) Scientific Title
Purpose
To study if the MIND eating plan can improve memory and mental function, fatigue, sleep quality, anxiety, and depression.
Who is this for?
Women 40-65 years old with stage II or stage III triple negative (ER-, PR-, HER2-) breast cancer who are receiving (within the past 6 months) or planning to receive chemotherapy before surgery (neoadjuvant).
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General health sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> followed 6 months later by: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer treatment can lead to cognition (ability to think) problems and low quality of life.</li> <li class="seamTextUnorderedListItem">The Neurodegenerative Delay (MIND) eating plan is high in anti-inflammatory nutrients (omega-3, carotenoids, B vitamins, etc.) and limits foods that are not healthy for the brain (butter, cheese, red meat, fried foods, sugar, etc.).</li> <li class="seamTextUnorderedListItem">The MIND eating plan may help improve brain function during cancer treatment.</li> <li class="seamTextUnorderedListItem">In this trial, you will be sent some of the main foods in the MIND eating plan.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06582615' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.osu.edu/wellness/exercise-and-nutrition/the-mind-diet' target='_blank'>Ohio State University: The MIND Diet and Brain Health</a> </li></ul>
156
Patient Navigation to Improve Breast Cancer Risk Management for Women at High Risk of Breast Cancer
Feasibility Testing of a Patient Navigation Intervention to Improve Risk Management Among Women at High Risk of Breast Cancer Scientific Title
Purpose
To study if patient navigation can improve management of breast cancer risk.
Who is this for?
Women at high risk for breast cancer who are not receiving risk-reduction strategies.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Patient Navigation</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Links to websites on breast cancer risk and risk management</li> <li class="seamTextUnorderedListItem">Phone calls from a patient navigator, monthly for 8 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Links to websites on breast cancer risk and risk management</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Women with a family history of breast cancer have a higher lifetime risk of developing it. Risk management can benefit women at high risk of breast cancer and can include surveillance, preventative surgeries, and medications that can lower the risk of breast cancer and allow early detection. </li> <li class="seamTextUnorderedListItem">Patient navigation is designed to guide a patient through the healthcare system and reduce barriers to screening, follow-up, diagnosis, treatment, and supportive care. The patient navigation in this study is designed to give women the information and support they need to make choices about their breast cancer risk that they feel good about, which may improve risk management.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06950008' target='_blank'>ClinicalTrials.gov</a> </li></ul>
157
Improving Quality of Life of Young Black Women After Treatment
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors Scientific Title
Purpose
To compare how Y-AMBIENT education sessions and follow up phone calls improve quality of life after breast cancer treatment.
Who is this for?
Black or African American women ages 18 to 44 years old with stage I, stage II, or stage III breast cancer who have completed treatment with chemotherapy and/or radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT education sessions, 3 times within 4 months</li> <li class="seamTextUnorderedListItem">Y-AMBIENT follow up phone calls, 3 times within 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education sessions, 3 times within 4 months</li> <li class="seamTextUnorderedListItem">Follow up phone calls, 3 times within 4 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Additional Procedures</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT is telephone-based intervention with education sessions designed to improve quality of life. Session 1, titled <q>My Self, My Soul,</q> covers topics related to spiritual growth and finding meaning in illness. Session 2, titled <q>My Body,</q> covers topics related to breast changes, aches/pains, fatigue, and weight changes. Session 3, titled <q>My Mind and My Relationships,</q> covers topics related to anxiety, fear, and relationships with others.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, education sessions include a culturally-targeted cookbook and a guide to grocery shopping smart.</li> <li class="seamTextUnorderedListItem">For both groups, all sessions will take approximately one hour, and follow-up phone calls will last about 20 minutes.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05452681' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.komen.org/breast-cancer/survivorship/health-concerns/quality-of-life/#:~:text=Quality%20of%20life%20after%20treatment,even%20years%20after%20treatment%20ends.' target='_blank'>Susan G. Komen: Quality of Life After Breast Cancer Treatment</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/pcd/issues/2016/16_0096.htm' target='_blank'>Centers for Disease Control and Prevention: Quality of Life of Black Breast Cancer Survivors</a> </li></ul>
158
Improving Quality of Life for Young African American Women with Stage I-III Breast Cancer
Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment Scientific Title
Purpose
To study if Y-AMBIENT education sessions help African American women with breast cancer manage daily life.
Who is this for?
Black or African American women 18-44 years old with stage I, stage II, or stage III breast cancer who are receiving chemotherapy and/or radiation.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT education sessions, by phone, 3 sessions within 4 months</li> <li class="seamTextUnorderedListItem">Phone calls discussing treatment and concerns, 3 times within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Enhanced Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Phone calls discussing treatment and concerns, 3 times within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Y-AMBIENT is a telephone-based intervention that includes three themed education sessions with three follow-up sessions, written materials, and videos.</li> <li class="seamTextUnorderedListItem">The Y-AMBIENT sessions are 1 hour each and may improve quality of life and other health-related outcomes.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05243056' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/managing-life' target='_blank'>Breastcancer.org: Managing Life With Cancer</a> </li></ul>
159
Web App to Improve Adherence to Hormone Therapy for People with Stage I-III HR+, HER2- Breast Cancer
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy Scientific Title
Purpose
To study the ability of a web app to improve your ability to take hormone therapy on time as prescribed.
Who is this for?
People with stage I, stage II, or stage III hormone receptor positive (HR+), HER2 negative (HER2-) breast cancer who have begun treatment with an aromatase inhibitor or tamoxifen (Nolvadex®) less than 6 months ago.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Web app, 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Adherence is your ability to take medication on time as prescribed.</li> <li class="seamTextUnorderedListItem">Through the app, you will receive weekly reminders about hormone therapy, report any side effects, and watch videos with tips to help reduce side effects.</li> <li class="seamTextUnorderedListItem">In the app, you can also send messages with questions about the side effects you may be experiencing.</li> <li class="seamTextUnorderedListItem">Anastrozole (Arimidex®), letrozole (Femara®), and exemestane (Aromasin®) are types of hormone therapy called aromatase inhibitors. Aromatase inhibitors block some production of estrogen that helps cancer grow.</li> <li class="seamTextUnorderedListItem">Tamoxifen (Nolvadex®) is a type of hormone therapy called a selective estrogen receptor modulator (SERM). SERMs work by blocking the activity of estrogen.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05488145' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/hormonal-therapy' target='_blank'>Breastcancer.org: Hormone Therapy</a> </li></ul>
160
Brief, Virtual Programs to Improve Mental Health for Women with Stage I-III Breast Cancer
Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors Scientific Title
Purpose
To study short, virtual programs called digital micro-interventions to help improve mental health.
Who is this for?
Women with stage I, stage II, or stage III breast cancer whose diagnosis was within the last 5 years and who have symptoms of anxiety and/or depression.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to receive 1 of 6 digital micro-interventions: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Savoring</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Think of a positive memory and meditate on it, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Gratitude</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Think of a list of things you are grateful for and reflect on it, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 3: Challenge Unhelpful Thoughts</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Generate balanced, helpful thoughts, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 4: Psychoeducation</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Learn about mental health, distress, and well-being, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 5: Behavioral Activation</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Identify tasks to accomplish in daily life, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 6: Acceptance</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Learn how to accept distressing emotions or thoughts, virtual</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times within 1 week</li> <li class="seamTextUnorderedListItem">Interview, virtual</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Digital micro-interventions are virtual, brief interventions that address specific mental health problems and are designed to be completed in a short period of time.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07160439' target='_blank'>ClinicalTrials.gov</a> </li></ul>
161
Online Portal to Educate and Refer Racially Diverse People to Clinical Trials
Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida Scientific Title
Purpose
To study the tailored ALEX (Agent Leveraging Empathy for eXams) Research Portal to navigate Black and Hispanic adults with cancer and their family members through referral to cancer clinical trials.
Who is this for?
People who are Black, African American, Hispanic, and/or Latinx. People with cancer and their family members may enroll in this trial. You must live in Florida.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ALEX (Agent Leveraging Empathy for eXams) portal</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care portal</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Racial and ethnic minorities are underrepresented in cancer clinical trials.</li> <li class="seamTextUnorderedListItem">The ALEX (Agent Leveraging Empathy for eXams) Research Portal uses culturally responsive, virtual community health educators to reach diverse populations.</li> <li class="seamTextUnorderedListItem">Clinicians can utilize the ALEX portal to refer patients to trials. Community health educators can use the portal to help provide information to patients and schedule follow-ups. Patients and family members can use the portal to access key information and make referrals.</li> <li class="seamTextUnorderedListItem">The standard of care portal provides participants with access to existing online cancer clinical trial resources in one location.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05655494' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/inside-clinical-trials/diversity-in-clinical-trials-2/' target='_blank'>Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/inside-clinical-trials/diversity-in-clinical-trials/' target='_blank'>The Lack of Diversity in Clinical Trials</a> </li></ul>
162
Virtual Program to Increase Symptom Management and Health Care Visits for Young Adults with Stage I-III Breast Cancer
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS) Scientific Title
Purpose
To study a digital health program called AYA STEPS, which is designed to help adolescent and young adult (AYA) cancer survivors manage symptoms and receive recommended follow-up care.
Who is this for?
People, age 18-39 years, with stage I, stage II, or stage III breast cancer who have completed all cancer treatments (except hormone therapy if recommended) within the last 3 months and whose diagnosis was 1-5 years ago.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">AYA STEPS, virtual, 6 sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education, virtual, 6 sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 3 months</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">AYA STEPS provides cognitive-behavioral and related skills to improve participants' ability to self-manage symptoms and increase health care visits.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06371768' target='_blank'>ClinicalTrials.gov</a> </li></ul>
163
Integrative Medicine at Home Program for People With Stage I-IV Breast Cancer
Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE) Scientific Title
Purpose
To find out whether the Integrative Medicine at Home program can help reduce symptoms and improve treatment satisfaction.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are currently receiving treatment.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Integrative Medicine at Home program, 3 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Enhanced Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Integrative medicine handout</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Integrative Medicine at Home program offers virtual (online rather than in-person) group classes focusing on mind-body practice.</li> <li class="seamTextUnorderedListItem">Mind-body practice is a health practice that combines mental focus, controlled breathing, and body movements to help relax the body and mind and reduce symptoms such as tiredness (fatigue), pain, or insomnia (sleep problems).</li> <li class="seamTextUnorderedListItem">The classes will be led by an Integrative Medicine Service (IMS) clinical therapist using Zoom video conferencing platform.</li> <li class="seamTextUnorderedListItem">If you are in Group 2, you will be given a handout to encourage you to visit Memorial Sloan Kettering's Integrative Medicine website to access pre-recorded, on-demand meditation videos and audios.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05053230' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine' target='_blank'>Memorial Sloan Kettering Cancer Center: Integrative Medicine</a> </li></ul>
164
Genetic Testing Educational Video for People with Stage I-IV Breast Cancer
Video Education With Result Dependent dIsclosure Scientific Title
Purpose
To study if an educational video improves knowledge of genetic testing for inherited cancer risk and could be used as an alternative to genetic counseling before genetic testing.
Who is this for?
People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have not received genetic testing.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch educational video about genetic testing for inherited cancer risk</li> <li class="seamTextUnorderedListItem">Complete interview, by video or telephone</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 weeks</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive genetic counseling</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 weeks</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The video summarizes the core educational components of a genetic counseling visit.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05225428' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/genomics/gtesting/genetic_testing.htm' target='_blank'>Centers for Disease Control and Prevention: Genetic Testing</a> </li></ul>
165
Understanding the Experience of People with Advanced Breast Cancer Receiving Hospice Care
The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients with Metastatic Breast Cancer Receiving Hospice Care Scientific Title
Purpose
To better understand the in-home hospice experience for people with advanced breast cancer and their caregivers.
Who is this for?
People with advanced (some stage III) or metastatic (stage IV) breast cancer who live in Massachusetts and are planning to receive hospice care at home. Caregivers are also eligible to participate.
Full eligibility criteria
Contact research site
Share with my doctor
Share with my patient
- What's involved?
- What's being studied?
- How can I learn more?
-
<p class="seamTextPara"> You will be assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Telehealth appointments, by Zoom or phone, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Survey, by email or phone</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Usual Care</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Survey, by email or phone</li></ul>
-
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Telehealth check-in appointments will be with your oncology care team (doctor, physician assistant, nurse practitioner, or hospice nurse) by Zoom or phone call.</li></ul>
-
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06507930' target='_blank'>ClinicalTrials.gov</a> </li></ul>
